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The stability and translation of messenger RNA (mRNA) in a cell is partially controlled by an array of 
turnover and translation regulatory RNA-binding proteins (TTR-RBPs). These proteins bind to the 
untranslated regions (UTRs) and poly(A) tail of mRNA and facilitate its processing, nuclear export, 
turnover and translation. Interestingly, a diverse range of viruses utilise different host TTR-RBPs to 
facilitate infection of host cells.  
Human antigen R (HuR) is a TTR-RBP which binds uracil rich sequences in mRNA, leading to increased 
mRNA stability and translation. Mammalian HuR has been shown to bind RNA sequences rich in uracil 
in the 3’UTR of a range of alphavirus genomes. Disruption of this interaction via deletion of the HuR 
binding sequences in the viral genome or knock-down of HuR by RNAi has been to shown to 
significantly decrease virus titre during Sindbis virus (SINV) infection of mammalian cells. Semliki 
Forest virus (SFV) genomic RNA also binds HuR via a uracil rich element (URE) and a conserved 
sequence element (CSE) at the 3’ of its 3’UTR.  
The main aim of this study was to investigate the significance of the URE and CSE of the SFV4 3’UTR 
during SFV4 infection of mammalian cells. This was achieved by engineering rSFV4 mutants with 
deletions of the URE and CSE from the SFV4 3’UTR and a rSFV4 with an additional four UREs in its 
3’UTR. These rSFV4 mutants also expressed a reporter protein, either eGFP or Guassia luciferase for 
detection by confocal imaging and analysis of replication by luciferase assay, respectively.  
Akin to infection with SINV, this study identified that during infection of mammalian cells with SFV4, 
host HuR translocates from the nucleus to the cytoplasm. Infection of NIH/3T3 cells with rSFV4 lacking 
the URE in its 3’UTR resulted in significantly less HuR relocalising to the cytoplasm. A concurrent 
reduction in infectious virions, a reduction in viral RNA abundance, and a reduction in viral gene 
expression was also observed. In comparison, an addition of four UREs to the SFV4 3’UTR, increased 
the rate and amount of HuR relocalising to the cytoplasm post-infection, increased the concentration 
of infectious virions, increased viral RNA abundance and increased viral gene expression. These results 
suggest a significant role for the URE of the SFV4 3’UTR during infection in mammalian cells and 
suggest that the interaction between the URE of SFV4 and host HuR may, at least in part, be 





Mammalian cytoplasmic poly(A) binding protein (PABPC) protects mRNA transcripts from 
deadenylation and 3’ end degradation, facilitates mRNA nuclear export and mRNA translation.  
Infection of mammalian cells with the gammaherpesviruses of the Herpesviridae family results in the 
striking nuclear influx of PABPC from the cytoplasm. During lytic infection of mammalian cells with 
murine gammaherpevirus 68 (MHV-68) the viral protein muSOX elicits shut-off of host gene 
expression. This is achieved by the degradation of bulk host mRNA via an incompletely understood 
mechanism. The expression of muSOX on a transfected expression plasmid also results in the nuclear 
influx of PABPC suggesting a possible link between host shut-off and the nuclear influx of host PABPC. 
The secondary aim of this study was to investigate the role that PABPC may play during the host shut-
off of gene expression elicited by the viral muSOX protein during MHV-68 infection. To investigate 
this, an MHV-68 mutant encoding muSOX with a premature stop codon (MHV-68 ORF37stop) was 
utilised. This study found that the nuclear influx of PABPC during infection of mammalian cells with 
MHV-68 occurred gradually over the course of lytic infection and did not occur during infection with 
MHV-68 ORF37stop virus.  Since gradual nuclear influx of PABPC occurs in mammalian cells following 
a block in mRNA nuclear export, the possibility of MHV-68 causing a block in mRNA nuclear export 
was investigated. By separation of the nuclear and cytoplasmic fractions post-infection and analysis 
of host mRNA abundance by RT-qPCR, no block in mRNA nuclear export was detected during MHV-68 
infection despite PABPC relocalising to the nucleus.   
The roles which TTR-RBPs play during infection of host cells with a range of viruses are still being fully 
elucidated. These results suggest that HuR plays a significant role during Semliki Forest virus infection 







































1.1 DNA and RNA viruses  
Despite being the most abundant entities in the biosphere, viruses can not replicate by themselves 
and require host cells to propagate. Different viruses may consist of different genetic material, either 
DNA or RNA, which can either be single-stranded (ss) or double-stranded (ds), as represented by the 
Baltimore classification of viruses. Interestingly, viruses which infect prokaryotes typically have a 
dsDNA or ssDNA genome, whereas viruses which infect eukaryotes most commonly have a positive-
sense ssRNA (+ssRNA) genome closely followed by ssDNA and dsDNA genomes (Figure 1, Koonin et 












Figure 1.1 The genetic material of viromes. The number of virus genera which infect prokaryotes and 
eukaryotes separated in to the different Baltimore classes of viruses which represent the genetic 
material of the virus. Figure taken from (Koonin et al., 2015).  
 
Both DNA and RNA viruses subvert the normal metabolic processes of the cells they infect to promote 
the efficient replication of their viral genomes and the manufacture of new replicate virions. A diverse 
range of RNA binding proteins that help regulate mRNA decay and mRNA translation, termed 
‘turnover and translation regulatory RNA-binding proteins (TTR-RBPs)’, are targeted by a range of 
viruses to help establish infection (Pullmann et al., 2007; Pullmann and Rabb, 2014). For DNA viruses, 
such as the those of the Herpesviridae family, these proteins do not bind to the viral genome but to 
the viral mRNA after transcription of the viral genome in the nucleus. For RNA viruses, particularly 
21 
 
+ssRNA viruses such as those of the Togaviridae family, the TTR-RBPs can bind directly to the viral 
genome.  
1.2 Taxonomy of eukaryotic viruses 
The taxonomy of eukaryotic viruses is based on a number of factors including the nucleic acid of their 
genomes. The virion structure, virion size, mode of replication, range of host organisms and presence 
of a lipid envelope are also considered. Viruses of the Togaviridae and Herpesviridae both contain an 




















Figure 1.2 Taxonomy of eukaryotic viruses. Eukaryotic viruses are predominantly classified depending 






Arboviruses are transmitted via arthropod vectors to either vertebrates or plants. The three families 
of viruses that contain the majority of arboviruses which infect mammals are Flaviviridae, Reoviridae 
and Togaviridae (Beckham and Tyler, 2015). Many arboviruses are also classified under the new 
Bunyavirales order (originally the Bunyaviridae family). The more clinically relevant arboviruses are 
spread by mosquito, tick and sandfly species (Beckham and Tyler, 2015; Kuno and Chang, 2005). The 
transmission cycle of arboviruses is not always limited to transmission via an arthropod host and can 
less commonly be transmitted through other routes such as ingestion of tissues from infected 
vertebrates (Kuno, 2001). Furthermore, humans are incidental hosts for some alphaviruses because 
significant viremia is not achieved during infection for transmission back to the arthropod vector (Kuno 
and Chang, 2005).  
The Powassan virus (POWV) and the tick-borne encephalitis virus (TBEV) of the Flaviviridae family are 
transmitted by ticks, predominantly by species of the Ixodes and Dermacentor genera (Kemenesi and 
Banyai, 2019; Chitimia-Dobler et al., 2019; Ostfeld and Brunner, 2015). Other viruses of the 
Flaviviridae family are transmitted by mosquitoes. The Aedes aegypti and Aedes albopictus species 
are the most common vectors that spread dengue virus (DENV) and Zika virus (ZIKV) whereas Culex 
pipiens is the principal vector for West Nile virus (WNV) (Higuera and Ramirez, 2019; Ferreira-de-Lima 
and Lima-Camara, 2018; Magalhaes et al., 2018; Vogels et al., 2017). 
Rift Valley fever phlebovirus (RVFV), Crimean-Congo hemorrhagic fever orthonairovirus (CCHFV) and 
sandfly fever Naples phlebovirus (SFNV) of the Bunyavirales order are transmitted via mosquitoes, 
ticks or phlebotomine sandflies respectively (Schoffel et al., 2018; Papa et al., 2017; Tavana, 2015). 
Akin to many viruses of the Bunyavirales order and Flaviviridae family, most alphaviruses of the 
Togaviridae family are spread by arthropod vectors.  
 
1.4 Togaviridae  
Alphavirus is the sole genus of the Togaviridae family of viruses. As of 2019 the International 
Committee on Taxonomy of Viruses (ICTV) recognize that there are 31 species in the Alphavirus genus. 
In 2018 the Rubivirus genus, in which the rubella virus is classified under, was moved from the 
Togaviridae family to the new Matonaviridae family.  Alphaviruses infect a range of vertebrate hosts, 





Alphaviruses have been traditionally divided in to the Old World and New World alphaviruses 
depending on the geographical location in which they were initially prevalent (Powers et al., 2001). 
They are predominantly transmitted via an arthropod host, most commonly the mosquito. A small 
number of alphaviruses are unlikely to be spread by an arthropod host, including sleeping disease 
virus (SDV) and salmon pancreas disease virus (SAV), both of which infect fish (Villoing et al., 2000; 
Weston et al., 1999). The classification and general symptoms of the more clinically relevant 





















Table 1.1 Clinically relevant New World and Old World alphaviruses. Despite some genera of mosquitos 
being the primary vector in transmission cycles of specific alphaviruses in the wild, most alphaviruses are 
capable of being transmitted by a range of mosquito species (Fragkoudis et al., 2008; Wesula Olivia et al., 
2015; Wiggins, Eastmond and Alto, 2018; Weaver and Forrester, 2015; Armstrong and Andreadis, 2010; 
Lim et al., 2018; Kenney, Adams and Weaver, 2010; Torres et al., 2017; Carey et al., 2019). 
Alphavirus 
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There is currently no clinically used antiviral or vaccine for new world alphaviruses but research is 
focused on targeting both the viral proteins themselves as well as virus-host interactions (Carey et al., 
2019). Incidence in humans is currently low, with only several reported cases of eastern equine 
encephalitis virus (EEEV) infections each year (Lindsey, Staples and Fischer, 2018). Despite this, there 
is concern of possible future outbreaks and given the morbidity and mortality following infection with 
some of the new world alphaviruses there is an urgent requirement for successful, regulatory body 
approved vaccines or antivirals. Infection in humans with EEEV, western equine encephalitis virus 
(WEEV) and Venezuelan equine encephalitis virus (VEEV) can also be achieved through aerosol 
dissemination. These features give rise to considerations of the new world alphaviruses as serious 
bioterrorism threats (Sidwell and Smee, 2003; Steele and Twenhafel, 2010).  
The mortality rates for the old world alphaviruses are relatively lower than those of the new world 
alphaviruses but can still elicit severe and persistent symptoms in humans (Herrero et al., 2016). 
Chikungunya virus (CHIKV) is of increasing concern due to recent outbreaks affecting millions of 
individuals worldwide across Africa, Asia (including India and Thailand), several European countries 
and the Americas (Feng et al., 2019). Specific mutations in CHIKV envelope proteins, namely E1-A226V 
and E2-L210Q, and the widespread distribution of Aedes mosquitoes have facilitated CHIKV outbreaks 
(Tsetsarkin et al., 2007; Sahu et al., 2013; Tsetsarkin and Weaver, 2011; Fortuna et al., 2018). The 
arthralgia occurring in many patients following CHIKV infection can persist for many years and cause 
significant decrements to quality of life. Because of its relatively small risk of serious clinical illness in 
humans compared to CHIKV, SFV is often used in the laboratory as a model for old world alphaviruses. 
 
1.4.1.1 Semliki Forest Virus 
Semliki Forest virus (SFV) infection in humans can cause a mild febrile illness characterised by fever, 
headache myalgia and arthralgia. SFV was originally isolated in 1942 from Aedes abnormalis 
mosquitoes resident in the Semliki Forest in Uganda (Smithburn and Haddow, 1944).  
SFV infection has been well studied in vivo in laboratory mice. Following intraperitoneal (ip) 
inoculation of mice, SFV replicates in smooth muscles, endothelial cells and the pancreas resulting in 
high titre plasma viraemia that facilitates its access across the blood-brain barrier (Fazakerley et al., 
2006; Soiluhanninen et al., 1994). SFV is neuroinvasive in mice, replicating in neurones and 
oligodendrocytes and promoting the immune system facilitated demyelination of neurons and viral 
encephalitis (Fazakerley et al., 2006). In vitro, SFV replicates in a broad range of commonly used 
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laboratory cells including NIH/3T3, HEK293, chicken embryo fibroblasts (CEF), Vero and BHK-21 cells 
(Reigel and Koblet, 1979; Barry et al., 2009; Kiiver et al., 2008).  
Several strains of WT SFV exist in laboratory circulation and are categorised by their virulence in adult 
mice.  All strains currently analysed in the laboratory are virulent in neonatal or suckling mice (Bradish, 
Allner and Maber, 1971). Virulent strains in adult mice include Prototype, L10, Osterrieth and V13 
whereas avirulent strains include A7, A7(74), V42 and A8 (Bradish, Allner and Maber, 1971; Deuber 
and Pavlovic, 2007; Glasgow et al., 1991).  
The A7(74) strain was derived through selection for avirulence in adult mice from the AR2066 strain 
isolated from Mozambique in 1959 (McIntosh, Brooke Worth and Kokernot, 1961). A7(74) causes 
limited central nervous system infection in adult mice and is usually cleared by 10 days post infection 
despite remaining virulent in neonatal mice (Fazakerley et al., 1993). The difference for the age-
related difference in disease progression are thought to be a result of the inability of SFV A7(74) to 
complete the replication cycle in mature murine neurons resulting in aggregation of virus particles in 
the cytoplasm (Fazakerley et al., 1993).  
The L10 and Prototype strains were derived from passages in adult mice of the original SFV strain 
isolated from a pool of  Aedes abnormalis mosquitoes from the Semliki Forest in Uganda (Smithburn 
and Haddow, 1944; Bradish, Allner and Maber, 1971). SFV4 is a molecular cDNA clone of the Prototype 
strain (Liljestrom and Garoff, 1991). SFV4 and L10 strains therefore have the same origin as each other 
and show similar replication kinetics in cell culture but varying virulence in adult mice.  
SFV L10 is highly virulent in mice irrespective of age or route of inoculation.  Despite this, SFV4 is only 
neurovirulent in mice in vivo when inoculated intracerebrally or at high doses (Fragkoudis et al., 2007). 
Differences in virulence in mice between the SFV strains have been attributed to nucleotide sequence 
differences in the E1 and E2 glycoprotein genes, the 5’ and 3’ untranslated regions and the non-
structural genes, especially nsP3 (Saul et al., 2015; Tuittila and Hinkkanen, 2003; Tarbatt et al., 1997). 
 
1.4.1.2 Alphavirus virion structure and structural proteins  
High resolution images of alphavirus virions have been achieved by cryo-EM and X-ray crystallography 
(Vaney, Duquerroy and Rey, 2013). Resolution as high as 3.5 Å has been achieved for Sindbis virus 
particles (Chen et al., 2018). The mature virion is 65-70nm in diameter with a molecular mass of 





Viruses have evolved to utilise ribosomal frameshifting to translate additional viral proteins without 
increasing genome size (Chirico, Vianelli and Belshaw, 2010). During translation of 6K in the alphavirus 
structural polyprotein the host ribosome can frameshift resulting in a C-terminal extension of the 6K 
protein (Firth et al., 2008). This novel protein, named transframe (TF), is encoded in the -1 open 
reading frame and terminates the translation of the polyprotein in the C-terminus of E1. SINV TF 
mutants result in reduced mortality rates in infected mammals, and reduced levels of virion release 
following infection in both insect and mammalian cells (Snyder et al., 2013).  The SINV ∆TF mutant 
replicates the viral genome at comparable levels to WT suggesting the reduction in virion levels may 
be related to virion assembly and/or virion budding (Snyder et al., 2013). The arrangement and 
functions of the structural proteins and molecules of the mature virion are summarised in table 1.2. 
The virions are composed of ~11.5 kb positive-strand genomic RNA encapsulated in an icosahedral 
nucleocapsid (NC) made of 240 capsid protein (CP) monomers. The NC is enveloped in a host derived 
lipid bilayer with 240 E1 and 240 E2 protruding viral glycoproteins arranged in 80 spikes making an 
icosahedral lattice anchored in to the NC (Jose, Snyder and Kuhn, 2009).  Each glycoprotein spike is 
composed of three E1-E2 heterodimers and contain transmembrane helixes which span the lipid 
bilayer. The glycosylation pattern of E1 and E2 differs between viruses of the genus and can affect the 
level of infectivity in different mammalian and arthropod species (Mukhopadhyay et al., 2006; Vaney, 
Duquerroy and Rey, 2013). E1 and E2 are also palmitoylated at or near to their transmembrane 
domains (Schmidt, Bracha and Schlesinger, 1979).  
A viral 6kDa membrane-associated protein, 6K, associates with E1-E2 spikes at the endoplasmic 
reticulum and is partially retained in low numbers in the mature virion (Lusa, Garoff and Liljestrom, 
1991). An SFV ∆6k mutant forms unstable infectious virions with altered E1-E2 spike structure and 












Table 1.2 The functions of structural components of the alphavirus virion. The alphaviruses are 
enveloped, small, spherical virions composed of multiple structural proteins that convey a multitude of 
interconnected functions in virion assembly and infection (Mukhopadhyay et al., 2006; Vaney, Duquerroy and 
Rey, 2013; Ziemiecki, Garoff and Simons, 1980; Kielian and Rey, 2006; Voss et al., 2010; Li et al., 2010; Sjoberg, 
Lindqvist and Garoff, 2011; Zhang et al., 2011; Tang et al., 2011; Myles, Pierro and Olson, 2003; Loewy et al., 








Glycoprotein forming viral surface 
spikes. 
Ectodomain contains class II fold and 
three domains in a linear arrangement 
and transmembrane helix embedded in 
lipid bilayer. 
Fusion loop. 
E1 ectodomain forms a protein lattice covering most of lipid 
bilayer. 
Fusion of the virion envelope with host endosomal membrane 
via fusion loop.  Fusion loop hidden at the E1-E2 interface at 
normal pH but exposed at low pH (i.e. in endosomes after cell 
entry). 
E2 
Glycoprotein forming viral surface 
spikes. 
Ectodomain contains three domains (A, 
B and C) in linear arrangement with Ig 
superfamily-type folds. 
Transmembrane helix embedded in 
lipid bilayer. 
Receptor binding and subsequent receptor-mediated 
endocytosis for cell entry. 
Most neutralising antibodies are targeted against E2 
Residues interact with CP for structural scaffolding and to drive 
budding. 
Varying amino acid sequence and glycosylation of E2 among 
alphaviruses can confer varying tissue and species specificity. 
E3 
Polyprotein with E2 until trans-Golgi 
network. 
Prevents p62/P1 from priming for fusion in the acidity of the 
golgi network by bracing domain B of E2 on to E1 fusion loop. 
Cleaved from p62 at trans-Golgi network through the action of 
furin but has some affinity for E2 post cleavage. 
Identified in mature virions including SFV and VEEV, suggesting 
some E3 may be retained. 
p62 (in SFV, 
pE2 in other 
alphaviruses) 
Precursor to E2 and E3. 
p62 interacts with folded E1 in the ER to form p62-E1 
heterodimer. 
E3 cleaved by furin in the Golgi, followed by E1-E2 priming for 
fusion at low pH and translocation of E1-E2 heterodimers to 
the plasma membrane. 
Capsid 
protein (CP) 
Forms the case of the nucleocapsid. 
Chymotrypsin-like C-terminal domain 
with a hydrophobic pocket. 
Highly basic N-terminal tail. 
Chymotrypsin-like domain functions as a serine protease which 
autocleaves the CP from its polyprotein. 
Disordered N-terminal tail interacts with viral genomic RNA. 
Residues interact with E2 for virion formation and to drive 
budding. C-terminal domain has hydrophobic pocket that binds 
the C-terminal domain of E2 in mature virion. 
6K peptide 
Two transmembrane domains, one 
lumenal domain, and one 
palmitoylated cytoplasmic domain. 
Translated to comparable 
concentrations to E1 and E2 yet mostly 
omitted from mature virion. 
Reduced infectivity and stability of virion following deletion of 
6K peptide in SFV. 
Forms cation-selection ion channels in lipid bilayers that and 
thus may be involved in virion formation and budding. 
May facilitate ability to infect multiple species, i.e. a range of 
mammalian and arthropod species. 
TF 
Protein translated by frameshifting to 
extend the C-terminus of 6K. 
Proposed roles in virion assembly and/or release. 
SINV ∆TF confers reduced mortality rates in mammals 
compared to WT. 
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1.4.1.3 Alphavirus non-structural proteins 
All four viral non-structural proteins (nsPs) are required for viral RNA replication as first determined 
using SINV temperature sensitive mutants (Hahn, Strauss and Strauss, 1989; Rupp et al., 2015). 
Despite working cooperatively to form the viral RNA replication complexes, the nsPs also have their 
own individual functions and subcellular locations during infection.  
nsP4 elicits the RNA-dependent RNA polymerase activity required for viral RNA replication. Despite 
this the nsP4 alone is not capable of replicating the viral RNA during infection and functions as part of 
replicase complexes with the other viral nsPs (Rupp et al., 2015).  The P123+nsP4 replicase complex 
synthesises negative strand RNA from the full viral RNA genome. Following further cleavage of P123, 
complexes of nsP1+P23+nsP4 and nsP1+nsP2+nsP3+nsP4 both synthesise positive strand genomic and 
subgenomic viral RNA (Shirako and Strauss, 1994). The synthesis of the subgenomic positive sense 
RNA is in part selected for by nsP2 which acts as a transcription factor recruiting the 
nsP1+nsP2+nsP3+nsP4 replicase complex to the negative sense subgenomic promoter sequence 
(Suopanki et al., 1998). The core catalytic domain of nsP4 also possesses terminal adenylyltransferase 
(TATase) activity suggesting roles in the maintenance of poly(A) tails on viral RNAs (Tomar et al., 2006).  
The viral nsP1 contains Rossman-like methyltransferase (MTase) and guanylyltransferase (GTase) 
domains that catalyse the addition of a methylated guanine cap to the 5’ of viral genomic and 
subgenomic RNAs  (Rozanov, Koonin and Gorbalenya, 1992; Rupp et al., 2015). nsP1 also contains an 
amphipathic helix and palmitoylation site which allow for nsP1 and the replicase complexes to be 
anchored in to host cell membranes (Ahola et al., 1999; Spuul et al., 2007; Kiiver et al., 2008). Nascent 
viral RNAs are prepared for nsP1 mediated capping by removal of a 5’ phosphate group through the 
nucleoside triphosphatase (NTPase) activity of nsP2. The NTPase domain is located at the N-terminus 
of nsP2 along with a helicase domain whereas the C-terminus contains a protease domain (Russo, 
White and Watowich, 2006; Saisawang et al., 2015; de Cedron et al., 1999). Other putative domains 
exist within the protein with unconfirmed functions (Rupp et al., 2015). The helicase and NTPase 
domains unwind viral RNA secondary structures during viral RNA replication. The protease activity of 
nsP2 is required for the proteolytic processing of the non-structural polyprotein (Saisawang et al., 
2015; Vasiljeva et al., 2003). The cleavage of the non-structural polyprotein by nsP2 can occur in both 
trans and cis depending on the cleavage site and the virus species. The site of the nsP3-nsP4 junction 
is preferentially cleaved early in infection whereas the nsP2-nsP3 junction is preferentially cleaved 
later in infection (Vasiljeva et al., 2003). 
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Multiple domains of nsP2 are utilised to elicit inhibition of host transcription (Tamm, Merits and 
Sarand, 2008). During infection nsP2 resides in the cytoplasm and on host lipid membranes within 
replication complexes but also partially translocates to the nucleus during infection (Peranen et al., 
1990). Nsp2 of Sindbis virus (including SFV nsP2 on a VEEV icDNA) has been shown to interact with 
Rbpb1, the catalytic subunit of RNAPII. This interaction results in the ubiquitination and subsequent 
degradation of Rbpb1 and global transcription inhibition (Akhrymuk, Kulemzin and Frolova, 2012).  
Akin to the other nsP’s, mutations in nsP3 result in defects in viral RNA synthesis. The functions of 
nsP3 during infection are less well defined than for the other nsP’s. The C-terminus of nsP3 comprises 
a hyper-variable domain (HVD), the centre contains a zinc-binding domain and the N-terminus 
contains a macrodomain. The HVD has been attributed to multiple interactions with host cell proteins 
early in infection (Gotte, Liu and McInerney, 2018). The degradation and thus controlled expression 
of nsP3 in some alphaviruses, including SFV4, is partially controlled through a degradation signal at 
the C-terminus of the protein (Varjak, Zusinaite and Merits, 2010). The subcellular location of nsP3 
during infection is either at the active sites of viral RNA replication as part of the replicase complexes 
on internal host cell membranes or in nsP3 cytoplasmic aggregates (Gotte, Liu and McInerney, 2018). 
In SFV, the majority of nsP3 is found at replication complexes and colocalises with dsRNA (Salonen et 
al., 2003; Gotte, Liu and McInerney, 2018). This feature allows for the identification of the subcellular 
location of replicase complexes during SFV infection through identification of the subcellular location 
of nsP3.  
nsP3 elicits RNAi suppressor activity in mosquito cell lines and mutations in nsP3 nucleotide sequence 
can affect vector specificity indicating important roles of nsP3 during infection of mosquito cells 
(Lastarza, Grakoui and Rice, 1994; Mathur et al., 2016). The nucleotide sequence of nsP3 has also been 
shown to be a key regulator of neurovirulence in mice between different SFV strains. The replacement 
of nsP3 from neurovirulent strains of SFV like SFV4 to the avirulent A7(74) strain result in a 
neurovirulent A7(74) mutant (Tuittila et al., 2000; Saul et al., 2015).  
In mammalian cells, there are multiple nsP3-host interactions that facilitate infection and inhibit the 
host cell antiviral response (Gotte, Liu and McInerney, 2018). One well defined nsP3 interaction is with 
the isoforms of Ras GTPase-activating protein-binding protein (G3BP). This interaction inhibits G3BP’s 
roles in stress granule formation leading to the disassembly of stress granules during alphavirus 






Table 1.3 The summarised functions of the alphavirus non-structural proteins and non-structural 
polyproteins. Each viral nsP has individual functions during infection as we as functioning as part of 
RNA replicase complexes. Most function in the cytoplasm or on host membranes apart from nsP2 
which partially translocates to the nucleus to inhibit host transcription. 
 
1.4.1.4 Alphavirus genome organisation 
The alphavirus genome is encoded on single stranded positive sense RNA. The genomic RNA contains 
a 7-methyl-GpppA cap and a poly(A) tail that mimics host mRNA. There are two open reading frames 
encoding the polyproteins for the non-structural proteins required for RNA synthesis and the 
structural proteins encoding new virus particles (Pietla, Hellstrom and Ahola, 2017). The structural 
polyprotein is under the control of a subgenomic promoter present in the negative strand RNA 
replication intermediate.  
 
Non-structural protein Function 
 
nsP1 
Methyltransferase and Guanyltransferase. 
Anchoring of replicase complexes to host membranes 




Transcription Factor for subgenomic viral RNA replication 
NTPase and Helicase 
Protease (used for proteolytic processing of non-structural 
polyproteins) 
Inhibition of host transcription/gene expression 
Component of viral RNA replicase 
 
nsP3 
Component of viral RNA replicase 
Interaction with a range of host proteins including G3BP leading to 
disassembly of stress granules 
Key virulence determinant  
 
nsP4 
RNA dependent RNA polymerase  
Component on viral RNA replicase 
TATase activity 
P123+nsP4 Short lived, negative viral RNA synthesis 
nsP1+P23+nsP4 Very short lived, transient complex 





Figure 1.3 The schematics of the alphavirus genome. The ss(+)RNA genome encodes two polyproteins 
under the control of a genomic and subgenomic promoter and mimics host mRNA. 
 
Many alphaviruses including most strains of CHIKV have an opal stop codon at the 3’ of the nsP3 
genome sequence (Jones et al., 2017). The opal stop codon causes translation to terminate after nsP3 
yielding P123 polyprotein. There is a read through efficiency of 15% which yields the full P1234 
polyprotein (Kim et al., 2004). SFV4 encodes an arginine codon at this position so does not translate a 
P123 polyprotein and instead constituently translates the full P1234 polyprotein. The avirulent SFV 
A7(74) strain encodes an opal stop codon at this position and substitution with an arginine codon 
increases pathogenicity suggesting a role in SFV pathogenesis in mice (Gotte, Liu and McInerney, 2018; 
Tuittila and Hinkkanen, 2003). 
1.4.1.5 Cis-acting RNA elements in Alphavirus RNA 
Multiple cis-acting RNA sequences and RNA secondary structures present in the alphaviral genomic 
RNA, subgenomic RNA and negative sense RNA replication intermediate elicit roles in alphavirus 
replication. The RNA sequences and secondary structures mostly function via interaction with viral or 
host trans-acting proteins. Some of these sequences exist in the coding regions of the viral RNA but 
many are also located in the untranslated regions (UTR’s).  Four of these RNA sequences and/or RNA 
secondary structures are conserved amongst virus species in the alphavirus genus and termed 
conserved sequence elements (CSE’s). There are three untranslated regions in the alphavirus genome; 
the 5’UTR, the 3’UTR and a junction region in between the non-structural and structural polyprotein 
sequences. 
Conserved RNA sequence elements (CSEs) in the alphavirus genome 
At the 5’ of the alphavirus RNA genome a CSE (CSE1) consisting of approximately the first 44 nt in the 
5’UTR shows conserved secondary structure (Ou, Strauss and Strauss, 1983). CSE1 forms a stem-loop 
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structure and has proposed roles as a promoter for positive strand synthesis on the negative strand 
template (Jose, Snyder and Kuhn, 2009).  A 51nt CSE (CSE2) exists within the coding region of nsP1 
near the 5’ end of the genome. This CSE (CSE2) functions as an enhancer element for RNA synthesis 
(Frolov, Hardy and Rice, 2001; Michel et al., 2007). Mutations in the alphavirus CSEs have been shown 
to have different degrees of inhibition on viral replication depending on the species of the host cell. 
For instance, mutations to the 51 nt CSE of SINV result in a greater inhibition on viral replication in 
mosquito cell lines than mammalian cell lines (Fayzulin and Frolov, 2004). These differences suggest 
that the CSE elements interact in trans with host cell proteins.  
There is also a 24 nt CSE (CSE3) located in the junction region between the non-structural and 
structural polyprotein ORFs. This conserved sequence acts as a highly efficient subgenomic promoter 
sequence in the negative strand for the subgenomic structural polyprotein (Levis, Schlesinger and 
Huang, 1990; Raju and Huang, 1991; Wielgosz, Raju and Huang, 2001).  
Finally, a conserved 19 nt (CSE4) resides at the 3’ end of the 3’UTR adjacent to the poly(A) tail. This 
sequence is heavily conserved among all alphavirus species and has been proposed to act as an RNA 
promoter for negative strand synthesis (Hill et al., 1997; Lemm et al., 1998). This CSE also contains 
uracil (U)‑rich regions known to interact with host cell RNA binding proteins including the host protein 
Human antigen R (HuR) (Dickson et al., 2012). The 19nt CSE of Sindbis virus has been shown to be 
required for negative strand synthesis through experiments utilising full or partial CSE deletion SINV 
mutants (Hardy and Rice, 2005). These findings support a role for the CSE as a copromoter for negative 
strand RNA synthesis.  
Other groups have shown that SINV lacking part (Kuhn, Hong and Strauss, 1990) or all (Raju et al., 
1999) of the 19nt CSE in its 3’NTR is still able to produce viable virus and propagate an infection of 
BHK‑21 cells. Following a number of passages some but not all of these SINV CSE deletion mutants 
gained AU‑rich additions to their 3’NTR (Raju et al., 1999; George and Raju, 2000). These data suggest 
that although not absolutely required for infection in BHK‑21 cells the CSE is important for viral RNA 
replication and the AU‑richness of the CSE plays an important role in its function. 
Other RNA elements in the alphavirus RNA genome 
An RNA packaging signal interacts with capsid protein during nucleocaspid formation. This RNA 
element varies in position amongst alphavirus species but usually resides in the 5’ of the genome so 
that only full genomic RNA is encapsulated in to virion particles (Weiss et al., 1989; Linger et al., 2004). 
Many alphaviruses have 40-60 nt repeated sequence elements (RSEs) in their 3’UTR (Ou, Trent and 
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Strauss, 1982). The function of the RSEs are mostly unconfirmed but show RNA secondary structure 
and are thought to interact with host cell proteins (Ou, Trent and Strauss, 1982; Rupp et al., 2015).  
To the immediate 5’ of the 3’ CSE (CSE4) is an adjacent uracil rich region that is conserved amongst 
most of the old world and new world alphaviruses. This uracil rich element (URE) is evident in this 
position in WEEV, EEEV, VEEV, Highlands J virus (HJV), Middelburg virus (MIDV) SINV and SFV (both 
SFV4 and A7 strains) amongst others (Santagati et al., 1994; Ou, Trent and Strauss, 1982). Alphavirus 
URE and CSE (CSE4) RNA sequence fragments from WEEV, VEEV, EEEV, SINV and SFV have been shown 
to bind the host protein HuR (Sokoloski et al., 2010). Furthermore, during mammalian cellular 
infection with WEEV or SINV the bulk of cellular HuR relocates to the cytoplasm from the nucleus. The 
cytoplasmic build-up of host HuR is also evident during CHIKV and RRV infection despite the absence 
of a URE in this position in the 3’UTR in these viruses. However, CHIKV and RRV contain other uracil 
rich regions elsewhere in their 3’UTRs. These alternative uracil rich regions and the CSE4 have been 
shown to bind HuR despite lacking the conserved URE seen in other alphaviruses (Dickson et al., 2012). 
The sequence and position of the URE, CSE4 and the RSEs in the SFV4 3’UTR are illustrated in figure 







GREY = RSE     Green = URE     Blue = CSE (CSE4)     
Figure 1.4 The 3’UTR of SFV4 genome. The Uracil rich element (URE) and conserved sequence element 
(CSE) are uracil and adenine rich and are known to bind host HuR. The repeated sequence elements 
have no confirmed function. Sequence taken from NCBI Accession Number: NC_003215.1. 
 
1.4.1.6 Alphavirus replication in mammalian cells 
In mammalian cells alphaviruses have a life cycle consisting of attachment, entry, replication, 
assembly of virions and budding off the plasma membrane. The alphavirus virion binds to host cell 
receptors via E2. Interaction with host-cell receptors induces conformational changes of the E1-E2 
spikes (Li et al., 2010).  Following clathrin-dependent receptor-mediated endocytosis (De Tulleo and 
Kirchhausen, 1998), the virion enters the cell encapsulated in an endosome. Alphaviral surface 
proteins embedded in endosome membrane form cation permeable pores leading to a net loss of 
35 
 
cations to the cytoplasm and lowering the pH of the endosome (Wengler, Koschinski and Dreyer, 
2003). The low pH of the endosome induces further conformational change in the E1-E2 glycoprotein 
heterodimer spikes resulting in their dissociation and the exposure of the fusion loop of E1 (Li et al., 
2010; Gibbons et al., 2004). The fusion loop inserts in the endosomal membrane and initiates fusion 
of the viral lipid membrane with the endosomal membrane (Vaney, Duquerroy and Rey, 2013; Kielian 
and Rey, 2006). Of note, the low pH may not be required for fusion in mosquito cells (Hernandez, Luo 
and Brown, 2001). Post fusion the NC is released in to the cytoplasm where it disassembles, possibly 
through interaction with ribosomes (Wengler and Wurkner, 1992) or through priming for disassembly 
from the acidic environment of the endosome during cell entry (Melton et al., 2002; Wengler and 
Gros, 1996).  
Depending on the alphavirus species and strain, the full genomic RNA is translated to produce either 
one non-structural polyprotein; P1234, or two non-structural polyproteins; P1234 and P123. The latter 
is a result of an opal termination codon that exists to the immediate 3’ of the nsP3 ORF sequence with 
a readthrough efficiency of around ~15%. Termination of translation at this sequence yields a 
truncated form of the full non-structural polyprotein. SFV4 contains an arginine codon instead of the 
opal stop codon which is present in other strains of SFV such as SFV A7(74). Insertion or deletion of 
the opal stop codon in various strains of alphaviruses have been shown to affect replication, pathology 
and tissue specificity (Jones et al., 2017). 
Alphavirus replication occurs in the cytoplasm. Replication complexes form on smooth membranes 
(spherules) within type 1 cytopathic vacuoles (CPV-1) (Kujala et al., 2001). In sindbis virus (SINV) and 
SFV infection these are thought to initially develop at the plasma membrane and then move more 
internally in to the cytoplasm via endosomal‑lysosomal compartments (Frolova et al., 2010). These 
structures help prevent recognition of viral dsRNA (a replication intermediate) from the cell innate 
immune defences which recognise dsRNA as pathogen associated molecular pattern (PAMP) (Akira 
and Hemmi, 2003). 
The non-structural polyprotein is cleaved in cis by the papain-like cysteine protease at the C-terminal 
domain of nsP2. The full polyprotein, the partially cleaved polyprotein intermediates and the 
individual nsPs are all involved viral replication (Pietla, Hellstrom and Ahola, 2017). A replication 
complex consisting of P123 polyprotein and nsP4 synthesise minus-strand RNA early in infection. As 
P123 is cleaved in to individual viral proteins a replication complex of the individual nsPs forms the 
replicase responsible for plus-strand viral RNA synthesis (Pietla, Hellstrom and Ahola, 2017). This 
ensures plus-strand genomic RNA and plus-strand subgenomic RNA are produced later in cellular 
infection, with subgenomic RNA in roughly a three-fold excess to full genomic RNA (Pietla, Hellstrom 
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and Ahola, 2017). A role for RNAse-L in the switch from negative to positive sense viral RNA synthesis 
has also been postulated (Sawicki et al., 2003).  Cleavage of the polyproteins to yield individual nsPs 
is required for some of the individual viral nsP functions (other than replicase formation) during 
infection (Gorchakov et al., 2008).  
Association of the replication complexes with membranes in the CPV1 spherules is required for their 
activity and hence visualisation of nsP3 during infection identifies the location of the replication 
complexes (Pietla, Hellstrom and Ahola, 2017).  The compact nature of the spherules prevents most 
host proteins interacting with the active viral RNA replication however a small number of host factors 
can be identified within replication spherules. Host G3BP1 and G3BP2 are present in replication 
spherules and interact with the C-terminal domain of nsP3 (Pietla, Hellstrom and Ahola, 2017). This 
interaction also inhibits stress granule formation during infection (Fros et al., 2012). Other host 
proteins known to interact with the viral RNA and viral RNA replicase complexes include PCBP1, hnRNP 
M, hnRNP A1, hnRNP K and hnRNP C (Varjak et al., 2013). Futhermore, hnRNP A1 has been shown to 
play significant roles in SINV RNA synthesis and bind to the viral genomic and subgenomic promoters 
(Lin et al., 2009; Gui et al., 2010).  
The N-terminal domain of nsP2 utilises its RNA triphophatase activity to prepare viral RNAs for 
5’capping by removing the 5’ gamma-phosphate of nascent viral RNAs (Vasiljeva et al., 2000). Nsp1 
anchors in the membranes of replication complexes and facilitates the 5’capping and cap methylation 
of genomic and subgenomic viral RNAs using its innate guanine-7-methyltransferase and 
guanyltransferase enzymatic activities (Cross, 1983; Ahola et al., 1999; Jose, Snyder and Kuhn, 2009).  
Host HuR protein binds to uracil rich elements in the 3’UTR of full genomic and subgenomic positive 
strand viral RNA. This stabilises the viral RNA and may facilitate translation of the viral polyproteins. 
HuR is then bound to the viral RNA and so builds-up in the cytoplasm. 
Following the replication of the subgenomic RNA the structural polyproteins, CP-p62-6K-E1 and CP-
p62-TF, are produced in large quantities. The capsid protein is released from these polyproteins by 
autoproteolysis and the new N-terminus signals the sequence for insertion in to the ER membrane. 
The translated p62 interacts with folded E1 in the ER to form p62-E1 heterodimers (Ziemiecki, Garoff 
and Simons, 1980; Li et al., 2010). Three p62-E1 heterodimers interact and develop in to trimeric p62-
E1 spikes which translocate to the Golgi apparatus. In the trans-Golgi network p62 is cleaved by furin 
to release E3, forming (E1-E2-E3)3 spikes and subsequent (E1-E2)3 spikes at neutral pH, priming the 
E1-E2 trimeric spike for fusion at low pH (Mulvey and Brown, 1996; Vaney, Duquerroy and Rey, 2013; 
Voss et al., 2010; Sjoberg, Lindqvist and Garoff, 2011). The E1-E2 trimeric spikes are transported in 
vesicles to the plasma membrane. 
37 
 
In the cytoplasm newly synthesised full genomic RNA interacts with capsid protein via a packaging 
RNA signal sequence in the viral RNA to form the nucleocapsid. Residues of C in the nucleocapsid 
interact with E2 at the plasma membrane during the formation of virions and help drive budding (Tang 






















Figure 1.5 Alphavirus infection of a murine fibroblast cell. Following endocytosis, the viral genome is 
released in to the cytoplasm where host ribosomes translate the non-structural polyprotein. Replicase 
complexes formed from the nsPs replicate negative strand RNA and subsequently full genomic and 
subgenomic positive strand RNA. The structural proteins translated from the subgenomic RNA are 
processed and matured in the ER and golgi apparatus and exported to the host cell membrane. Newly 
formed full genomic RNA interacts with capsid protein forming the nucleocapsid. The nucleocapid 






The Alpha-, Beta- and Gamma-herpesvirinae are the three subfamilies of viruses that exist in the 
Herpesviridae family, part of the Herpesvirales order. A key feature of herpesviruses is their ability to 
elicit lytic replication while also establishing latency in a subset of host cells (Ackermann, 2006).  
1.5.1 Alphaherpesvirinae and Betaherpesvirinae 
Herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2) and varicella-zoster virus 
(VSV) are the clinically relevant human herpesviruses in the Alphaherpesvirinae subfamily (Enquist et 
al., 1999). These viruses establish latent infection in the peripheral nervous system of the host 
remaining there until death of the host and reactivating lytic replication intermittently.  
Human herpesviruses 6 and 7 (HHV-6 and HHV-7) and cytomegalovirus (CMV) are the clinically 
relevant human herpesviruses in the Betaherpesvirinae subfamily (Santos, 2016). CMV infection can 
result in several end-organ diseases such as hepatitis, gastrointestinal ulceration and pneumonitis 
(Clement and Humphreys, 2019). 
1.5.2 Gammaherpesvirinae 
There are four genera in the gammaherpesvirinae subfamily; Lymphocryptovirus, Macavirus, 
Percavirus and Rhadinovirus. The two clinically relevant human viruses in this subfamily are human 
gammaherpesvirus 8 (HHV-8, also known and referred to in this report as Kaposi’s sarcoma associated 
herpesvirus (KSHV)) of the Rhadinovirus genus and human gammaherpesvirus 4 (HHV-4, also known 
and referred to in this report as Epstein-Barr virus (EBV)) of the Lymphocryptovirus genus. The host 
range for gammaherpesviruses is diverse including mammals, birds and amphibians.  
Many gammaherpesviruses are of importance in veterinary medicine. For instance, the alcelaphine 
gammaherpesvirus 1 (AlHV-2) and ovine gammaherpesvirus 2 (OvHV-2) of the Macavirus genus are 
both agents of malignant catarrhal fever (MCF), a fatal lymphoproliferative disease, in wildebeest and 
sheep respectively (Mushi and Rurangirwa, 1981; Ackermann, 2005; Bildfell et al., 2017). Most 
information regarding host interactiions during infection with gammaherpesviruses comes from 
research using HHV-4, HHV-8 and murine gammaherpesvirus 68 (MHV-68).  
KSHV is causative agent of four human diseases; Kaposi’s sarcoma, multicentric Castleman’s disease, 
KSHV inflammatory cytokine syndrome and primary effusion lymphoma (Taylor and Blackbourn, 
2011). Kaposi’s sarcoma was first identified in AIDS patients and generally only presents in 
immunocompromised patients. Multicentric Castleman’s disease is a lymphoproliferative disorder 
and primary effusion lymphoma is an aggressive B-cell lymphoma (Ali and Rayes-Danan, 2016). 
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Epstein–Barr virus (EBV) is one of the most common viruses found in humans, infecting B cells and 
epithelial cells (Ackermann, 2006). EBV is a causative agent for several lymphoproliferative diseases 
such as Hodgkin’s lymphoma, hemophagocytic lymphohistiocytosis and Burkitt’s lymphoma. EBV can 
also cause hairy leukoplakia and central nervous system lymphomas in immunocompromised patients 
(Taylor and Blackbourn, 2011).  
 
1.5.2.1 MHV-68 
Murid gammaherpesvirus 68 is in the Rhadinovirus genus and considered a model virus for studying 
the pathogenesis of gammaherpesviruses in mammalian host cells. Despite this MHV-68 was first 
isolated from bank voles (Myodes glareolus) in Slovaki and then passaged through a mouse brain 
(Terry et al., 2000; Blaskovic et al., 1981). While both Myodes glareolus of the Cricetidae family and 
Mus musculus of the Muridae family are both from the Rodentia Order, these species are from 
different families. Four other murine gammaherpesvirus strains were isolated at the same time in 
Slovakia as MHV-68 (Blaskovic et al., 1981). These murine herpesviruses were shown to be closely 
antigenically related by complement fixation and viral neutralization experiments (Svobodova et al., 
1982). After initially being classed as an alphaherpesviruses (Svobodova, Blaskovic and Mistrikova, 
1982) they, along with MHV-68, were later sequenced and identified as gammaherpesviruses (Virgin 
et al., 1997).  MHV-68 was then selected for use in future research.  
 
1.5.2.3 Genome and virion structure of gammaherpesviruses 
The gammaherpesviruses have a linear, monopartite, double-standed DNA (dsDNA) genome of ~180 
kbp. The genome is encapsulated by capsid proteins to form the nucleocapsid. This is surrounded by 
an amorphous protein layer called the tegument (Liu and Zhou, 2007). Herpesviruses also have an 
outer lipid envelope derived from the host cell membrane. The genome contains internal and terminal 
reiterated DNA sequences that act as origins of replication (White, Calderwood and Whitehouse, 
2003). The large size of the dsDNA genome allows gammaherpesviruses to encode most of their viral 
proteins from individual DNA promoters with individual transcription start sites (Ueda, 2018). These 
genes are transcribed in to separate mRNA transcripts encoding 5’ and 3’ UTRs and a poly(A) tail.  
Some of the open reading frames (ORFs) overlap and some of the coding regions of genes overlap 
within the same ORF. Furthermore, some ORFs can be encoded from more than one promoter and 
many of the ORFs are antisense to each other (Arias et al., 2014). These features maximize the coding 
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capacity of the genome size allowing for a relatively large number of viral proteins with high capacity 
for gene regulation compared to the 10 individual viral proteins encoded by alphaviruses. Most genes 
are not spliced but some splicing and splice variants do occur (Majerciak and Zheng, 2016). 
During the evolution of gammaherpesviruses many host genes have been taken and incorporated in 
to the viral genomes. For instance, KSHV encodes a complement binding protein, cyclin-D, BCL-2, a G 
protein coupled receptor, Flice inhibitory protein and interferon regulatory factor, all of which are 
believed to have originated from the host genome (Cannon, 2007; Ueda, 2018). MHV-68 encodes over 
80 genes, ORF 4-69 have homologs in KSHV and M1-M14 are believed to be MHV-68 specific genes 
although similar proteins exist in other gammaherpesviruses (Virgin et al., 1997). 
 
1.5.2.4 Replication of gammaherpesviruses 
Infection of laboratory mice with MHV-68 via intranasal inoculation initiates with virus replication in 
the lung that yields high titres of infectious virus. Concomitant with lytic infection, the virus establishes 
latent infection within epithelial and B cells in the lungs. From the lungs, the virus spreads to the spleen 
where latency is established within B cells (Hughes et al., 2010). 
Different glycoproteins mediate attachment and entry of gammaherpesvirus virions to different cell 
types. Some of these glycoproteins are indispensable for viral entry to certain cell types whereas 
others are not. For instance the homologs gp150, K8.1 and gp350 from MHV-68, KSHV and EBV 
respectively, mediate efficiency of attachment and entry of virion particles to specific cell types such 
as B cells but are not indispensable for replication (Carel et al., 1990; Stewart et al., 2004; Luna et al., 
2004). Host cell factors utilised by KSHV for cell entry include heparan sulfate (HS), integrins (α3β1, 
αVβ3 and αVβ5), and EphA2 receptor tyrosine kinase (EphA2R) (Kumar and Chandran, 2016).  
Following cell entry, the virus capsid protein is uncoated, and the DNA enters the host cell nucleus. 
Viral DNA is synthesised in the nucleus and viral mRNAs are exported out the nucleus to be translated 
on host ribosomes (Flemington, 2001). The viral genes have been appointed to three groups 
depending on the time of expression during lytic infections. These are immediate-early, early and late 
genes but most of the viral genes are still expressed at lower concentrations at other times points (de 
Mello, Bloom and Paixao, 2016).  Capsid proteins enter the nucleus and combine with viral genomes 
to form new nucleocapsids (Peng et al., 2010). The nucleocapsid buds through the nuclear membrane 
and then also through cellular membranes of the golgi apparatus before leaving the cell.  
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Gammaherpesviruses also establish latent infection in a subset of host cells. After KSHV lytic infection 
the virus enters lymphocytes and via expression of the viral latency-associated nuclear antigen (LANA) 
establishes latency (Wei et al., 2016). Gammaherpesvirus genomes exist as circular pieces of DNA 
called episomes which are tethered to cellular chromosomes via LANA (or the LANA homolog in MHV-
68) (Ponnusamy et al., 2015). External stimuli such as inflammation are believed to stimulate the virus 
to re-enter lytic replication. ORF50 replication transactivation activator (RTA) is known to be the 
primary viral protein responsible for lytic reactivation (Wu et al., 2000). Following expression of RTA, 
it activates synthesis of a cascade of viral proteins that drive viral replication. 
 
1.6 Mammalian mRNA  
1.6.1 Mammalian mRNA maturation 
The process of mammalian mRNA maturation includes capping, splicing and polyadenylation to yield 
mature mRNA. Within the cell these processes do not occur independently but rather begin co-
transcriptionally the moment the new nascent immature pre-mRNA emerges from the RNA 
polymerase (Carmody and Wente, 2009).  
Mammalian mRNA is synthesised during host gene transcription by RNA polymerase II. This 
polymerase recognizes a core promoter region just upstream of transcription start sites. The 
polymerase assembles on the promoter with the assistance of host transcription factors that bind this 
region. Transcription factors also bind proximal and distal promoter sequences that lie further 
upstream of the transcription start site (Martinez, 2002). Transcription initiation precedes 
phosphorylation of the C-terminal domain (CTD) of RNA polymerase II (Lee and Young, 2000) leading 
transcription elongation and the synthesis of a nascent pre-mRNA transcript (Casamassimi and Napoli, 
2007).   
The mammalian capping enzyme complex is recruited to the pre-mRNA via the phosphorylated CTD 
of RNA polymerase II and adds a guanine nucleotide via a 5’ to 5’ triphosphate linkage which is then 
methylated by methyl transferase. The cap not only inhibits RNA degradation from 5’ to 3’ 
exonucleases but it is also bound by the cap-binding complex (CBC) (Coller and Parker, 2004). The CBC 
is recognized by splicing proteins, mRNA export proteins and the translation initiation factor eIF4E 
(Pabis et al., 2013). The pre-mRNA undergoes splicing to remove a selection or all of the introns in the 
pre-mRNA. This is most commonly catalysed by the spliceosome (a complex of small nuclear 
ribonucleoproteins (snRNP’s) (Zheng, 2004). 
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 A ~250 nt or longer poly(A) tail is synthesised on the 3’ end of the mRNA by polyadenylate polymerase 
and poly(A) binding protein nuclear 1 (PABPN1) (Eckmann, Rammelt and Wahle, 2011). Poly(A) binding 
protein cytoplasmic 1 (PABPC1) and poly(A) binding protein cytoplasmic 4 (PABPC4) bind the poly(A) 
tail in the nucleus and facilitates nuclear mRNA export and subsequent mRNA stability and translation 
(Goss and Kleiman, 2013). 
Pre-mRNA is also bound by heterogeneous ribonucleoprotein particles (hnRNPs) which facilitate the 
proper processing and folding of pre-mRNAs. Some hnRNPs release host mRNA at the nuclear pore 
complex (NPC) while others are exported along with the mature mRNA and then shuttle back to the 
nucleus from the cytoplasm (Zheng, 2004).  
The nuclear export of mRNA is achieved through two main pathways utilising complexes of nuclear 
export proteins, some of which initially bind the nascent pre-mRNA as it undergoes maturation in 
the nucleus (Amaral et al., 2008). 
 
1.6.2 mRNA export in mammalian cells 
Bulk mRNA nuclear export is achieved through the nuclear export factor 1 (NXF1) pathway. NXF1 and 
its binding partner NXT1 co‑transcriptionally bind to ribonucleoprotein complexes on mRNA via 
recruitment by REF of the Transcription Export Complex (TREX) (Carmody and Wente, 2009). The 
NXF1‑NXT1‑mRNA‑ribonucleoprotein complex is brought to the nuclear pore complexes by 
ribonucleic acid export 1 (RAE1) which shuttles between the nucleus and cytoplasm while 
predominantly localising in the nucleus. RAE1 brings NXF1‑NXT1‑mRNP to the nuclear envelope by 
interacting with a Gle2p‑binding sequence (GLEBS motif) in the N-terminus of NUP98 in the nuclear 
pore complexes (Pritchard et al., 1999). NXF1 directly interacts with NUP98 through two binding 
domains, one located on the C terminus and the other formed across the binding site of NXF1‑NXT1 
(Blevins et al., 2003). Once on the cytoplasmic side of the nuclear envelope NXF1 is actively 
transported back to the nucleus leaving the mature mRNA in the cytoplasm ready to interact with 
ribosomes. 
A second pathway utilizes chromosome region maintenance 1 (CRM1) but requires an adaptor protein 
such as HuR to bind to the mRNA and interact with CRM1 (Watanabe et al., 1999; Brennan, Gallouzi 
and Steitz, 2000). This pathway exports a subset of mRNAs across the nuclear envelope. CRM1 is an 
active pathway, driven by the interaction of CRM1 with RanGTP which is hydrolysed to RanGDP on the 
cytoplasmic side of the nuclear pore (Askjaer et al., 1998).  
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1.6.3 mRNA decay 
Mammalian mRNA is subject to degradation immediately following transcription. Different transcripts 
will have varying half-lives due to a range of cis acting RNA sequences and RNA secondary structures. 
These sequences are often located in the 5’UTR and 3’UTR but can occur in the coding regions as well 
(Xu, Chen and Shyu, 1997; Yamashita et al., 2005). A range of trans acting factors interact with these 
sequences. RNA secondary structures inhibiting degradation include stem loop structures at the 5’ 
and 3’ which prevent access to host cell RNA decapping and deadenylation machinery and 
exonucleases (Conrad et al., 2007). Furthermore, identical transcripts may have different half-lives at 
different times depending on the physiological state of the cell and a range of trans acting RNA 
turnover proteins.  
In mammalian cells deadenylation is usually the rate-limiting step unless the mRNA is cleaved by an 
endonuclease such as RNAse-L (Chen and Shyu, 2011). Deadenylation can be orchestrated by two 
main pathways in humans. A super complex of the PAN2-PAN3 complex and CCR4-NOT complex 
containing CAF1 binds PABPC1 and shortens poly(A) tail length in deadenylation reactions. More 
commonly however poly(A) specific ribonuclease (PARN) is responsible for deadenylation in 
mammalian cells (Wu et al., 2005). Access for PARN to the 3’ end of mRNA is inhibited by the 
interaction of eukaryotic initiation factors 4E and 4G (eIF4E and eIF4G) with PABPC. However CUGBP1 
(amongst other RNA binding proteins) can bind to sequences in the 3’UTR of transcripts and recruit 
PARN to the poly(A) tail (Moraes, Wilusz and Wilusz, 2007). Sequences in the 3’UTR can also bind 
microRNAs (miRNAs) that have complementary sequences and recruit the RNA-induced silencing 
complex which in turn stimulates the PAN2-PAN3 and CCR4-NOT complexes to begin deadenylation 
of the poly(A) tail (Piao et al., 2010; Fabian et al., 2012).  
Once the tail is removed deadenylation-dependent decapping can occur utilising the decapping 
complex (Chen and Shyu, 2011). The decapping enzymes 1 and 2 (DCP1 and DCP2) catalyse the m7G 
cap removal (Coller and Parker, 2004; Ingelfinger et al., 2002). The transcript is then degraded by the 
exosome (from 3’ end) or XRN1 (from 5’ end) (Parker and Song, 2004). 
Degradation of mRNA is also actively initiated if an mRNA transcript is deemed as aberrant i.e. contains 
a premature stop codon, has been spliced incorrectly, or become hyper-polyadenylated to name a 
few. In these cases the RNA surveillance machinery detects the fault and actively promotes the 
transcripts degradation by endo- and exo-nucleases (Chang, Imam and Wilkinson, 2007; Houseley, 




1.6.4 Turnover and Translation RNA-binding proteins (TTR-RBPs) 
The rate of mRNA decay is also heavily influenced by RNA binding proteins which directly bind mRNA 
and inhibit or stimulate their degradation. These trans-acting proteins often bind to AU-rich elements 
(AREs) in the 3’ untranslated (3’UTR) region of mRNA (Xu, Chen and Shyu, 1997). Many of the mRNA 
transcripts with AREs are involved in immune responses, inflammation, the cell cycle or other 
response pathways that require rapid and transient control (Barrett, Fletcher and Wilton, 2012; Xu, 
Chen and Shyu, 1997).  
Different RNA-binding proteins will bind different mRNA transcripts dependent on the RNA sequence 
and RNA secondary structure. The RNA-binding proteins which effect host mRNA translation and 
turnover were originally termed ‘AU-rich element RNA binding proteins (ARE-RBPs). This was because 
RNA binding proteins which affect turnover and translation were initially shown to exclusively bind 
Uracil and Adenine rich elements, such as the binding of tristetraprolin (TTP) to the pentamer ‘AUUUA’ 
(Kedar et al., 2012; Wilusz, Wormington and Peltz, 2001). However, more recent analysis indicates 
some RNA binding proteins affecting turnover and translation can bind a broader set of sequences 
and thus the term ‘Turnover and translation regulatory RNA-binding proteins (TTR-RBPs)’ has been 
proposed (Pullmann et al., 2007; Pullmann and Rabb, 2014). Mammalian TTR-RBP’s elicit their effect 
on mammalian RNA in a heavily co-ordinated and integrated manner. Many of the TTR-RBPs bind to 
their own cognate mRNA or the mRNA of other TTR-RBPs and regulate their expression (Pullmann et 
al., 2007).  
The TTR-RBP AUF1 transcribes in to four splice variants with two quasi-RNA recognition motif (RRM) 
domains which bind AU-rich elements on mammalian mRNA transcripts. Two isoforms, p37 AUF1 and 
p40 AUF1, bind to AU-rich elements in mRNAs and promote their degradation (Gratacos and Brewer, 
2010). TTP also binds AU-rich elements in mRNAs and initiates deadenylation of the RNA transcripts 
to which it binds by recruitment of the CCR4-NOT deadenylation complex (Fabian et al., 2013). For 
instance TTP binds to TNF-alpha mRNA and promotes its deadenylation and subsequent degradation 
(Lai et al., 1999). 
 
1.6.4.1 HuR 
In contrast to TTR-RBPs which facilitate mRNA decay, Human Antigen R (HuR, related to Drosophila 
ELAV (Ma et al., 1996)) binds to AU-rich elements on a subset of mRNAs and inhibits their degradation 
(Fan and Steitz, 1998; Peng et al., 1998). This process can help regulate core cellular processes e.g. cell 
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proliferation or the innate immune response (Wang et al., 2000). Predominantly located in the 
nucleus, HuR utilises a novel HNS sequence in its hinge domain to aid shuttling between the nucleus 
and the cytoplasm, co-transporting and protecting mRNA transcripts from the nucleus (Fan and Steitz, 
1998). Moreover, HuR can bind the same mRNA transcripts as TTR-RBPs that promote degradation 
such as AUF1 or TTP, developing a dynamic system that changes depending on the given mRNA 
transcript, physiological conditions and external stimuli (Khalaj et al., 2017; Lal et al., 2004). The 
protein domains in the mammalian HuR protein can be seen in figure 1.6. 
Aside from inhibiting mRNA degradation HuR can facilitate mRNA nuclear export via interaction with 
CRM1, affect mRNA splicing and polyadenylation, and facilitate translation of mRNA via interaction 
with PABPC (Brennan and Steitz, 2001; Kimura et al., 2004; Izquierdo, 2008). The mRNA of HuR can be 
regulated by HuR itself and other TTR-RBPs such as TTP. Furthermore, polyadenylation variants of the 
HuR transcript have been identified which help regulate its half-life (Al-Ahmadi et al., 2009a; Pullmann 
et al., 2007). The function of HuR has been proposed to be affected by its phosphorylation state and 




Figure 1.6 Schematic of the mammalian HuR protein domains. RRM1 and RRM2 bind uracil and 
adenine rich regions in mRNAs. The hinge region contains the nuclear localisation and nuclear 
shuttling signals. The RRM3 is responsible for oligomerisation and interaction with PABPC. The 




PABPC is technically a TTR-RBP since it binds mRNA and helps regulate mRNA turnover and translation. 
There are multiple poly(A) binding proteins (PABPs) in mammalian cells, some are tissue specific 
(tPABP and ePABP) while others are universally expressed (PABPN1, PABPC1, PABPC4) (Goss and 
Kleiman, 2013). The nuclear PABP, PABPN1, with significant sequence variation to other forms, binds 
poly(A) tails in the nucleus and stimulates polyadenylate polymerase to extend poly(A) tail length to 
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~250 nucleotides (Eckmann, Rammelt and Wahle, 2011). The cytoplasmic versions, PABPC1 and 
PABPC4, are predominantly located in the cytoplasm despite being a nucleocytoplasmic shuttling 
protein. PABPC is translocated to the nucleus by importin-α which binds to PABPC’s RNA recognition 
motifs when not bound to mRNA (Kumar, Shum and Glaunsinger, 2011). PABPC nuclear build-up has 
been shown to occur when mRNA export via NXF1 is inhibited and thus it is suggested that PABPC 
nuclear export is dependent upon mRNA nuclear export (Burgess et al., 2011). 
PABPC1 and PABPC4 bind poly(A) tails on mRNA and protect the 3’ end of the transcript from 
exonucleases and deadenylation complexes (Houseley and Tollervey, 2009). The C-terminal domain 
of PABPC1 also binds the eukaryotic initiation factor 4G (eIF4G) in the translation initiation complex 
forming a stem-loop structure. This further protects the mRNA ends from degradation and also 
promotes translation initiation (Goss and Kleiman, 2013; Mangus, Evans and Jacobson, 2003). 
 
1.7 Virus inhibition and manipulation of RNA decay pathways 
Viruses of all eukaryotic cells manipulate RNA maturation, mRNA nuclear export and RNA decay 
pathways. For instance, hepatitis C virus (HCV) utilises host rck/p54, LSm1 and PatL1 for the translation 
of HCV RNA’s and this interaction is mediated via the HCV 5’ and 3’ UTRs (Scheller et al., 2009). 
Poliovirus avoids degradation from Xrn1 by forming a RNA cloverleaf secondary structure at the 5’ of 
its genome. This structure binds poly(rC) binding proteins in infected cells which protects the genome 
from degradation at the 5’end (Kempf and Barton, 2008).  Aside from evading or manipulating the 
host RNA degradation pathways, viruses also seek to inhibit host gene expression by inhibiting 
transcription, initiating RNA degradation, inhibiting RNA translation or blocking mRNA nuclear export. 
  
1.7.1 Host shut-off 
Mammalian detection of viral infection at the cellular level is achieved through pattern recognition 
receptors (PRRs) including Toll-like receptors and the cytoplasmic receptors MDA5 and RIG-I which 
recognise pathogen associated molecular patterns (PAMPs) such as viral glycoproteins or viral dsRNA (Akira 
and Hemmi, 2003; Takeuchi and Akira, 2008). When a mammalian cell detects a virus one of its primary 
responses is the production of Interferons, including type I (IFN-α X 12 subtypes, IFN-β, IFN-ω, IFN-κ, and 
IFN-ε), type II (IFN-γ), and type III (IFN-λ X 3 subtypes) and the subsequent activation of the IFN stimulated 
genes (ISGs) (Gonzalez-Navajas et al., 2012). 
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Following detection of viral infection by PRRs, host protein kinase R (PKR) is activated which phosphorylates 
eukaryotic initiation Factor-2 (eIF-2) which then forms an inactive complex with eukaryotic initiation facto 
2B (eIF-2B), thereby inhibiting viral and host AUG translation initiation. Furthermore, gene expression of 
IFNs leads to activation of 2'-5'-oligoadenylate synthetase 1, an enzyme which is further activated by dsRNA 
to synthesize 2',5'-oligoadenylates which in turn activates RNAse L. RNAse L forms a dimer and partially 
degrades global RNA (Ryman et al., 2002). The RNA degradation products stimulate IFN-β in a positive 
feedback loop. IFNs also stimulate a wide range of interferon stimulated genes (ISGs) through signalling 
cascades such as the JAK-STAT pathway (Joshi et al., 2010). Many of the genes which are upregulated in 
this way are involved in modulating anti-viral proteins such as RNAse L.  
In a contrast to host cells inhibiting gene expression as part of an anti-viral response, many viruses 
themselves attempt to shut-off host gene expression. This process has likely evolved to inhibit the anti-
viral response of host cells such as expression of IFNs and ISGs. 
 
1.7.1.1 muSOX 
The gammaherpesviruses have been shown to achieve significant loss of host cell mRNA transcripts 
during lytic infection and this is attributed to the viral mu-SOX protein (homologs SOX in KSHV and 
BGLF5 in EBV) (Rowe et al., 2007). muSOX (and homologs) have two distinct domains that are 
genetically separable; one with DNAse activity is used to help package the viral genome and the 
second is associated with host-shut off activity (Glaunsinger, Chavez and Ganem, 2005). muSOX 
distribution is predominantly nuclear during infection however its cytoplasmic localisation is required 
for it to elicit host mRNA turnover. muSOX also causes the relocalisation of PABPC to the nucleus. How 
SOX orchestrates host mRNA degradation is discussed in further detail in chapters 3 and 5. 
 
1.7.2 Virus utilisation of host TTR-RBPs 
Viruses utilise and manipulate the roles of host TTR-RBPs. For instance, Epstein-Barr virus (EBV) utilises 
AUF1 in a complex; C promoter binding factor 2 (CBF2), which binds to the EBV genome to enhance 
transcription of genes required for EBV-induced immortalization of B lymphocytes (Fuentes-Panana 






1.7.2.1 HuR in alphavirus infection 
HuR binds to alphavirus RNA via a conserved sequence element (CSE) and a uracil rich element (URE) 
just upstream of the poly(A) tail in both mosquito C6/36 and mammalian cells (Sokoloski et al., 2010; 
Dickson et al., 2012). The absence of a URE in the 3’NTR of chikungunya virus (CHIKV) and ross river 
virus (RRV) is compensated by the presence of novel repeated sequence elements in the 3’NTR which 
HuR has been shown to bind to (Dickson et al., 2012). During alphavirus infection the distribution of 
HuR changes from predominantly nuclear to predominantly cytoplasmic. Although the mosquito HuR 
homolog (aeHUR) binds to the 3’NTR of alphaviruses, no significant change in its sub-cellular location 
is observed, probably because it is already co-localised to the nucleus and cytoplasm in non-infected 
cells (Sokoloski et al., 2010). The relocalisation in mammalian cells is achieved in part by a change in 
the phosphorylation state of HuR. The binding of HuR to viral transcripts is likely to protect viral 
transcripts from degradation. In addition the depletion of HuR from the nucleus may aid in 
degradation of host mRNA and thus host shutoff of protein production (Barnhart et al., 2013). 
The importance of HuR binding the 3’NTR of alphaviruses has been studied extensively in the context 
of SINV. Using a C6/36 mosquito cell lysate deadenylation assay it was shown that the presence of the 
URE/CSE from SINV, VEEV, Eastern equine encephalitis virus (EEEV), Western equine encephalitis virus 
(WEEV) and SFV inhibit deadenylation for up at least 9 minutes of mock mRNA’s compared to controls 
(Sokoloski et al., 2010; Dickson et al., 2012). The mechanism by which alphaviruses protect their 
transcripts by binding HuR has not been fully elucidated in mammalian cells. The inhibition of 
deadenylation has been shown in mosquito cell extracts in respect to SINV but this was not 
conclusively shown in mammalian cells. 
In HuR RNAi depleted mammalian (293T) and aeHUR RNAi depleted mosquito cells (Aag2) SINV viral 
RNA was shown to have significantly shorter half-lifes compared to controls (Sokoloski et al., 2010). 
Furthermore, a 10-fold and 5-fold decrease in SINV viral growth was observed in mammalian and 
mosquito cells which were depleted (via RNAi) of HuR and aeHUR respectively. This suppression was 
observed to the same extent when infection with SINV with a deleted URE was analysed. Importantly 
infection of SINV-∆URE in HuR reduced 293T or aeHuR reduced Aag2 cells did not have an 
accumulative repressive effect on viral growth, suggesting these elements are acting synergistically 
rather than individually (Sokoloski et al., 2010). 
Since HuR is a host cell protein it functions to protect the transcripts of a subset of host cell transcripts. 
Therefore, one would hypothesise that depleting the host cell nucleus and the nuclear mRNA 
transcripts of HuR, would reduce the stability of those host cell transcripts that bind HuR. This is seen 
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in the context of SINV infection whereby the sequestration of HuR in the cytoplasm has resulted in 
the significant increase in decay of a sub-set of host mRNA’s in mammalian cells (Barnhart et al., 2013).  
 
1.7.2.2 PABPC in viral infection 
Due to its roles in host mRNA stability and initiation of translation, poly(A) binding protein C (PABPC) 
is targeted by a range of viruses in order to inhibit host cell protein production. One way this is 
achieved is by direct cleavage of the protein by protease 3C of the Norovirus (Kuyumcu-Martinez et 
al., 2004)  amongst others from the caliciviridae family, and by proteases 2A and 3C of the poliovirus 
(Rivera and Lloyd, 2008) amongst others of the picornaviridae. Another strategy adopted by Rubella 
virus utilises its capsid protein to bind to the C-terminal half of PABPC so that it cannot interact with 
translation initiation factors (Ilkow et al., 2008). The diverse set of viruses that target PABPC in this 
way strongly suggests that partially/fully inhibiting PABPC function is beneficial to virus replication in 
general. This suggests the nuclear build-up of PABPC observed during infection with a range of 
herpesviridae, bunyaviridae and reoviridae, namely; herpes-simplex virus 1 & 2 (Dobrikova et al., 2010; 
Salaun et al., 2010), epstein-barr virus (Park et al., 2014), kaposi’s sarcoma herpes virus (Covarrubias 
et al., 2009), bunyamweravirus and rotavirus (Harb et al., 2008) is a direct effect of viral proteins in an 
attempt to promote host shut-off. PABPC also builds up in the nucleus following a block in mRNA 
nuclear export (Burgess et al., 2011). 
 
1.8 General Aims 
The general aim of this study was to investigate the significance of the URE of the SFV4 3’UTR during 
infection of mammalian cells. A secondary general aim was to assess the role of PABPC in the host 






























2.1 Cell culture 
2.1.1 Mammalian cell culture maintenance  
All tissue culture was performed in a Class II Biological Safety cabinet under aseptic conditions. BHK-
21 and NIH/3T3 cells were obtained from long-term stocks of Dr.E Ebrahimi, University of Liverpool 
for MHV-68 experiments or from long term-term stocks of Dr. R Fragkoudis, The Pirbright Institute for 
SFV4 experiments. αβRKO cells were from long-term stocks of Dr.E Ebrahimi, University of Liverpool. 
Baby hamster kidney fibroblasts (BHK-21 cell line) 
BHK-21 cells [C-13] (ATCC CCL-10TM) were purchased from American Type Culture Collection (ATCC) 
and used for titration of MHV-68 and rSFV4 virus stocks and for rSFV4 propagation from icDNA 
plasmids. BHK-21 cells were maintained in Glasgow’s minimal essential medium with high-glucose and 
L-glutamine (GMEM, Gibco) supplemented with 10% (w/w) new born calf serum (NBCS, Gibco), 10% 
(w/w) tryptose phosphate broth (TPB, Gibco), penicillin (100 U/ml) and streptomycin (100 µg/ml). This 
medium will be referred to as complete GMEM-10 (cGMEM-10). 
Murine Fibroblasts (NIH/3T3 cell line) 
Murine NIH/3T3 cells (ATCC CRL-1685) were used for cell culture experiments as a model mammalian 
host-cell with a functional IFN system. For experiments involving SFV4, NIH/3T3 cells were maintained 
in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) with glucose (4500 mg/L) and L-Glutamine 
(584 mg/L) supplemented with 10% newborn calf serum (NBCS, Gibco), penicillin (100 U/ml) and 
streptomycin (100 µg/ml). This will be referred to as complete DMEM-10 (cDMEM-10). Prior to use, 
NBCS was decomplemented by heating to 56 °C for 30 minutes. For experiments involving MHV-68, 
NIH/3T3 cells were maintained in the same conditions, but 10% heat-inactivated foetal calf serum 
(FCS, Gibco) was used instead of NBCS.   
Interferon alpha/beta receptor null murine fibroblasts (IFN αβRKO cell line) 
Interferon alpha/beta receptor null (IFN αβRKO) cells lack interferon alpha beta receptors so have a 
defective Type 1 IFN system (Muller et al., 1994). These cells were obtained from IFNα/βR KO 129/Sv 
mice embryo fibroblasts (Dr. Ebrahimi, Personal Communications).  The IFNαβRKO cells were 
maintained in the same medium as the NIH/3T3 cells. Virus working stocks for MHV-68 and MHV-68 




2.1.2 Subculture of mammalian cells 
Mammalian cells were maintained in sterile T175 cm2 tissue culture flasks at 37 °C in a humidified 
atmosphere of 5% CO2. Cells were sub-cultured when they reached 80-90% confluence. At this point, 
the culture medium was removed, and cells were washed with either 10 ml of sterile phosphate 
buffered saline (sPBS) for SFV4-related work or versene for MHV-68-related work. After removal of 
the sPBS or versene, 5 ml of trypsin-EDTA (0.25%, Gibco) was added to the cells and they were 
incubated at 37 °C for 1-3 minutes until the cells detached from the plastic surface. The trypsin-EDTA 
was neutralised by the addition of 10 ml of complete medium and centrifuged at 400 x g at room-
temperature for 5 minutes to pellet the cells. The supernatant was then discarded, and the cell pellet 
dislodged and resuspended in 10 ml of complete medium. The cells were diluted 1 in 10 in sPBS, evenly 
mixed and 10 μl with tryphan blue exlusion assay was used to calculate the concentration of cells per 
millilitre using a Neubauer haemocytometer. The cells were then seeded into 175 cm2 tissue culture 
flasks to maintain a stock of cells, or into 6-well, 24-well or 96-well plates for experiments. Cells were 
passaged up to 30 times before fresh lower passage aliquots were resuscitated from frozen stocks. 
2.1.3 Cryopreservation and resuscitation of cell stocks 
Freezing cells for generation of stocks 
Frozen stocks for all cell lines were prepared and stored in liquid nitrogen. Briefly, cells were 
trypsinised during their exponential growth phase at 75-80% confluency and counted using a 
Neubauer haemocytometer. Cells were then centrifuged at 400 x g for 5 minutes at room temperature 
and the supernatant discarded. The cells pellet was then re-suspended in freezing medium (92.5% 
(w/w) c-DMEM-10 for NIH/3T3 and αβRKO cells or cGMEM-10 for BHK-21 cells and 7.5% (w/w) 
dimethyl sulfoxide (DMSO, Sigma Aldrich)) to give a concentration of 5 x 106 cells/ml. Aliquots of 1ml 
were then placed in cryovials (Nunc) and transferred to a Cool-Cell alcohol-free chamber (Corning) 
and placed at -80 oC. The Cool-Cell chamber controls temperature reduction at a rate of -1 °C per 
minute. After 24 hours the cells were transferred to a vapour-phase of a liquid nitrogen tank for long-
term storage. 
Thawing cells from frozen stocks 
Cells were taken from liquid nitrogen and placed on dry ice until they were thawed by placing the vial 
in a 37 °C water bath. The cells were then added to 10 ml medium and centrifuged at 400 x g for 5 
minutes to remove freezing medium.  The cell pellet was then resuspended in 4 ml of pre-warmed 
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complete medium, transferred to a 25 cm2 (Nunc) flask and incubated at 37 °C with 5% CO2 until 80-
90% confluent. Cells were then passaged as described above (Section 2.1.2). 
2.2 Generation of recombinant SFV4 infectious complementary DNA plasmids 
Infectious SFV4 virus was produced from transfecting BHK-21 cells with infectious complementary 
DNA (icDNA) plasmids encoding the full SFV4 genome under control of a human cytomegalovirus 
(CMV) immediate-early promoter. An exception was for SFV4(3F)-ZsGreen virus which was 
propagated from transfected in-vitro transcribed mRNA from a pSP6-SFV4(3F)-ZsGreen construct in 
BHK-21 cells. pCMV-SFV4 virus was previously generated from a full-length icDNA clone of SFV4 virus 
kindly provided by Professor Andres Merits (University of Tartu, Estonia). All pCMV-rSFV4 virus 
constructs were generated through molecular cloning to insert mutant or reporter DNA sequences 
with a pCMV-SFV4 backbone. Two reporter pCMV-SFV4 backbones were utilised in this study: the first 
with a Gaussia luciferase reporter gene engineered under the control of a second sub-genomic 
promoter (pSFV4-2SG-Gluc); the second was constructed with an enhanced green fluorescent protein 
(eGFP) gene fused to viral nsP3 (pCMV-SFV4(3F)-eGFP). 
Design of SFV4 constructs 
The genome organisation of SFV4 constructs used in this study are shown in Chapter 4. Recombinant 
SFV4 icDNA plasmids containing CSE/URE deletions or additions were designed using ApE plasmid 
editor (M. Wayne Davis) using the published/known sequences of existing SFV4 plasmid constructs 
pCMV-SFV4, pSFV4-2SG-Gluc and pCMV-SFV4(3F)-eGFP. 
Generation and cloning of pCMV-SFV4-2SG-Gluc 
Due to the need for a suitable 5’ restriction site before the URE in the 3’NTR of the SFV4 reporter 
icDNA plasmids, a single BamH I site was retained at this position. This modified the sequence of CMV-
SFV4-2SG-Gluc. This was achieved by insertion of a synthesised DNA sequence containing a single 
BamH I site and encoding a second sub-genomic promoter and Gaussia luciferase gene (2SG-Gluc) 
inserted in a pCMV-SFV4 backbone immediately after the structural genes. The sequence spanned the 
3’NTR and poly(A) tail of the SFV4 icDNA plasmid. The synthesised DNA sequence was supplied in the 
pUC57 backbone by Genscript. It was excised with Apa I and Bpu 1OI restriction enzymes (Section 
2.6.7), run on an agarose gel (Section 2.6.9) and gel purified (Section 2.6.10). The gel purified product 
was ligated (Section 2.6.8) into pCMV-SFV4 previously digested with restriction enzymes Apa I and 
Bpu 10I with FastAP treatment (Section 2.6.7). Five microliters of ligation reaction was transformed 
into JM109 competent cells (Section 2.5.3), and subjected to mini-prep (Section 2.5.4), restriction 
digest analysis (Section 2.6.7) and sequencing (Section 2.6.14).   
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Generation and cloning of pCMV-SFV4-2SG-Gluc URE/CSE mutants 
The URE/CSE mutant rSFV4 luciferase reporter constructs were generated through recombination of 
synthesised DNA sequences with the pCMV-SFV4-2SG-Gluc backbone. Briefly, the synthesised mutant 
dsDNA sequences were supplied in pUC57 by Genscript. The sequences corresponded to a modified 
3’NTR and poly(A) tail of the SFV4 genome. Sequences were cloned in-to pCMV-SFV4-2SG-Gluc and 
confirmed as described above for the 2SG-GLuc insert in pCMV-SFV4 except that a 5’ BamH I site 
(located downstream of Gaussia luciferase) was utilised instead of a 5’ ApaI site. 
Generation and cloning of pCMV-SFV4(3F)-eGFP URE/CSE mutants 
Several attempts were unsuccessful to produce the desired construct while attempting to clone 
URE/CSE mutant sequences into a pCMV-SFV4(3F)-eGFP backbone. Therefore, an alternative 
approach was taken for the GFP reporter constructs. Briefly, the second sub-genomic promoter and 
luciferase gene were removed from a selection of pCMV-SFV4-2SG-Gluc URE/CSE mutants by digesting 
with ApaI and BamH I (Section 2.6.7) with FastAP treatment (Section 2.6.7). A pair of oligonucleotides 
which encode a multiple cloning site (MCS) were subjected to in-situ hybridisation to anneal. The 
annealed oligonucleotide pair was then used to ligate the plasmid ends. Oligos 5’-
CACTAGTCCCGGGGGCGCGCCG-3’ and 5’-GATCCGGCGCGCCCCCGGGACT-AGTGGGCC-3’ were 
purchased from Eurofins. Briefly, oligos were annealed in a thermocycler by heating to 98 °C for 10 
minutes and by gradual cooling to 25 °C over a 45 minute period. Annealed oligos were then digested 
with ApaI and BamH I followed by enzyme inactivation (Section 2.6.7). Digested oligos were ligated 
into the digested and FastAP treated pCMV-SFV4 URE/CSE mutant backbones (Section 2.6.8), 
transformed into JM109 competent cells (Section 2.5.3), and subjected to mini-prep (Section 2.5.4), 
restriction digest analysis (Section 2.6.7) and sequencing (Section 2.6.14). The addition of a DNA 
sequence encoding nsP3(3F)-eGFP was achieved by excising the nsP3(3F)-eGFP section of the icDNA 
SFV4 plasmid from pCMV-SFV4(3F)-eGFP provided by Dr. R Fragkoudis (The Pirbright Institute). Briefly, 
a selection of the pCMV-SFV4 URE/CSE mutants was digested with SacI and NotI and FastAP (Section 
2.6.7). The nsP3(3F)-eGFP was excised by digesting pCMV-SFV4(3F)-eGFP with SacI and NotI (Section 
2.6.7), resolved through a 1% (w/v) agarose gel electrophoresis (Section 2.6.9), gel purified (Section 
2.6.10) and ligated (Section 2.6.8) to each pCMV-SFV4 URE/CSE mutant backbone. Ligation products 
were then transformed into JM109 competent cells (Section 2.5.3), and subjected to mini-prep 




2.3. Generation of virus stocks 





Table 2.1 List of viruses used in this study 
Virus Strain  
Virus Name Source Modification 










Identical to SFV4-2SG-Gluc with the URE (5’-auuuuuauuuuauuuugc-3’) and 18 bases from the CSE (5’-





Identical to SFV4-2SG-Gluc with URE (5’-auuuuuauuuuauuuugc-3’) and 11 bases from the  




Identical to SFV4-2SG-Gluc with 4 additional duplicated URE (5’-auuuuuauuuuauuuugc-3’) added immediately 
upstream to the original URE in the 3’NTR of the SFV4 genome 









Identical to SFV4(3F)-eGFP with 18 bases from the CSE (5’-aauugguuuuuaauauuu-3’) deleted from the 3’NTR of 





Identical to SFV4(3F)-eGFP with the URE (5’-auuuuuauuuuauuuugc-3’) and 18 bases from the CSE (5’-




Identical to SFV4(3F)-eGFP with 4 additional duplicated URE (5’-auuuuuauuuuauuuugc-3’) added immediately 
upstream to the original URE in the 3’NTR of the SFV4 genome 
MHV-68 MHV-68 X 
No modifications 
MHV-68 MHV-68 ORF37stop Bahram Ebrahimi 




2.3.1. Generation of rSFV4 stocks 
The icDNA rSFV4 plasmids with a CMV promoter were transfected directly into BHK-21 cells to 
propagate infectious virus. The rSFV4(3F)-ZsGreen virus was encoded by a cDNA plasmid with an SP6 
promoter. It was first in-vitro transcribed and then the RNA was transfected into BHK-21 cells. 
Infectious cDNA rSFV4 plasmids, once cloned and sequenced as described (Section 2.2), were 
produced on a larger scale using an endo-free plasmid maxi kit (Qiagen) (Section 2.5.4). 
2.3.1.1. In vitro transcription of SFV4(3F)-ZsGreen 
RNA from a pSP6-SFV4(3F)-ZsGreen construct was extracted prior to transfection due to the lack of a 
eukaryotic supported promoter which would enable expression of the plasmid-derived mRNA in 
eukaryotic cell lines. The construct was linearised using Spe I (Section 2.6.7), run on an 0.8% agarose 
gel (Section 2.6.9) and gel purified (Section 2.6.10). The gel-purified linearised plasmid was transcribed 
into mRNA using a MegaScript SP6 kit (Ambion). Briefly, each in vitro transcription reaction contained 
nuclease-free water up to 20 μl, 2 μl each of ATP solution, CTP solution and UTP solution (50 mM, 
Promega), 2 μl of a diluted GTP solution (10 mM, Promega), 2 μll of m7G(5’)ppp(5’)G cap analog (40 
mM, Promega), 2 μl of 10X reaction buffer, 1 μg of Spe 1 linearised pSP6-SFV4(3F)-ZsGreen, and 2 μl 
of enzyme mix. The reaction mixture was incubated at 37oC for 5 hours. The reaction was then kept 
on ice and 10 μl of the reaction was immediately electroporated into BHK-21 cells (section 2.3.1.2). 
2.3.1.2 Transfection of rSFV4 encoding nucleic acid for virus propagation 
The rSF4 strains were propagated by electroporating rSFV4 CMV plasmids into BHK-21 cells with the 
exception of SFV4(3F)-ZsGreen for which in-vitro transcribed mRNA (Section 2.3.1.1) was used. Briefly, 
less then 90% confluent BHK-21 cells grown in 175 cm2 flasks (Nunc) were trypsinised, counted and 
resuspended in sPBS at cell density of 2.5 X 107 per ml. Thirty micrograms of each rSFV4 plasmid (or 
10 μl of in vitro transcribed mRNA) was mixed with 400 ul of 2.5 X 107 per ml of BHK-21 cells in ice-
cold sPBS in a 0.4 cm electroporation cuvette (Bio-Rad). Cells were then electroporated in a Gene 
Pulser X-cell Electroporator (Bio-Rad) using the following protocol: square wave protocol at 850V, for 
2 pulses of 4 milliseconds each with a 5 second interval between pulses. Each aliquot of 1 X 107 cells 
was added to a 175 cm2 flask with pre-warmed cGMEM-10 and incubated at 37 °C and 5% CO2. The 
supernatant containing rSFV4 viruses was collected at 24 and 48 hours post-transfection by which 
point luciferase signal (luciferase-expressing viruses) or GFP fluorescence (GFP-expressing viruses) and 
CPE were detected. Supernatant from cells infected with rSFV4 viruses with deletion of part or all of 
the CSE from the 3’NTR was taken when CPE was observed and luciferase signal (luciferase-expressing 
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viruses) or GFP fluorescence (GFP-expressing viruses) was present. Typically, this occurred on day 5 
post-transfection for rSFV4 containing ∆CSE, day 7 for -∆URE∆11CSE and day 8 for –∆URE∆CSE. 
2.3.1.3. Purification of rSFV4 viruses 
Supernatant from transfected BHK-21 cells containing SFV4 virus particles was centrifuged at 4000 x 
g for 20 minutes at 4 °C to pellet cell debris and the supernatant containing virus particles was stored 
at -80 °C. For purification, all virus supernatants from a given virus preparation were thawed at 37 °C 
in a water bath. Viral particles were then precipitated from the supernatant by overnight incubation 
in a solution of 0.7% polyethylene glycol 8000 (PEG, Sigma-Aldrich) in 2.3% NaCl (Sigma-Aldrich) at 4 
°C with continuous gentle stirring. PEG-bound viral particles were precipitated by centrifugation at 
10,000 x g for 20 minutes at 4 °C and the PEG-virus pellet was resuspended in 10 ml of sterile low salt 
buffer (LSB, 0.15 M NaCl, 10 mM Tris, pH 7.4). The re-suspended virus was then purified by 
ultracentrifugation through a 20% sucrose cushion as follows. The virus suspension was added to an 
ultra-clear ultracentrifugation tube (Beckman) and a sucrose cushion (20% (w/v) sucrose in TNE buffer 
pH 7.4 (50 mM Tris-HCl pH 7.4, 100 mM NaCl and 0.1 mM EDTA pH 8.0), filter sterilised) was carefully 
added below virus suspension until the tube was full. The viral particles were then pelleted using a 
SW32 Ti rotor in an Optima XPN-100 ultracentrifuge (Beckman Instruments) at 82,700 x g for 1.5 hours 
at 4 °C. The supernatant was carefully decanted and the virus pellet re-suspended in 1 ml of LSB and 
left for 1 hour at 4 °C to fully re-suspend. The re-suspended viral particles were then aliquotted (20 μl) 
into cryovials (Nunc) and stored at -80 °C. 
2.3.2 Murine gammaherpesvirus-68 stocks 
MHV-68 and MHV-68 ORF37stop viral stocks were generated by infecting BHK-21 cells at a very low 
MOI with existing sub-master stocks (provided by Dr. Bahram Ebrahimi, The University Of Liverpool) 
and crude viral particles harvested by homogenisation of infected cells.  Briefly, 3 X 107 BHK-21 cells 
suspended in cDMEM-10 were infected with either MHV-68 or MHV-68 ORF37stop virus at an MOI of 
0.001. Virus and cells were incubated for 1 hour with vigorous shaking (220 rpm) at 37 °C. Cells were 
then plated at 3 X 106 cells per 175 cm2 tissue culture flask (Nunc) and incubated at 37 °C with 5% CO2. 
Virus was harvested upon visualisation of CPE approximately 5-6 days post infection. Cells were gently 
scraped off into suspension and centrifuged at 500 x g at 4 °C for 20 minutes. The supernatant was 
discarded, and the cell pellet was resuspended in 4 ml of sPBS. Resuspended pellets were transferred 
to a pre-chilled (4 °C) sterile dounce homogeniser (VWR International Ltd) and homogenised 20-30 
times with intermittent incubation on ice to prevent the homogeniser from over-heating. The 
homogenised pellet suspension was then transferred to a sterile glass universal container and 
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sonicated in an ice bath for 15 minutes and then centrifuged again as described above. The 
supernatant was kept on ice and resultant pellet was resuspended in 1 ml of sPBS and re-homogenised 
and centrifuged as described above. The two supernatant fractions were aliquoted in to cryovials and 
stored at -80 °C as virus stock. 
2.4 General Virus Techniques 
2.4.1 Infections 
To calculate the necessary amount of virus required to infect a given number of cells at the desired 
MOI the following formula was used: 
                                                                                MOI x Number of cells to be infected 
Volume of virus stock required =                                                   
                                                                                             Titre of virus stock            
SFV4 infection 
Cells were infected with SFV4 by incubation in 0.75% bovine serum albumin (Sigma-Aldrich) in PBS 
(PBSA). Briefly, cells were infected when they reached 70-90% confluency as described. Medium was 
removed and the SFV4 virus suspension was added directly onto the adherent cells and incubated at 
room temperature for 1 hour with gentle rocking. The virus suspension was then removed and 
replaced with medium or agar overlay before returning the cells to 37 °C with 5% CO2 incubation. 
MHV-68 Infection 
MHV-68 infections were conducted by the addition of the necessary amount of virus to the total 
number of cells to be infected in a small volume of cDMEM. Briefly, 80-90% confluent cells were 
trypsinised and pelleted as described (Section 2.1.2), resuspended in 4 ml of complete medium and 
counted using a Neubauer haemocytometer. The cell suspension was then diluted if required to give 
0.25X the number of cells required per ml that are to be infected. From this cell suspension 4 ml 
were placed into a bijou tube and the necessary amount of virus stock added. The 5-ml bijou tube 
with cells and virus was placed in a 50 ml centrifuge tube and incubated at 37 °C with vigorous 
agitation at 220 rpm. Cells were then seeded at 80-90% density (1 X 106 cells per well) into 6-well 
plates (plaque assay Section 2.4.2, qPCR Section 2.10) or at 75,000 cells per well in a 24-well plate 




2.4.2 Virus titration by Plaque Assay  
SFV4 and MHV-68 were titrated by plaque assay using BHK-21 cells in six-well and 24-well plates for 
stocks and samples respectively. To calculate the PFU/ml of each sample the following formula was 
used:  
                                                             Average number of plaques for given dilution  
  PFU/ml   =     
                                                                Volume of inoculum (ml) x dilution factor 
SFV4 virus titration asssay 
Six-well plates were seeded with 3 X 105 BHK-21 cells in 3 ml of cDMEM-10 and incubated at 37 °C and 
5% CO2 until cells were 80% confluent. Ten-fold serial dilutions of virus stocks were generated as 
follows. Briefly, 12 µl of virus stock was added to 1188 µl of PBSA to create a 10-2 dilution, followed by 
mixing by pipetting, taking 120 µl of the 10-2 dilution and adding to 1080 µl of PBSA to create a 10-3 
dilution. This was repeated until 10-12 dilution was prepared. Medium was removed from the BHK-21 
cells and 2 X 500 μl of each virus dilution were added to duplicate wells. Virus was incubated on cells 
for one hour at room temperature with gentle rocking. Following incubation, the virus suspension was 
removed, and 3 ml of 40-42 °C 4% Bacto agar and c-DMEM-2 in a 10:3 ratio was added to cells. Agar 
was allowed to set at room temperature for 5 minutes and then the cells were incubated at 37OC and 
5% CO2 for 3 days. Cells were fixed by addition of 10% neutral buffered formaldehyde (NBF; Leica 
Biosystems) directly on top of the agar in the wells and allowed to incubate at room temperature in a 
fume-cabinet for 1 hour. The agar and NBF discarded and the fixed cells were stained with 0.1% 
toluidine blue (Sigma-Aldrich) for one hour at room temperature with gentle rocking. Cells were then 
washed gently with tap water, allowed to air dry overnight and the plaques counted under a light 
microscope. The method was scaled down for 24-well plates. 
MHV-68 virus titration assay 
A 6.7 x 105 BHK-21 cells/ml suspension was prepared in cGMEM-10 from 80-90% confluent cells in 
T175 cm2 flasks as described (Section 2.1.2). Three millilitres of the cell suspension were added to each 
of 10 bijoux tubes. The serial dilutions were created identically as described for SFV4 with the 
exception that sPBS was used instead of PBSA. Each bijou was labelled with a serial dilution and one 
millilitre of the corresponding virus dilution was added to the cells. Bijoux were placed in 50 ml Falcon 
tubes and incubated for 1 hour at 37 °C and vigorous agitation at 220 rpm. Following incubation, 2 ml 
of each cell dilution were added to 6-well plates to give 100,000 cells per well. Cells were allowed to 
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adhere for 8 hours, then an agar overlay was applied as described for SFV4. Cells were also fixed, 
stained and counted 4 days post-infection as described for SFV4. 
2.5 General bacterial techniques 
2.5.1 Bacterial Culture 
Transformed bacteria were grown in Luria-Bertani (LB) medium or LB agar plates containing suitable 
antibiotic and grown overnight at 37 °C. Individual colonies were picked at random or selected via 
colony PCR (Section 2.6.13) and used to inoculate 10 ml of LB media. All LB medium was pre-sterilised 
by autoclaving before addition of appropriate antibiotic. Inoculated media were incubated overnight 
at 37 °C and 220 rpm. For large scale plasmid preparation, 150 ml of sterile LB medium with 
appropriate antibiotic was inoculated with 150 µl of bacterial culture containing the desired plasmid. 
Kanamycin was the antibiotic used for selection for all icDNA SFV4 plasmids and pCR-Blunt II-TOPO 
(Thermo Fisher) used in this study while ampicillin was the selective antibiotic for pUC18 (used as a 
positive control for bacterial transformations). The working concentration used for Kanamycin was 50 
µg/ml while Ampicillin was used at 100 µg/ml. 
2.5.2 Preparation and use of glycerol stocks 
Once the identity of a plasmid has been confirmed by sequencing, the colony or culture from which it 
was derived was used to inoculate 5 ml of LB Broth containing the appropriate antibiotic. The culture 
was incubated overnight at 37 °C and 220 rpm. The bacteria were then pelleted by centrifugation at 
500 x g for 10 minutes. The pellet was re-suspended in 50% glycerol in sterile water, mixed well and 
stored at -80OC. When required, the stocks were removed from -80 °C and placed immediately in dry 
ice to prevent the culture from thawing. A pipette tip was used to scrape a small amount of frozen 
bacteria culture from the tube and this was used to inoculate 5ml of LB media containing appropriate 
antibiotic and incubated overnight at 37 °C.  
2.5.3 Transformation of competent E.coli 
Competent E. coli bacteria were transformed with SFV4 icDNA plasmids or ligation products (derived 
from plasmids) to expand the desired clone via bacterial growth in culture followed by DNA plasmid 
extraction. Two commercially available strains of chemically competent Escherichia coli were used. 
Single-use JM109 with greater than 108 colony forming unites/µg 
Competent JM109 bacteria were pre-aliquotted into 50 µl microtubes and kept at -80 °C. Prior to use, 
competent cells were thawed on ice.  Either 10 ng of (plasmid) DNA in a maximum volume of 5 µl or 
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5 µl of ligation product was added to the bacteria, were mixed gently and returned to the ice. To act 
as a positive control, one mucrolitre of 100 pg/μl of pUC18 was added to one aliquot of competent 
bacteria cells; another aliquot of bacteria with no DNA acted as a negative control. Competent bacteria 
were incubated with plasmid DNA for 30 minutes on ice before being heat-shocked for 20 seconds at 
42 °C in a water bath. Bacteria were then replaced on ice for 2 minutes followed by the addition of 
450 μl of SOC medium (Sigma-Aldrich) without antibiotics before being incubated at 37 °C and 220 
rpm for 1 hour. Following incubation, 10µl and 100 µl aliquots of transformed bacteria were plated 
on separate LB agar plates with appropriate antibiotic. For ligation reactions, transformed bacterial 
culture was centrifuged at 500 x g for 10 minutes. All but 50 µl of supernatant was removed, the pellet 
was re-suspended by vortexing and then spread on a pre-warmed LB agar plate with appropriate 
antibiotic. Plates were incubated overnight at 37 °C. 
XL10-Gold® ultra-competent cells 
Bacteria were thawed on ice and 100 µl aliquots transferred to pre-chilled microtubes. Then 4 µl of β-
mercaptoethanol was added to each aliquot followed by very gentle mixing by pipetting and 
incubation on ice for 10 minutes. DNA or ligation product were added to competent cells.  The 
subsequent steps were then the same as described for JM109 cells with the exception that the heat 
shock at 42 °C was conducted for 30 seconds. 
2.5.4 Plasmid DNA extraction from bacterial cultures 
Mini DNA Preparation 
Small-scale extraction of plasmid DNA from bacterial cultures were carried out using the Isolate II 
Plasmid Mini Kit (Bioline Cat. No. BIO-52056). All centrifugations were carried out using benchtop 
microfuges at 11,000 x g (~ 13,000 rpm) at room temperature.  Briefly, 10 ml of sterile LB broth with 
appropriate antibiotic was inoculated with a bacterial colony and incubated for 12-16 hours at 37 °C 
at 220 rpm. After incubation, 5ml of bacterial culture was centrifuged at 11,000 x g for one minute, 
supernatant discarded; the remaining 5 ml were stored at 4 °C for future use. The pelleted cells were 
re-suspended in 250 µl of Resuspension Buffer P1 containing RNase A followed by lysis of bacteria 
with the addition of 250 µl of Lysis Buffer P2 and incubation at room temperature for 4-5 minutes. 
Lysis was then inhibited by addition of 300 µl of neutralisation buffer and several tube inversions 
followed by centrifugation at 11,000 x g for 10 minutes at room temperature. The supernatant was 
added to an Isolate II Plasmid Mini Spin Column placed in a collection tube, centrifuged for one minute 
and the supernatant discarded. The column was then washed twice, first with 500 µl of Wash Buffer 
PW1 pre-heated to 50 °C and then with 600 µl of room-temperature Wash Buffer PW2 (first 
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supplemented with ethanol according to manufacturer’s instructions); the column was centrifuged 
for one minute after each wash with the flow-through discarded. Finally, columns were centrifuged 
for 2 minutes to remove any traces of alcohol. The column was then placed in a nuclease-free tube, 
30 μl of 70 °C water was added to the membrane and the column centrifuged for one minute. The 
concentration of plasmid DNA retained in the flow-through was measured using a Nanodrop 
spectrophotometer (Section 2.6.6) and the preparation was stored at -20 °C. 
Endotoxin-free Maxi DNA Preparations 
Large-scale preparations of plasmid DNA for later transfection into mammalian cells were extracted 
from bacterial cultures using the Endo-Free Plasmid Maxi-Kit (QIAGEN). Briefly, 100 ml of LB broth 
with appropriate antibiotic was inoculated with 100 µl of starter culture obtained from a culture used 
for mini-prep containing confirmed correct plasmid from DNA sequencing. Inoculated broth was 
incubated overnight at 37 °C and 220 rpm then centrifuged at 6000 x g for 15 minutes at 4 °C and the 
supernatant was discarded. The pellet was re-suspended in 10 ml of Buffer P1 containing RNase A 
followed by lysis of bacteria by addition of 10 ml of Buffer P2, gentle mixing and incubation for 5 
minutes at room temperature. Lysis was then inhibited by addition of 10 ml of pre-chilled Buffer P3 
and mixed by several tube inversions. The lysate was then added to a QIAfilter cartridge with the 
nozzle cap in place. After 10 minutes of stationary incubation the nozzle cap was removed, and the 
lysate forced through the membrane by insertion of a cartridge plunger. Then 2.5 ml of Buffer ER was 
added to the filtered lysate with mixing by inversion and incubation for 30 minutes on ice to remove 
endotoxins. During the incubation, a Qiagen-tip 500 was equilibrated by adding 10 ml of Buffer QBT 
to the column and allowing it to empty by gravity flow. The filtered lysate was then added and allowed 
to flow through the column followed by two additions of 30 ml of Buffer QC to wash the membrane, 
the flow-through liquid being discarded each time. The DNA was then eluted by the addition of 15 ml 
of Buffer QN to which 10.5 ml (0.7 volumes) of room-temperature isopropanol was added, mixed and 
then centrifuged at 15,000 x g for 30 minutes at 4 °C. The supernatant was then discarded, and the 
pellet washed in 10 ml of 70% ethanol and centrifuged again at 15,000 x g for 10 minutes. The 
supernatant was then discarded, the pellet air-dried for 3-5 minutes and re-suspended in 200 μl of 
nuclease-free water. The DNA concentration was measured using a Nanodrop spectrophotometer 





2.6 General nucleic acid and molecular techniques 
2.6.1 Extraction of RNA from mammalian cells 
RNA was extracted using an RNeasy Mini Kit (Qiagen). All centrifugations were performed using a 
benchtop microfuge and at room temperature unless stated otherwise. Briefly, 70% confluent 
NIH/3T3 cells were infected (section 2.4.1) with rSFV4 at an MOI of 10. At given timepoints post-
infection, the supernatant was discarded, and the cells were washed, trypsinised and pelleted as 
described for seeding flasks/plates (Section 2.1.2). The cell pellet was re-suspended in 600 µl of buffer 
RLT with 1% (v/v) β-mercaptoethanol and centrifuged in a QIAshredder spin column (Qiagen) for 2 
minutes. Six hundred microliters of 70% ethanol was then added to the homogenised lysate, mixed 
well and then centrifuged in two sets of 600 µl through a RNeasy spin column for 15 seconds at 8000 
x g and the flow-through discarded.  The column membrane was then subjected to three washes, 
firstly by addition of 700 µl of Buffer RW1, followed by two separate additions of 500 µl of Buffer RPE. 
The column was centrifuged at 12,000 x g for 15 seconds between each wash and for 2 minutes 
following the last wash; the flow-through was discarded after each wash step. The column was then 
centrifuged in a clean collection tube for 2 minutes at 12,000 x g to remove residual wash buffer and 
alcohol. RNA was eluted in two elution steps in to an RNAse-free tube by two separate additions of 30 
µl of RNAse-free water directly to the membrane and centrifugation at 8000 x g for 1 minute after 
each addition. RNA samples were stored at -80 °C. 
2.6.2 Nuclear and Cytoplasmic Fractionation followed by RNA extraction 
The nuclear and cytoplasmic fractions of NIH/3T3 cells were separated and RNA extracted using the 
PARIS kit (ThermoFisher Scientific). Briefly, cells in sPBS were pelleted at 500 x g at 4 °C for 5 minutes 
and re-suspended in 500 µl ice-cold cell fractionation buffer with gentle pipetting followed by a 10-
minute incubation on ice. The nuclear fraction was then pelleted at 500 x g at 4 °C for 5 minutes and 
the supernatant containing the cytoplasmic fraction was separated into a clean RNase-free microfuge 
tube and incubated on ice. To prevent contamination with any left-over cytoplasmic fraction, 500 µl 
of ice-cold fractionation buffer was then added to the nuclear pellet, followed by very gentle pipetting 
and centrifugation as before, and the supernatant was discarded. The nuclear pellet was then lysed 
by addition of 500 µl of ice-cold disruption buffer with sequential mixing by vortex and one minute 
incubations on ice until a homogenous lysate was achieved. 500 µl of 2 X lysis/binding solution 
containing β-mercaptoethanol was then mixed well with each of the lysates at room temperature 
followed by mixing with 500 µl of 100% ethanol (Sigma). The nuclear and cytoplasmic lysates were 
each then applied to individual PARIS RNA kit filter cartridges, placed in collection tubes in two sets of 
700 µl, and centrifuged at 14,000 x g at room temperature for one minute with the flow-through 
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discarded at the end of each spin step.  The cartridges were then washed 3 times, first with 700 µl of 
wash solution 1, and then twice with 500 µl of wash solution 2/3. The cartridges were centrifuged at 
14,000 x g at room temperature for one minute after addition of each wash solution. Cartridges were 
centrifuged again at 14,000 x g to remove residual traces of wash solution. RNA was eluted with two 
sets of 40 µl of elution solution heated to 97 °C, and centrifuged as before after each addition of 
elution solution. RNA was stored at -80 °C. 
2.6.3 DNase Treatment of RNA samples 
To ensure complete removal of DNA, the RNA samples were subjected to treatment with Turbo DNase 
(Ambion). Briefly, 0.1 volume of Turbo DNase buffer was added to the RNA samples followed by 1 ul 
of Turbo DNase, the solution mixed and incubated for 37 °C  for 30 minutes. Then 0.1 volume of DNase 
Inactivation Reagent was added and incubated for 5 minutes at 24 °C with intermittent mixing by 
flicking the tube. The samples were then centrifuged at 10,000 x g for 1.5 minutes and the supernatant 
(RNA) transferred to clean RNase-Free tubes.  
2.6.4 RNA clean-up of DNase Treated RNA samples 
The RNeasy MinElute clean-up kit (Qiagen) was used to remove the enzyme solution post DNAse-1 
treatment and to concentrate the RNA. All centrifugations were carried out using benchtop 
microfuges at 11,000 x g (13,000 rpm) at room temperature. Briefly, RNA samples were adjusted to 
total volume of 100 µl where necessary by addition of nuclease-free water. Then 350 µl of buffer RLT 
and 250 µl of 100% ethanol were added to the samples with mixing by pipetting in between each 
addition. The samples were transferred to individual RNeasy mini elute spin columns and centrifuged 
at 8,000 x g for 15 seconds with the flow-through discarded. The columns were washed twice, first 
with 500 µl of buffer RPE and next with 500 µl of 80% ethanol. The columns were spun at 8,000 x g for 
15 seconds for the first wash, 2 minutes for the second and at 12,000 x g for 5 minutes in a clean 
collection tube after both washes to remove any traces of solution. Columns were then placed in clean 
RNase-free tubes and RNA was eluted by addition of 14 µl of RNase-free water and centrifugation at 
12,000 x g for 1 minute. RNA was then measured using a Nanodrop spectrophotometer (Section 2.6.6) 
and stored at -80 °C. 
2.6.5 Reverse Transcription of RNA samples 
For RNA samples that were not used in a one-step qPCR reaction, the RNA was reverse transcribed to 
complementary DNA (cDNA). RNA samples were first treated with Turbo DNase followed by Turbo 
DNAse inactivation reagent (Section 2.6.3) and then purified (Section 2.6.4). To obtain cDNA, the RNA 
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sample was reverse transcribed using SuperScript III reverse transcriptase (Invitrogen) and a poly(dT) 
primer (Sigma). Briefly, the necessary amount of RNAse-free water was added to a PCR tube for a 
reaction volume of 13 µl for the given sample followed by 300 ng of oligo (dT)18, 1 µl of 10 mM dNTP 
mix and 1 µg of total RNA. The mixture was heated to 65 °C for 5 minutes followed by a 1-minute 
incubation on ice. Then 4 µl of 5X first-strand buffer, 1 µl 0.1 M DTT, 1 µl RNaseOUT Recombinant 
RNase Inhibitor and finally 1 µl of SuperScript III RT (200 units/µl) were added. The reaction was 
incubated for 60 minutes at 50 °C and then heat-inactivated at 70 °C for 15 minutes. RNA was then 
digested by the addition of 1 µl of RNase H and incubation at 37 °C for 20 minutes, followed by heat-
inactivation at 65 °C for 20 minutes. 
2.6.6 Nucleic acid quantification 
The quantity and quality of nucleic acid samples (total RNA and dsDNA) was estimated using UV/VIS 
spectrophotometry using 1 ul of sample and a NanDrop 1000 Spectrophotometer (ThermoFisher). 
2.6.7 Restriction Digest and FastAP treatment 
Digestion of double-stranded DNA was required for generation and cloning of rSFV4 infectious 
plasmids and was achieved using FastDigest restriction enzymes (ThermoFisher). This enabled 
insertion of manufactured dsDNA sequences (GenScript) into icDNA SFV4 plasmid backbones for the 
development of new rSFV4 viruses. FastAP thermosensitive alkaline phosphatase (ThermoFisher) was 
used to catalyse the release of the 5' phosphate group from linearised icDNA SFV4 plasmids acting as 
a backbone prior to ligation. FastAP thermosensitive alkaline phosphatase and all FastDigest 
restriction enzymes used (BamH I, ApaI, Bpu10I, SacI, NotI, SpeI, HpaI) (ThermoFisher) have an optimal 
reaction temperature of 37 °C and are active in FastDigest Buffer (ThermoFisher). Reactions were set 
up in sequential order with nuclease-free water up to 20 µl, 2 µl of 10 X FastDigest Reaction Buffer, 1 
µg of the given plasmid, 1 µl of each required restriction enzyme and 1 µl of FastAp thermosensitive 
alkaline phosphatase for digesting backbone (FastAp not added to insert). Reaction mictures were 
incubated for 2 hours at 37 °C followed by heat-inactivated by heating at 80 °C for 10 minutes. 
2.6.8 DNA Ligations 
DNA ligations were performed using T4 DNA Ligase (Thermo Fisher). Briefly, insert and backbone DNAs 
were mixed together in a 3:1 molar ratio up to a total of 100 ng of DNA in x µl (where x is ≤ 7 µl) in a 
PCR tube. Then seven minus x µl of nuclease-free water was added, followed by 2 µl of 5 X ligation 
buffer and finally 1 µl of T4 ligase. The reaction was mixed well and centrifuged at 500 x g for 15 
seconds, then left in water and ice to warm gradually to room temperature overnight. The following 
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morning ligation reactions were taken out of the water bath and left at room temperature for 5 hours 
followed by transformation into competent bacteria cells (Section 2.5.3). 
2.6.9 Gel Electrophoresis 
Linearised DNA was analysed and separated by agarose gel electrophoresis. DNA was run on an 
agarose gel with the ideal agarose concentrations depending on the size of DNA  0.8% (for >10kb), 1% 
(for 2-10kb), 1.5% (1kb-4kb), 2% (50bp-1kb). Agarose was dissolved in 1 X TAE buffer with 0.5 µg/ml 
ethidium bromide (ThermoFisher). Samples that did not contain FastDigest Green Buffer 
(ThermoFisher) or GoTaq Green Buffer (Promega), used in the restriction digest or PCR reaction 
respectively, were mixed with 6X loading dye (ThermoFisher). DNA samples were loaded into 
individual lanes alongside appropriate DNA molecular size markers: GeneRuler 100 bp plus or 
GeneRuler 1 kb plus (ThermoFisher). DNA fragments were resolved by gel electrophoresis  (between 
40 and 100 volts depending on the size of DNA being separated and the percentage of agarose in gel) 
for 45-120 minutes. Nucleic acid bands were visualised using a BioRad Gel Doc XR+ UV transilluminator 
(BioRad). 
2.6.10 Extraction of DNA from gels 
DNA was extracted from TAE agarose gels using the Isolate II PCR and Gel Kit (Bioline). Briefly, under 
UV illumination the given DNA band was excised from the gel using a sterile scalpel and placed in a 
nuclease-free microtube. The excised gel was weighed and 200 µl of Binding Buffer CB was added per 
100 mg of gel, followed by incubation at 50 °C for 10 minutes with intermittent vortexing. Samples 
were loaded onto Isolate II PCR and Gel Kit columns placed in collection tubes and centrifuged for one 
minute at 11,000 x g (~13,000 rpm). The flow-through was discarded and the membrane was washed 
twice with 700 µl Wash Buffer CW added to the column with centrifugation for one minute at 11,000 
x g after each wash; the flow-through was discarded after each spin. The membrane was then dried 
by centrifugation for 2 minutes at 11,000 x g and the DNA was then eluted into a nuclease-free 
microtube by addition of 15 µl of 70 °C Elution Buffer C. The concentration of the extracted DNA was 
measured by NanoDrop (Section 2.6.6) and the samples were stored at -20 °C. 
2.6.11 Blunt-end TOPO cloning  
The PCR products were confirmed by gel electrophoresis (Section 2.6.9) to be of a suitable size to 
correspond to the distance between the two primers in the SFV4 genome. The Zero Blunt TOPO PCR 
Cloning Kit (Invitrogen) was used to clone the blunt PCR product into a suitable vector, pCR-Blunt II-
TOPO, to enable amplification and DNA sequencing. Briefly, 4 µl of each PCR reaction (after DNA 
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polymerase had been deactivated) was mixed with 1 µl of salt solution and 1 µl pCR-Blunt II-TOPO 
reagent. The reaction was incubated for 30 minutes at room temperature, followed by incubation on 
ice and transformation into competent JM109 cells (Section 2.5.3). 
2.6.12 Standard PCR 
Standard PCR was performed using Q5 High-Fidelity DNA polymerase (New England Biolabs) when 3’-
5’ exonuclease activity was used to minimise possible errors during polymerisation. Other standard 
PCRs were conducted using GoTaq G2 DNA polymerase (Promega). The 50 µl reactions contained 1 µl 
of 10 mM dNTPs, 2.5 µl of 10 µM forward primer, 2.5 µl of 10 µM reverse primer, 10-100 ng of 
template DNA or 2 µl of cDNA from reverse transcription reaction (Section 2.6.5), 10 µl of 5 X Q5 or 
GoTaq reaction buffer, 0.5 µl Q5 or GoTaq G2 DNA polymerase and nuclease-free water to make up 
the total volume to 50 µl. Water was added first, followed by buffer, then all other reagents and finally 
enzyme. The PCR reactions were performed using a standard thermocycler.  The initial denaturation 
stage was set at 98 °C for 30 seconds (Q5 reactions) or 95 °C for 2 minutes (GoTaq reactions). The 
cycling stage was set for 30-35 cycles and consisted of denaturation, annealing and elongation steps 
in succession. The denaturation was set to 98 °C for 10 seconds for Q5 reactions and 95 °C for 30 
seconds for GoTaq reactions. The annealing temperature was set depending on the primer pair used 
(Table 2.2) for 30 seconds for both Q5 and GoTaq reactions. The elongation step was set to 72 °C for 
all reactions plus 30 seconds per kb for Q5 polymerase and one minute per kb for GoTaq polymerase. 
After the cycling stage, a final extension stage of 72 °C for 2 minutes (Q5 reactions) and 5 minutes 
(GoTaq reactions) was incorporated into the cycling parameters to ensure completion of DNA chain 
elongation before holding the reactions at 4 °C. PCR products were stored long-term at -20 °C. 
Standard PCR primers 
PCR primers used in this study are shown in table 2.2: 
 
 
Table 2.2 Primers used in this study for standard PCR 
 
Primer Name Primer Sequence 
Annealing temperature 
used (OC) 
B4-ApaI-FWD 5'-GGTGCAGAAAATCTCGGGTG-3' 54 
B4-BamHI-FWD 5'-GCCAGGTGGACAAGATCAAG-3' 54 
ORF37StopFA 5’-GACATCGACGGAGGAAGCAG-3’ 60 
ORF37StopRB 5’-GTCTTTGATGTTGCCAGGAG-3’ 60 
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2.6.13 Colony PCR 
When it was necessary to detect correct cloning products from a ligation reaction and subsequent 
bacterial transformation, a colony PCR was utilised. Briefly, reactions with GoTaq G2 DNA polymerase 
were set up identical to those described above (Section 2.6.12) in a 96-well plate with the exception 
of no template added. Colonies were then picked with a sterile pipette tip, rinsed briefly into the PCR 
reaction mixture in the 96-well plate and then spread on a corresponding numbered grid on a 
kanamycin LB agar plate. The reaction followed the PCR protocol for GoTaq G2 DNA Polymerase 
(Section 2.6.12) in a standard thermocycler with an additional 8 minutes for the initial denaturation 
step. Colony PCR products were run through an agarose gel by gel electrophoresis (Section 2.6.9). 
Colonies corresponding to correct inserts (based on positive PCR reactions) were selected for and used 
to inoculate 5 ml of LB Broth with Kanamycin (50 µg/ml). The overnight cultures were then used in 
mini plasmid DNA preparationa (Section 2.5.4) followed by sequencing (Section 2.6.14) 
2.6.14 Sequencing 
All recombinant plasmids were sequence-verified by commercial sequencing (Source biosciences, 
Nottingham, UK). Results were aligned and edited using ApE plasmid Editor. 
2.7 Genetic reversion analysis of viral mutants 
Viral mutants were assessed for genetic reversion to wild-type strain sequence or other genetic 
variation by PCR and/or sequencing analysis. For this assessment genetic material from SFV4 
((+)ssRNA virus) was reverse transcribed while that from MHV-68 (dsDNA virus) was used directly.  
2.7.1 Genetic reversion analysis of rSFV4-URE/CSE viruses 
The URE/CSE deletions and additions to the 3’NTR of the SFV4 genome manufactured in this study 
were checked for genetic reversion in virus stocks. Genetic reversion could occur during propagation 
of the virus from icDNA plasmids through genetic mutation during viral replication.  
Screening of rSFV4-URE/CSE mutants for alterations in the 3’UTR 
NIH/3T3 monolayers were infected with each of the SFV4-2SG-Gluc and SFV4(3F)-eGFP viruses (Table 
2.1) at MOI of 10 and cells were collected at 9 hours post infection (h.p.i.). Briefly, 6-well plates were 
seeded with 3 X 105 NIH/3T3 cells and incubated at 37 °C with 5% CO2. When the monolayers reached 
75-80% confluence, medium was removed, and 500 µl of test rSFV4 virus diluted in PBSA was added 
to the cell monolayer. The cells were incubated at room temperature for one hour with gentle rocking. 
This was followed by removal of virus in PBSA and replacement with 3 ml of pre-warmed cDMEM-10 
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and incubation at 37 °C with 5% CO2. At 9 h.p.i. medium was removed and cells were collected by 
trypsinisation and centrifugation as described (Section 2.1.2). RNA was then extracted (Section 2.6.1), 
treated with Turbo DNase (Section 2.6.3), purified and concentrated (Section 2.6.4). Purified viral RNA 
was then used for cDNA synthesis using oligo (dT)18 (Section 2.6.5). The 3’NTR of region of viruses 
was amplified by PCR (2.6.12) using the primers ‘3’race’ and either ‘B4-ApaI-FWD’ or ‘B4-BamHI-FWD’ 
for the rSFV4-2SG-Gluc viruses and the rSFV4(3F)-eGFP viruses respectively. PCR products were cloned 
into pCR-Blunt II-TOPO (Section 2.6.11) and grown on kanamycin LB agar plates (Section 2.5.1). 
Colonies were analysed by colony PCR (Section 2.6.13) for the presence of the 3’NTR in SFV4 genomes. 
Colonies with correctly cloned sequences were selected to inoculate 5ml of LB Broth with Kanamycin 
(Section 2.5.1) and grown overnight at 37 °C. Bacterial culture was used for mini-prep plasmid 
extraction (Section 2.5.4). Purified plasmids were verified by sequencing (Section 2.6.14) utilising the 
primers ‘M13-For’ and ‘M13-Rev’ which are complementary to 5’ and 3’ of the insert site of the pCR-
Blunt II-TOPO vector. 
2.7.2 Analysis of genetic reversion of MHV-68 ORF37stop virus 
The MHV-68 ORFstop mutant stock was checked for reversion by proteolytic lysis of virions and 
subsequent PCR using viral DNA as the template. The MHV-68 viral stock was used as a control.  A 50 
µl reaction as set up using GoTaq G2 polymerase as described (Section 2.6.12) with the exception of 
the addition of 1 µl of proteinase K recombinant PCR grade (ThermoFisher) instead of GoTaq DNA 
polymerase. The template used was 1µl of the test virus stock. The reaction mixture was then 
incubated for 20 minutes at 55 °C followed by enzyme deactivation by heating to 95 °C for 10 minutes. 
Following deactivation and cooling, 0.25 µl of GoTaq G2 DNA polymerase (5U/µl) was added to the 
reaction mixture followed by the PCR reaction (section 2.6.12) for 35 cycles with an annealing 
temperature of 60 °C. 15 µ each PCR reaction was used in a diagnostic restriction enzyme digest 
(Section 2.6.7) using HpaI for 2 hours. Results were analysed by gel electrophoresis on a 2% agarose 
gel (Section 2.6.9). 
2.8 Immunostaining and Confocal Microscopy 
Sample preparation 
Immunostaining was performed in 24-well plates (Nunc). Prior to seeding cells, a sterile poly-D-lysine 
coated 12mm sterile coverslip was placed in each well. NIH/3T3 cells were seeded at 50,000 cells per 
well 12 hours prior to SFV infection (Section 2.4.1) and at 75,000 cells per well post MHV-68 infection 
(Section 2.4.1). Following infection, cells were incubated at 37 °C and 5% CO2 until they were fixed at 




Fixing of adherent cells and immunostaining 
At the required time post infection, medium was removed and cells were washed twice for 1 minute 
in sPBS. Cells were then fixed for 10 minutes in 4% paraformaldehyde (PFA, Sigma-Aldrich). PFA was 
made fresh prior to fixing by dissolving 4g of paraformaldehyde in 100 ml of sPBS with 67 µl of 5M 
NaOH and heating at 55 °C until dissolved. The PFA was then cooled to room temperature and 
adjusted to pH 7.4 with HCl. Cells were then washed three more times in sPBS for 5 minutes each and 
then treated with 0.3% Triton-X-100 (Sigma-Aldrich) in sPBS for 10 minutes followed by a single 5 
minute wash in sPBS. To block non-specific binding sites, the cells were then subjected to blocking by 
adding 5% normal goat serum (NGS, Sigma-Aldrich) in sPBS for 30 minutes. The NGS was then removed 
and immediately followed by incubation with primary antibody(s) for 1 hour. Primary antibodies were 
used simultaneously in concentrations as stated (table 2.3) diluted in sPBS with 1% NGS. Following 
incubation, primary antibodies were removed and cells were washed three times for 5 minutes each 
using sPBS. Secondary antibodies were then added and incubated at room temperature in the dark 
for 1 hour. Secondary antibodies (Table 2.3) were used at a dilution of 1 in 500 in sPBS with 1% NGS. 
Following antibody incubation, the cells were washed three more times in sPBS for 5 minutes each 
time. Nuclear staining was then achieved by addition of NucBlue® Reagent (2 drops per ml of sPBS, 
ThermoFisher) or TO-PRO®-3 Iodide (2 µl per 1ml of sPBS, ThermoFisher) and incubated for 15 
minutes. Nuclear staining was followed by three washes in sPBS for 5 minutes each. Coverslips were 
then mounted on microscope slides (Superfrost) using 10 µl of Vectashield® Antifade Mounting 
Medium (VectorLabs) and stored in the dark at 4 °C until imaging. Immunostained cells were imaged 
on a Zeiss LSM 510 confocal microscope using AIM image software.  
Image data analysis 
Image analysis was conducted using Image J software. To calculate the percentage of a protein 
(staining) found in the nucleus or cytoplasm compared to that found in the whole cell, the signal 
(corrected integrated density) from the area was divided by the signal (corrected integrated density) 
obtained from the whole cell. Integrated density was corrected for background fluorescence using the 











Host Target Primary / 
secondary 
Antibody Type Dilution used  Source 
Anti-HuR (19F12AE12) Mouse HuR Primary 
Monoclonal, IgG1 
1 in 200  Abcam, ab170193 
Anti-PABPC Rabbit 
PABPC, C-terminus 
Primary Polyclonal, IgG 1 in 200  Abcam, ab21060 
Anti-mrnp41 (D-18) Rabbit 
RAE1 (mrnp41), 
internal region 
Primary Polyclonal, IgG 1 in 400 Santa Cruz, sc-74891 
Anti-TTP (H-20) Rabbit 
TTP,  
C-terminus 



















1 in 3 
Dr Stevenson, 
Cambridge University 
Alexa Fluor 488 goat anti-mouse, 
high-cross adsorbed 
Goat Mouse IgG (H+L) Secondary Polyclonal, IgG 1 in 500 
ThermoFisher, A-11029 
Alexa Fluor 568 goat anti-rabbit, 
highly cross-adsorbed 
Goat Rabbit IgG (H+L) Secondary Polyclonal, IgG 1 in 500 
ThermoFisher, A11036 
Alexa Fluor 568 goat anti-mouse, 
preadsorbed 
Goat Mouse IgG (H+L) Secondary Polyclonal, IgG 1 in 500 Abcam, ab175701 
Alexa Flour 633,  
goat anti-rabbit 




2.9 In vitro characterisation of rSFV4 URE/CSE mutants 
2.9.1 rSFV4-2SG-Gluc one-step and multi-step growth curves 
Cell preparation, infection and sample acquisition  
NIH/3T3 monolayers were infected with rSFV4-2SG-Gluc viruses at an MOI of 0.01 or 10 and samples 
were taken at suitable time points for quantification of luciferase activity and infectious virus. Briefly, 
6-well plates were seeded with 3 X 105 NIH/3T3 cells and incubated at 37 °C with 5% CO2. Infections 
for each rSFV4-2SG-Gluc virus at each MOI were set up in triplicate wells. When the monolayers 
reached 75-80% confluence, medium was removed and 500 µl of the given rSFV4-2SG-Gluc virus at 
the required MOI diluted in PBSA was added onto the cells in the given well (time point 0). The cells 
were incubated at room temperature for 1 hour with gentle rocking. This was followed by removal of 
virus in PBSA and replacement with 3 ml of pre-warmed cDMEM-10 and incubation at 37 °C with 5% 
CO2. Samples (2 X 200 µl) were taken at 0, 3, 6, 9, 12, 18, 24 and 48 hours post-infection and frozen 
immediately at -20 °C or -80 °C for luciferase and plaque assays respectively. Medium removed for 
samples was replaced with 400 µl of sterile cDMEM-10 at each time point. Plaque assays for growth 
curves of rSFV4 were conducted in 24-well plates as described (Section 2.4.2). 
Luciferase assay  
To measure the activity of secreted Guassia luciferase, 5 µl of each medium sample was added to a 
96 well plate for each time point and then assayed for luminescence using the Dual Luciferase 
Reporter Assay (Promega) and a GloMax-Multi detection luminometer (Promega). The luciferase 
assay substrate and buffer and the stop-n-glow substrate and buffer were diluted 1 in 10 with milliQ 
water compared to manufacturers recommended concentrations. Each well was analysed by initially 
adding 70 µl of luciferase assay substrate to initiate the FFluc reaction. This was followed by addition 
of 70 µl of diluted Stop&Glo substrate and buffer to quench the FFluc reaction and initiate the Rluc 
reaction. Both reactions were given a 10 second equilibration time and a 10 second integration time. 
The Rluc activity was measured by the luminometer in relative light units. The Rluc reading 
corresponded to the activity of the levels of Gluc in the given sample. Gluc readings were normalised 
against non-infected controls, firefly readings have not been reported in this report.  
2.9.2 rSFV4-infected cell viability and caspase 3/7 assays 
Cell preparation, infection and sample acquisition 
The effect of the URE/CSE alterations on SFV4-induced host cell caspase activity and cell death were 
analysed using the Caspase-Glo 3/7 Assay (Promega) and CellTiter-Glo 2.0 Assay (Promega). The two 
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assays were conducted simultaneously on separate plates. Cells were infected with rSFV4-2SG-Gluc 
URE/CSE mutant viruses at MOI of 10 and 0.01. Briefly, 96-well plates were seeded with 7,500 NIH/3T3 
cells per well (Section 2.1.2). When cells were ~75% confluence, medium was removed and 20 µl of 
the given virus in PBSA was added to cells (this is time point 0) followed by incubation for one hour at 
room temperature with gentle rocking. The virus inoculum was then removed and 100 µl of cDMEM-
10 was added to wells followed by incubation at 37 °C and 5% CO2. Cells were prepared for analysis at 
regular intervals post-infection from 0 to 72 hours. Cells without virus treatment acted as negative 
control.  All infections were performed in triplicate. 
CellTiter-Glo 2.0 Assay 
CellTiter-Glo® 2.0 measures the level of metabolically active cells by measuring ATP present in a 
sample through the emission of a luminescent signal from the ATP- dependent mono-oxygenation of 
luciferin molecules by a recombinant luciferase enzyme. When cells die they become metabolically 
inactive and the available ATP is diminished, thus a decrease in luminescence signal signifies cell death. 
CellTiter-Glo® 2.0 assay plates were first equilibrated to room temperature for 30 minutes, then 100 
µl of CellTiter-Glo® 2.0 Reagent was added to each well and the side of the plate was vigorously tapped 
for 2 minutes to ensure complete cell lysis. Luminescence signal was stabilised by incubating the plate 
for 10 minutes at room temperature before reading the luminescence signal using the GloMax-Multi 
detection luminometer with a one second integration time. 
The Caspase 3/7 Assay 
The Caspase-Glo® 3/7 assay system was used to assess cell death because of apoptosis by measuring 
the relative activities of caspase 3 and/or 7 in cells. In addition to virus-infected cells, a negative 
control (no virus infection), and a blank reaction control containing Caspase-Glo® 3/7 reagent and 
cDMEM-10 alone were also run in triplicate per plate for subsequent normalisation calculations. 
Briefly, at the correct time point, plates were removed from the incubator and held at room 
temperature for 20 minutes. Then 75 µl of cDMEM-10 was removed from each well and 25 µl of 
Caspase-Glo® 3/7 assay was added. Lysis was ensured by tapping the side of the plate vigorously for 
2 minutes followed by one hour incubation at room temperature to reach peak, stable luminescence 
signal. Luminescence signal was measured using the GloMax-Multi Detection Luminometer with a one 




2.10 Quantitative real-time polymerase chain reaction  
2.10.1 RT-qPCR of host transcripts using Pfaffl method 
Cell preparation and rSFV4 infection 
Six-well plates were seeded with 3 x 105 NIH/3T3 cells per well (Section 2.1.2). When 75-80% 
confluent, cells were infected (Section 2.4.1) with SFV4-2SG-Gluc, SFV4-2SG-Gluc-dURE or SFV4-2SG-
Gluc-5xURE at a MOI of 10 with 3 replicates per virus and 3 replicate NIC wells. Cells were then 
incubated in cDMEM-10 at 37 °C and 5% CO2. At 6 and 12 h.p.i. medium was removed and cells were 
trypsinised and pelleted as described (Section 2.1.2). Cells were then washed in 1 ml ice-cold sPBS and 
placed in a RNase-free microtube ready for nuclear and cytoplasm fractionation with RNA extraction 
(Section 2.6.2), Turbo DNase treatment (Section 2.6.3) and subject to qPCR. 
Cell preparation and MHV-68 infection 
NIH/3T3 cells were infected with MHV-68 or MHV-68 ORF37stop as described (Section 2.4.1) and then 
seeded in 6-well plates at 1 x 106 cells/well. RNA samples were taken at 9 h.p.i. as described for SFV4 
infection. 
One-step qRT-PCR of RNA samples 
Purified and DNase-treated nuclear and cytoplasmic RNA samples were reverse-transcribed and 
quantified using a 1-step SYBR Green qPCR reaction and results analysed using the 2-∆∆CT Livak method. 
18S ribosomal RNA gene was used as reference for normalization of input total RNA between samples. 
All primers were used with 10 ng of purified total RNA sample apart from 18S RNA which was used 
with 100 pg of purified total RNA because of the high prevalence of 18S RNA present in eukaryotic 
cells. A Power SYBR® Green RNA-to-CT™ 1-Step Kit (ThermoFisher Scientific) was utilised for all qPCRs 
in this project. Briefly, 10 ng of the given purified RNA template sample was used for each reaction in 
a 96-well reaction plate. Reactions were repeated in triplicate wells for each replicate sample and 
primer set used (Table 2.4). Negative controls contained all PCR reaction components including 
primers but no RNA. For each independent variable (different viruses used and NIC) a master mix of 
221 µl of dH2O, 250 µl of 2x RT-PCR mix (2x) and 4 µl of 125x RT enzyme mix was added to an RNase-
Free tube and vortexed. Seventy-six microlitres of the master mix was added to a separate RNase-free 
tube to which 400 pg of the given template diluted in RNase-Free water was added and briefly 
vortexed. This less concentrated template mix was used for the 18S RNA qPCR reactions. 210 ng of 
the given template was added to the remaining master mix and briefly vortexed. 19 µl of the template 
reaction mix was then added to the corresponding well of a 96-well plate. For the negative controls, 
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79.56 µl of water, 90 µl of 2x RT-PCR mix and 1.44 µl of 125x RT enzyme mix were added to an RNase-
free tube, vortexed and 19 µl of this was added to each negative control well. Then 1 µl of diluted 
primer pair was added to each designated well to give a final primer concentration of 100 nM. Samples 
were run in a StepOnePlus® RealTime PCR System (Applied Biosystems). The reaction underwent three 
stages. The first was a reverse transcription (RT) step of 48 °C for 30 minutes to reverse transcribe the 
RNA samples in to cDNA. The second stage activated the PCR enzyme by heating to 95 °C for 10 
minutes. The final stage was 40 cycles of two steps in succession. The first of these was a denaturation 
step of 95 °C for 15 seconds and the second was an annealing and extension step of 60 °C for 1 minute. 
Calculation of amplification efficiency of primer pairs 
Each primer pair was subject to qPCR using the same kit at different concentrations of template to 
work out the primer efficiencies. For each primer pair, dilutions of RNA template of 100 ng, 10 ng, 1 
ng, 100 pg and 10 pg were used. Amplification efficiency was calculated using the slope of the standard 
curve of CT values from the concentration gradient in the following formula: E = 10-1/slope. The 
amplification efficiency percentage was then worked out with the following formula: %E = (E-1) X 100.  
Calculating relative abundance of RNA samples using the 2-∆∆CT Livak Method 
The relative RNA abundance in a virus infected sample compared to a non-infected control (NIC) was 
calculated using the Livak method. The formula used was: 
Normalisation of the target gene to the reference gene for both control and test samples: 
∆CT(Test) = CT(Target, Test) - CT(Ref, Test) 
∆CT(Control) = CT(Target, Control) - CT(Ref, Control) 
Normalisation of ∆CT of the test sample to the ∆CT of the control sample: 
  ∆∆CT = ∆CT(Test) - ∆CT(Control) 
Calculation of the normalised expressed ratio: 
  2-∆∆CT = Expression Ratio 
The reference gene was 18S RNA, the control was RNA from NIC and the test sample was RNA from 
the given virus-infected sample. 
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Table 2.4 List of qPCR primers used in this study  
 
Target mRNA/cDNA Forward Primer  Reverse Primer  
18S RNA 5’-CGGACAGGATTGACAGA-3’ 5’-CAATCGCTCCACCAACTAA-3’ 
β-Actin 5’-AGGTGACAGCATTGCTTC-3’ 5’-GCTGCCTCAACACCTCAA-3’ 
IFN- β 5’-CCGAGCAGAGATCTTCAGGAA-3’ 5’-CCTGCAACCACCACTCATTCT-3’ 
HuR 5’-CCACATGGCGGAAGACTGC-3’ 5’-CACAAAACCGTAGCCCAAGC-3’ 
TTP 5’-CACCATGGATCTCTCTGCCA-3’ 5’-GGTCATGGCTCATCGACTGG-3’ 
RNase L 5’- GCATTGAGGACCATGGAGAC-3’ 5’- GGAGGAGAAGCTTTACAAGGT3 -3’ 
Caspase 9 5’-AGTTCCCGGGTGGTGTCTAT -3’ 5’-GCCATGGTCTTTCGCTCAC-3’ 
MHV-68 glycoproteinB 5’-TGTTGGATGTACCCTACAGT-3’ 5’-AGAGTGGTTGGCTGACATAC-3’ 
Cyclophilin A 5’-GGATTTGGCTATAAGGGTTC-3’ 5’-CTGCCGCCAGTGCCATTATG-3’ 
PARN 5’-CTCTTCAGCGCCTTCGGTAACAT-3’ 5’-TATTAACGGCAATTTGTACTTGT-3’ 
Xrn1 5’-GGAGTCATTCCTGATCGGGATGC-3’ 5’-ATTCCAATGACGGTGCCTCGAAG-3’ 
Hsp70 5’-ACAAGAGCACCGGCAAGGCC-3’ 5’-CTCGGCCTCCTGCACCATGC-3’ 
 
 
2.11 Statistical Analysis 
Graph pad Prism v7 was used for graph preparation, calculation of means, standard deviation (SD) and 
p-values. One-way or Two-way ANOVAs were used to assess significance of group data. Additionally, 
the Graph pad Prism multiple t-test was utilised to assess statistical significance at individual time 

































        PABPC and HuR subcellular localisation  
 
 













A broad range of host RNA-binding proteins are utilised by viruses to replicate their genomes and 
avoid host cell mediated RNA degradation. The TTR-RBPs discussed in chapter 1 play key roles in 
facilitating successful infection cycles for a broad range of virus families. Host TTR-RBPs, such as HuR, 
bind specific cis-acting sequences present in viral genomic RNA (RNA viruses) (Sokoloski et al., 2010; 
Shwetha et al., 2015) or in viral transcribed mRNA (DNA viruses) (Jehung et al., 2018). The binding of 
these host TTR-RBPs can directly affect the stability, splicing, nuclear export, translation or sub-cellular 
location of the host and viral RNA (Pullmann et al., 2007). TTR-RBPs can also act as adapter proteins 
to recruit other host cellular proteins to the bound RNA (Kim et al., 2009). Furthermore, the quenching 
of host TTR-RBPs after binding to viral RNA can reduce the availability of TTR-RBPs to bind to host-cell 
RNA affecting host-cell processes which utilise the TTR-RBPs (Hyde et al., 2015).  
3.2 HuR relocalisation in mammalian cells during alphaviral infection 
HuR, a TTR-RBP, binds mRNA in a cell affecting the mRNA stability (usually by increasing its half-life), 
mRNA translation and in some cases splicing, polyadenylation and/or nuclear export (Brennan and 
Steitz, 2001; Barnhart et al., 2013). Alphavirus genomic RNA, such as that of SINV, bind HuR during the 
course of an infection of host cells which is evident in both mammalian and mosquito cell lines 
(Sokoloski et al., 2010). During infection of mammalian cells with SINV, WEEV and CHIKV host HuR 
changes from a predominantly nuclear to a predominantly cytoplasmic distribution (Dickson et al., 
2012). In mosquito cells, where the sub-cellular distribution of HuR is more uniform there is no obvious 
change in distribution despite mosquito cellular HuR still binding to the alphaviral 3’UTR (Sokoloski et 
al., 2010). There is no direct confirmation of a change in sub-cellular distribution of HuR during SFV 
infection despite evidence that HuR binds SFV4 3’UTR. It has been previously postulated that nsP2 of 
SINV and other alphaviruses could be targeting HuR or the nucleo-cytoplasmic shuttling of HuR. This 
suggestion is rooted in the fact that viral nsP2 translocates partially in to the nucleus during infection 
where most HuR resides under basal conditions in mammalian cells (Sokoloski et al., 2010). 
3.3 SFV4 nsP2 nuclear localisation  
The nsP2 of SFV4 contains a nuclear localisation signal consisting of three arginines (RRR). An SFV4 
nsP2 mutant (SFV4-RDR) where the second arginine in the nuclear localisation signal is substituted for 
aspartic acid (RDR) loses its ability for nsP2 to enter the nucleus (Breakwell et al., 2007; Rikkonen, 
1996). In contrast to this finding nsP2, during infection of BHK-21 cells with SFV4-RDR, has been shown 
to partially relocate in to the nucleus (both at 8 and 24 h.p.i.) (Tamm, Merits and Sarand, 2008). The 
SFV4-RDR virus elicits a significantly larger Type I IFN response during infection of MEFs compared to 
SFV4 wild type virus suggesting a failure to inhibit the IFN response in host-cells following infection 
82 
 
(Breakwell et al., 2007). Interestingly in the same study, SFV4-RDR virus infection in mammalian cells 
inhibited host RNA production to comparable levels to SFV4 (Breakwell et al., 2007), although DNA 
synthesis was significantly less inhibited in an earlier study (Rikkonen, 1996).  
The shut off of host-cell transcription seen during old world alphaviral infection has been partially 
attributed, at least in part, to nsP2 function in the nucleus where it promotes the ubiquitination and 
subsequent degradation of Rbp1, a catalytic subunit of RNAPII (Akhrymuk, Kulemzin and Frolova, 
2012). This host shut off activity was demonstrated during infection of SINV and through expression 
of nsP2 from SINV, SFV and CHIKV in transient transfection assays (Akhrymuk, Kulemzin and Frolova, 
2012). Interestingly, a SINV mutant, SINV/2V/GFP, incapable of the catalytic processing of nsP2-nsP3 
and thus preventing nsP2 from entering the nucleus, inhibits host cell transcription significantly less 
than SINV (Akhrymuk, Kulemzin and Frolova, 2012). Taken together with the previous finding that 
SFV4-RDR inhibits host cell RNA transcription to comparable levels to SFV4 (Breakwell et al., 2007) this 
suggests that SFV4-RDR either allows enough nsP2 in to the nucleus to inhibit host cell transcription 
through ubiquitination of Rbp1 or inhibits host cell RNA production through other mechanisms.  
3.4 SFV4 icDNAs 
The full genome of many strains of most alphaviruses including SFV4 are encoded on expression 
plasmids as infectious cDNA (icDNA). The schematics of these are discussed more in Chapter 4. The 
icDNA can be transcribed in vitro to mRNA which can then be transfected in to host cells and produce 
infectious virus. Furthermore, if the expression vector contains a promoter capable of expression in 
the host cell then the icDNA can be transfected directly in to the cell to cultivate the virus. In this study 
SFV4s-Green was in-vitro transcribed from pSP6-SFV4(3F)-Zs-Green and the infectious mRNA was 
transfected in to BHK-21 cells. SFV4 and SFV4-RDR used were originally created from SP6 plasmids 
using an identical methodology. 
3.5 PABPC, gammaherpesviruses and muSOX 
Given PABPC roles in host RNA stability and translation it is not surprising that a diverse set of viruses 
families (Alvarez et al., 2006; Zhang et al., 2007; Piron et al., 1998; Blakqori, van Knippenberg and 
Elliott, 2009) inhibit PABPC’s roles in host cell protein production and/or utilise PABPC’s capabilities 
to increase viral RNA stability and translation.  As discussed in Chapter 1 infection of mammalian cell 
lines with a range of viruses result in the build-up of host PABPC in the nucleus (Blakqori, van 
Knippenberg and Elliott, 2009; Harb et al., 2008; Kumar and Glaunsinger, 2010). For 
gammaherpesviruses this has been attributed to a single viral protein, muSOX/SOX/BGLF5 (MHV-68 
(Covarrubias et al., 2009) / KSHV (Lee and Glaunsinger, 2009) / EBV (Park et al., 2014)), capable of 
causing nuclear retention of PABPC when expressed independently on an expression plasmid or during 
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virus lytic infection. However, at the time of this study, subcellular location of PABPC has not been 
investigated during lytic infection of mammalian cells with a gammaherpesvirus lacking a functional 
muSOX (or its homolog) gene. A MHV-68 virus lacking a functional muSOX gene, MHV-68 ORF37stop, 
results in lytic infection and RNA loss in a Type 1 IFN-receptor KO cell line (Sheridan et al., 2014). In 
this study MHV-68 ORF37stop was able to replicate in NIH/3T3 cells (a cell line with functional IFN-
receptors) and was used to assess the subcellular location of PABPC during infection without a 
function muSOX gene. 
3.6 Objectives 
The aim of this study was to determine: 
1. The subcellular location of HuR during SFV4, SFV4-RDR, MHV-68 and MHV-68 ORF37stop 
virus infection of NIH/3T3 cells. 
 
2. The subcellular location of PABPC during SFV4, SFV4-RDR, MHV-68 and MHV-68 ORF37stop 
infection of NIH/3T3 cells. 
 
3. The subcellular location of PABPC at multiple time points post infection with MHV-68 and 
MHV-68 ORF37stop infection in NIH/3T3 cells. 
 
3.7 Results  
The subcellular location of HuR during SFV4 and SFV4-RDR infection was assessed. HuR is 
predominantly found in the nucleus in basal conditions in mammalian cell lines. Following both SFV4 
and SFV4-RDR infection of murine NIH/3T3 cells, cellular HuR accumulated in the cytoplasm with a 
concomitant reduced abundance in the nucleus (Figure 3.1). This suggested that the nuclear 
localisation of nsP2 is not required for SFV4 induced HuR relocalisation from the nucleus to the 










Figure 3.1 HuR relocalises to the cytoplasm during SFV4 and SFV4-RDR infection. NIH/3T3 cells were 
infected with SFV4 or SFV4-RDR at 5 MOI and fixed at 6 h.p.i. Fixed cells were immunostained against 
PABPC (red) and HuR (green) with DAPI stain (blue).  
 
To confirm SFV4 virus replication in NIH/3T3 where HuR had relocalised to the cytoplasm, NIH/3T3 
cells were infected with SFV4(3F)-ZsGreen (Figure 3.2). The Zs-Green is fused with nsP3 and therefore 
indicates the subcellular location of nsP3 and by extension the replication complexes within 
spherules/CPV-1 within the cell (discussed in Chapter 1).  
 







The relocalised HuR did not exclusively co-localise with SFV4 nsP3 suggesting that the relocalised HuR 
in the cytoplasm may be omitted from the SFV4 replication complexes. There are some areas in the 
cytoplasm where HuR and PABPC did appear to co-localise but this may be due to the abundancy of 
the proteins and the intensity of the immunostaining.  
 
 
Figure 3.2 HuR partially relocalises to the cytoplasm in NIH/3T3 cells where SFV4(3F)ZsGreen is 
actively replicating and the relocalised HuR does not colocalise with viral nsP3. NIH/3T3 cells were 
infected with SFV4(3F)-ZsGreen at 10 MOI and fixed at 9 h.p.i. Fixed cells were stained against HuR 
(red) with DAPI (blue), nsP3-ZsGreen is shown in green. 
 
PABPC and HuR sub-cellular location were also assessed in the context of MHV-68 and MHV-68 
ORF37stop infection (Figure 3.3). During MHV-68 infection PABPC abundance increased in the 
nucleus. In the cells where PABPC relocated to the nucleus the HuR staining was less intense however 
unlike during SFV4 infection HuR remained nuclear. This suggests that MHV-68 infection of NIH/3T3 
cells resulted in PABPC relocation to the nucleus. Futhermore, there may be a small reduction in HuR 
protein expression. This possible reduction appears to be evident during infection with MHV-68 
ORF37stop virus suggesting the muSOX is not responsible for the possible reduction in intensity of 
HuR immunostaining. 






During infection of NIH/3T3 cells with MHV-68 lacking a functional muSOX protein, host PABPC 
remains predominantly in the cytoplasm. The increased abundance of PABPC in the nucleus following 
MHV-68 infection and the absence of this during MHV-58 ORF37stop infection confirms that muSOX 



















Figure 3.3 MHV-68 with functional muSOX gene causes PABPC to relocate to the nucleus. NIH/3T3 
cells were infected with MHV-68 or MHV-68 ORF37stop at MOI of 1 and fixed at 12 h.p.i. Cells were 
stained against PABPC (red), HuR (green) and DAPI stain (blue). PABPC resides in the cytoplasm under 
basal conditions, relocated to the nucleus following MHV-68 infection and remained in cytoplasm 


















Utilisation of an antibody against MHV-68 glycoprotein confirmed MHV-68 was actively replicating in 
NIH/3T3 cells in which PABPC became retained in the nucleus. Furthermore, this confirmed that MHV-
68 ORF37stop virus was capable of replicating in cells without apparent relocalisation of PABPC to the 











Figure 3.4 MHV-68 ORF37stop fails to cause PABPC nuclear retention despite active replication in 
NIH/3T3 cells. NIH/3T3 cells were infected with MHV-68 or MHV-68 ORF37stop at MOI of 5 and fixed 
at 24 h.p.i. Cells were stained against PABPC (red), MHV-68 glycoprotein (green) and DAPI stain (blue).  
 
NIH/3T3 cells were infected with MHV-68 or MHV-68 ORF37stop virus and every two hours post 
infection the percentage of PABPC which was nuclear at each time point was calculated (Figure 3.5). 
There was a significantly higher percentage of PABPC in the nucleus compared to the cytoplasm in 








 Overlay with DAPI  
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MHV-68 ORF37stop or NIC (p=>0.01). The PABPC nuclear build-up was a gradual process accumulating 
over time post lytic infection with MHV-68.  
There was no significant difference (p=<0.05) in the percentage of PABPC that is nuclear at any time 
point post infection with MHV-68 ORF37stop virus compared to NIC (Figure 3.5). This confirmed that 
the absence of PABPC build-up during MHV-68 ORF37stop infection was not a delayed or intermittent 




Figure 3.5 PABPC sub-cellular relocation to nucleus during MHV-68 infection is a gradual process 
beginning 4-8 h.p.i. and steadily increasing over the course of cellular infection. NIH/3T3 cells were 
fixed and immunostained against PABPC every two hours post infection with MHV-68 or MHV-68 
ORF37stop virus. The influx and nuclear retention of PABPC during MHV-68 infection was statistically 
significant from 8 h.p.i. onwards compared to NIC and MHV-68 ORF37stop. The percentage of nuclear 
PABPC during MHV-68 ORF37stop infection was not statistically different to NIC at any time point post 
infection but a higher variation between cells was observed. 
 
3.8 Discussion 
HuR has been shown to bind to the URE/CSE element of the SINV 3’UTR in the context of a SINV 
infection in both mammalian and mosquito cells (Sokoloski et al., 2010). Furthermore, it has also been 
demonstrated HuR binds to the 3’UTR of SFV expressed on capped and polyadenylated reporter RNAs 
in cell-free mosquito cell extracts (Sokoloski et al., 2010). The relocalisation of HuR to the cytoplasm 










































has been documented in mammalian cells during SINV, WEEV, CHIKV and RRV infection (Dickson et 
al., 2012) but at the time of this study, this observation was yet to be made during SFV infection. This 
study confirms that, akin to infection with other alphaviruses, HuR subcellular location changes from 
a predominantly nuclear distribution to a cytoplasmic one in NIH/3T3 cells following infection with 
SFV4.  
The cytoplasmic HuR observed during SFV4 infection in NIH/3T3 cells co-localised with PABPC. This 
may be attributed to both HuR and PABPC binding the SFV4 genomic RNA (Sokoloski et al., 2010). HuR 
has been shown to bind the SFV4 3’UTR and SFV4 genomic RNA contains a poly(A) tail, possibly 
maintained by nsP4 terminal adenylyltransferase activity (Rubach et al., 2009; Tomar et al., 2006), 
which will bind host PABPC. There are also small intensely stained foci of PABPC and HuR staining that 
occur in some infected cells. These foci may be attributed to stress-granules. PABPC and HuR are 
known to localise within stress-granules in mammalian cells (Buchan and Parker, 2009) however 
further study is required to confirm the identity of the PABPC and HuR foci observed in this study. 
SFV4 is known to stimulate stress-granule formation via eIF2alpha phosphorylation and then locally 
disassemble the stress-granules in areas of the cytoplasm containing high viral RNA concentration 
(McInerney et al., 2005). 
It has been postulated that a viral protein may be responsible for the initial influx of HuR to the 
cytoplasm and that nsP2 which partially resides in the nucleus during alphaviral infection may be 
responsible for this observation (Sokoloski et al., 2010). However, this study has shown the HuR 
relocalisation still occurs within six h.p.i. following infection with SFV4-RDR virus. This suggests that 
the nuclear localisation of nsP2 is not required for the initial relocalisation of HuR to the cytoplasm 
during SFV4 infection in NIH/3T3 cells. This does not exclude cytoplasmic nsP2 or another viral protein 
from being responsible for an initial influx of HuR to the cytoplasm. Furthermore, nsP2 following 
infection with SFV4-RDR partially resides in the nucleus during SFV4 infection of mammalian cells 
(Tamm, Merits and Sarand, 2008). 
It is evident that HuR does relocate to the cytoplasm after 24 hours following transfection of URE/CSE 
SINV containing RNAs (Barnhart et al., 2013). This suggests that a viral protein is not required for the 
ultimate sub-cellular location of HuR post-infection during SINV infection but may be responsible for 
the initial influx from the nucleus.  It should be noted that HuR is a nucleo-cytoplasmic shuttling 
protein, which constantly shuttles between the nucleus and cytoplasm (Kim and Gorospe, 2008). In 
physiological conditions, the vast majority of HuR resides in the nucleus. Therefore, if URE/CSE SINV 
containing RNAs bind HuR and retain it in the cytoplasm then over time as HuR shuttles between the 
two cellular compartments its cytoplasmic distribution may increase. Whether or not the URE/CSE 
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element is responsible alone for the change in distribution of HuR seen during SFV4 infection or 
another initial trigger is involved is investigated in Chapter 4.  
Akin to many TTR-RBPs, the phosphorylation state of HuR is thought to have varying degrees of control 
on its subcellular location (Kim and Gorospe, 2008; Pullmann et al., 2007). There is evidence that 
during SINV infection host HuR is partially dephosphorylated compared to mock infected cells (Dickson 
et al., 2012). This suggests that SINV infection causes an alteration in the phosphorylation state of HuR 
which may be at least in part responsible for its change in sub-cellular location, or possibly a 
consequence of the change in sub-cellular location.  
HuR can also be induced to a predominantly cytoplasmic distribution following certain cellular 
stressors as discussed in chapter 1 (Bhattacharyya et al., 2006). It is therefore possible that the stress 
of the viral infection of alphaviruses may be contributing to the change in HuR sub-cellular localisation. 
It should be noted that HuR remains nuclear in many other viral infections, including MHV-68 as 
assessed in this study as well as measles and dengue virus infections (Dickson et al., 2012). The 
significance of the URE and CSE of the SFV4 3’UTR to induce the build-up of HuR in the cytoplasm 
during SFV4 infection and the subsequent consequences of this were investigated in Chapter 4.  
The nuclear HuR which has relocalised during SFV4 infection to the cytoplasm does not appear to co-
localise with viral nsP3. SFV4 nsP3 (green, Figure 3.2) localises within replication complexes where the 
SFV4 RNA is actively replicating. These replication structures (as discussed in Chapter 1), built-up of 
membrane in-vaginations and SFV4 nsPs, form at the plasma membrane and later fuse with 
endosomes in the cytoplasm to create cytopathic vacuoles type 1 (CPV-1) (Kujala et al., 2001; Frolova 
et al., 2010). These replication spherules are thought to restrict access to many host cellular proteins 
by physical hindrance thus allowing viral replication to occur in the absence of many host cellular 
proteins (Kallio et al., 2016; Kujala et al., 2001).  
The possible reduction of HuR staining intensity following MHV-68 and MHV-68 ORF37stop infection 
may indicate a reduction in HuR expression however further protein expression analysis, such as 
western blot, are required to confirm this reduction in HuR protein levels. The possible reduction in 
HuR protein levels appears to be evident during MHV-68 ORF37stop infection suggesting this possible 
reduction is not predominantly a consequence of muSOX mediated host mRNA degradation. Despite 
not being a direct consequence of muSOX, a reduction in HuR concentration may facilitate muSOX 
mediated degradation of host mRNA transcripts. For instance, binding of HuR to IL-6 mRNA provides 





The build-up of PABPC in the nucleus of mammalian cells infected with MHV-68, KSHV and EBV has 
been attributed to muSOX (Covarrubias et al., 2009), SOX (Lee and Glaunsinger, 2009) and BGLF5 (Park 
et al., 2014) viral proteins respectively. The absence of nuclear accumulation of PABPC in this study in 
NIH/3T3 cells following MHV-68 ORF37stop virus confirms the requirement of a functional muSOX 
gene for the build-up of PABPC in the nucleus during MHV-68 infection. During rotavirus infection of 
mammalian cells the nuclear build-up of PABPC is attributed to nsP3 (Piron et al., 1998; Harb et al., 
2008). Rotavirus nsP3 has a higher affinity for eIF4G than PABPC and competitively inhibits the eIF4G-
PABPC interaction (Piron et al., 1998). The exact mechanism of PABPC nuclear localisation during 
rotavirus infection remains unclear but it is correlated with a reduction in interaction of PABPC with 
mRNA in the cytoplasm. 
The relocalisation of PABPC to the nucleus during MHV-68 infection of NIH/3T3 cells was shown in this 
study to be a gradual process over the course of infection. This is akin to the time-dependent 
relocalisation of PABPC to the nucleus during HSV-1 infection (Salaun et al., 2010). Like HuR, PABPC is 
a nucleo-cytoplasmic shuttling protein. PABPC is exported out of the the nucleus bound to mRNA and 
is imported back in to the nucleus through the action of importin-α. It is thought the reduction of 
mRNA in the cytoplasm due to the mRNA degradation initiated by muSOX contributes to the build-up 
of PABPC in the nucleus (Kumar, Shum and Glaunsinger, 2011). When PABPC is unbound from mRNA 
in the cytoplasm its binding affinity for importin-α increases. In addition, since PABPC is exported out 
the nucleus bound to mRNA, mammalian PABPC has been shown to build-up in the nucleus when 
NXF1 mediated mRNA nuclear export is inhibited (Burgess et al., 2011). This suggests that a block in 
mRNA nuclear export may be at least partially responsible for the nuclear retention of PABPC during 

































4.1 Overview   
The binding of host trans-acting factors to viral RNA can significantly affect the rate of translation of 
viral genes, viral genome replication and elicit evasion from the host anti-viral response. The 3’UTR 
from both the Old and New world alphaviruses have been shown to bind the host protein HuR and 
cause its redistribution from the nucleus to the cytoplasm in mammalian cells (Sokoloski et al., 2010).  
Alphaviral 3’UTRs also bind the Aedes mosquito HuR homolog, abbreviated to eaHuR, during infection 
of mosquito cell lines (Sokoloski et al., 2010). In Aedes mosquito cell lines where there is already a 
comparable distribution of eaHuR between the nucleus and cytoplasm the subcellular redistribution 
of eaHUR is not observed following alphavirus infection (Dickson et al., 2012). 
The specific SFV4 genome sequences which bind HuR in the SFV4 genome have been determined to 
be a Uracil Rich Element (URE) and a Conserved Sequence Element (CSE) in the SFV4 3’UTR 
immediately 5’ of the poly(A) tail (Sokoloski et al., 2010). Alphaviruses which do not contain the 
conserved URE in their 3’UTR, namely Chikungunya virus (CHIKV) and Ross River virus (RRV), still bind 
HuR during infection of mammalian cells via their CSE and other U-rich sequences in their 3’UTR 
(Dickson et al., 2012). When HuR binding sites in the SINV genome are removed or HuR mRNA is 
knocked-down (via siRNA interference) prior to SINV infection, a significant reduction in virus 
replication is observed (Sokoloski et al., 2010). Taken together, these observations strongly suggest a 
key role played by cellular HuR in alphaviral genomic RNA processing and replication. 
4.2 SFV4 icDNAs 
SFV and SINV are amongst the most thoroughly studied alphaviruses due to their relatively lower 
safety classification (Containment Level 2, CL2) and the existence of easily manipulated expression 
vectors enabling efficient and intensive research in to their replication and interactions with host cells. 
SFV4 has a multitude of developed icDNA plasmids which encode the full viral genome including 
antibiotic resistance genes for replication of the plasmid in bacterial vectors and CMV promoters 
enabling expression of the virus in transfected cells. This negates the need of in vitro synthesis of the 
mRNA as required for more rudimental icDNAs which utilised an SP6 or similar promoter. Reporter 
genes such as GFP can also be relatively easily added to the icDNAs fused to viral genes such as nsP3 
(Tamberg et al., 2007) or expressed under a duplicated subgenomic promoter (Karlsson and 
Liljeström, 2004). This enables tracking of viral proteins within cells during infection and analysis of 






The significance of the URE and CSE of the SFV4 3’UTR for SFV4 replication in mammalian cells was 
investigated in this study. The hypothesis predicted that a lack of HuR binding sites in the SFV4 3’UTR 
would inhibit virus replication in mammalian cells as well as examining if the sequestration of host 
HuR on SFV4 RNA had an indirect effect on the abundance of host-cell mRNA transcripts.  
Specific objectives 
1. Generate recombinant SFV4 (rSFV4) infectious complementary DNA (icDNAs) containing 
nucleotide sequence deletions or additions from/to the URE and CSE of the SFV4 3’UTR. Then 
grow infectious virus stocks from engineered icDNAs. 
 
2. Determine if genetic reversion and/or other nucleotide changes occur in the generated virus 
stocks at the site of mutation generated in the corresponding icDNA. 
 
3. Assess the subcellular localisation of host HuR during the course of infection of NIH/3T3 cells 
with the rSFV4 viruses. 
 
4. Evaluate the growth characteristics of rSFV4 viruses in NIH/3T3 cells. 
 
5. Determine impact on induction of caspase activity and cell death following infection with the 
rSFV4 viruses. 
 
6. Assess if presence or absence of HuR binding sites in the SFV4 3’UTR affect the abundance 














4.4.1 rSFV4 viruses containing URE/CSE deletions or additions 
Two sets of rSFV4 icDNAs, each with a different reporter protein, were utilised for the experiments in 
this chapter. Firstly a icDNA encoding Guassia luciferase (Gluc) expressed under a duplicated 
subgenomic promoter (Karlsson and Liljeström, 2004), and secondly, a rSFV4 encoding eGFP fused to 
viral nsP3 (Tamberg et al., 2007) (Figure 4.1.i). 
The URE and CSEs which bind HuR are present in the viral 3’UTR immediately upstream of the poly(A) 
tail. Five rSFV4 icDNAs containing deletions of all or parts of these elements were engineered including 











Figure 4.1. Schematic representation of rSFV4 viral genomes i. SFV4 genome encoding Gaussia 
luciferase under the control of a duplicated subgenomic promoter and the SFV4 genome encoding 
GFP fused to nsP3. ii. The URE element and conserved sequence element in the 3’UTR of SFV4 are 
located immediately 5’ of the poly(A) tail. iii. Schematics of the rSFV4 viruses used in this study 
showing deletions and/or additions of the URE and/or the CSE.  
 
4.4.2 Production of infectious virus from rSFV4 icDNAs 
Infectious SFV4 virus stocks were generated by transfecting rSFV4 icDNA plasmids in to BHK-21 cells 
as previously described (Chapter 2). The average time for a WT SFV4 icDNA plasmid to produce viable 
virus following transfection in to BHK-21 cells is 24-48 hours (Rausalu et al., 2009). Interestingly, a 
deletion of the CSE from the SFV4 3’UTR delayed the time required to produce infectious virus from 
transfected icDNAs to day 5 post-transfection. The deletion of the URE in addition to part or all of the 
CSE further delayed infectious virus production (to 7-8 days post transfection) as compared to deletion 
of the CSE alone. Deletion or additions of the URE with an intact CSE did not affect the number of days 
required for the propagation of virus (Figure 4.2). The production of virus was determined by 
SFV4 3’NTR and deletion of URE/CSE
SFV4-2SG-Gluc
SFV4(3F)-eGFP
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visualisation of cytopathic effect (CPE), a significant luciferase signal compared to controls (from the 













Figure 4.2 Time taken in days for evidence of virion production and CPE following transfection in to 
BHK-21 cells of rSFV4 icDNAs containing alterations to the SFV4 3’UTR. The data is representative of 3 
replicate experiments. 
 
4.43 Viral reversion and mutagenic pressures 
The delayed production of virus from the SFV4 icDNAs containing CSE deletions suggests that the CSE 
plays a crucial role in virus replication. This is in line with previously published data, which showed 
that deletion of CSEs from other alphaviruses has a deleterious effect on virus growth and virus 
production (Hardy and Rice, 2005; George and Raju, 2000; Raju et al., 1999). Interestingly, despite an 
initial delay in propagation, virus progeny produced from the SFV4 icDNAs with a deleted CSE did not 
show a significant decrease in virus replication rate nor virus titre following infection of NIH/3T3 cells 
(Figure 4.12 and 4.14). This suggested that compensatory genetic modifications (reversions) may have 
occurred in those viral genomes since the virus was now able to replicate its genome to a level 
comparable to the wild-type virus. To identify if compensatory mutations or full reversion had 










































































and reverse transcribed. The 3’ end of the SFV 3’UTR was subject to PCR and the PCR product ligated 
in to a vector and sequenced (Figure 4.3). 
 
Figure 4.3. Sequencing of the 3’UTR of the rSFV4. The expected sequence is shown first, followed by 
the sequence of the transfected icDNA and then 5 individual sequences obtained from the given viral 
stock. No reversion was seen in this part of the viral genome for any of the rSFV4 viruses apart from 
viruses from the SFV4-2SG-Gluc-∆CSE stock. 
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SFV4_URE+CSE        GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dCSE_replicon  GAAUAAUUGGAUUUUUAUUUUAUUUUGC------------------CCAAAAA
SFV4-dCSE_1         GAAUAAUUGGGUUUUUU--UUAUUUUGC------------------CCAAAAA
SFV4-dCSE_2         GAAUAAUUGGAUUUUUA--UUUUUUUGC------------------CCAAAAA
SFV4-dCSE_3         GAAUAAUUGGAUUUUUA--AUAUUUUGC------------------CCAAAAA
SFV4-dCSE_4         GAAUAAUUGGAUUUUUA--UUAUUUUGC------------------CCAAAAA
SFV4-dCSE_5         GAAUAAUUGGAUUUUUA--AUAUUUUGC------------------CCAAAAA
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SFV4_URE+CSE   GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4_replicon  GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4_1         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4_2         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4_3         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4_4         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4_5         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
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SFV4_URE+CSE        GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dURE_replicon  GAAUAAUUGG------------------AAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dURE_1         GAAUAAUUGG------------------AAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dURE_2         GAAUAAUUGG------------------AAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dURE_3         GAAUAAUUGG------------------AAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dURE_4         GAAUAAUUGG------------------AAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dURE_5         GAAUAAUUGG------------------AAUUGGUUUUUAAUAUUUCCAAAAA
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                         1
SFV4_URE+CSE             GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-dURE+dCSE_replicon  GAAUAAUUGG------------------------------------CCAAAAA
SFV4-dURE+dCSE_1         GAAUAAUUGG------------------------------------CCAAAAA
SFV4-dURE+dCSE_2         GAAUAAUUGG------------------------------------CCAAAAA
SFV4-dURE+dCSE_3         GAAUAAUUGG------------------------------------CCAAAAA
SFV4-dURE+dCSE_4         GAAUAAUUGG------------------------------------CCAAAAA
SFV4-dURE+dCSE_5         GAAUAAUUGG------------------------------------CCAAAAA
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                           1
SFV4_URE+CSE               GAAUAAUUGGAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4_dURE+d11CSE_replicon  GAATAATTGG-----------------------------AATATTTCCAAAAA
SFV4_dURE+d11CSE_1         GAATAATTGG-----------------------------AATATTTCCAAAAA
SFV4_dURE+d11CSE_2         GAATAATTGG-----------------------------AATATTTCCAAAAA
SFV4_dURE+d11CSE_3         GAATAATTGG-----------------------------AATATTTCCAAAAA
SFV4_dURE+d11CSE_4         GAATAATTGG-----------------------------AATATTTCCAAAAA
SFV4_dURE+d11CSE_5         GAATAATTGG-----------------------------AATATTTCCAAAAA
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SFV4_URE+CSE         GAAUAAUUGG------------------------------------------------------------
SFV4-5xURE_replicon  GAAUAAUUGGAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUU
SFV4-5xURE_1         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUU
SFV4-5xURE_2         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUU
SFV4-5xURE_3         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUU
SFV4-5xURE_4         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUU
SFV4-5xURE_5         GAAUAAUUGGAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAUUUUU
                    71
SFV4_URE+CSE         ------------AUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-5xURE_replicon  AUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-5xURE_1         AUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-5xURE_2         AUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-5xURE_3         AUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-5xURE_4         AUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
SFV4-5xURE_5         AUUUUAUUUUGCAUUUUUAUUUUAUUUUGCAAUUGGUUUUUAAUAUUUCCAAAAA
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Of the five separate amplified sequences for each virus the 3’UTR matched the corresponding 
sequence of the transfected (parental) icDNA in all instances apart from virus propagated from the 
SFV4-2SG-Gluc-∆CSE icDNA. Each sequence reverse-transcribed from virions from the SFV4-2SG-Gluc-
∆CSE viral stock had an additional deletion of 2 nucleotides. Furthermore, one sequence contained an 
A to G substitution. The nucleotides deleted from two samples from the SFV4-2SG-Gluc-∆CSE viral 
stock reverted part of the wild-type SFV4-2SG-Gluc CSE sequence “UUUUUAAUAUUU” but this is not 
the case for all samples in which the two base deletions show no obvious reconstruction of the CSE 
sequence. Interestingly, SFV4-2SG-Gluc-∆URE+∆CSE and SFV4-2SG-Gluc-∆URE+∆11CSE did not show 
any nucleotide sequence changes (reversion or novel) in the amplified section of the 3’UTR.  
Despite no reversion or novel sequence changes seen in the viral stocks of all the rSFV4 viruses apart 
from SFV4-2SG-Gluc-dCSE, there may have been other compensatory sequence changes that have 
occurred in the viral genome to enable efficient viral replication. The consistency of the plaques 
produced from a viral stock can suggest how heterogeneous the virion population of the stock is. The 
plaque morphology can also suggest the ability of the virus to spread from cell to cell and induce cell 
death.  
The morphology of plaques produced by the rSFV4-2SG-Gluc viruses in BHK-21 cells was assessed. The 
plaques produced from SFV4-2SG-Gluc-5xURE are similar in appearance to those produced by SFV4-
2SG-Gluc-WT. When the URE is removed, as for SFV4-2SG-Gluc-∆URE, the plaques are slightly larger 
but turbid. The turbid nature of the plaques suggests a reduction in virus mediated lysis or virus 
replication rate since all the cells in the plaque have not lysed before a new layer of cells have taken 
their place.  
The viruses containing CSE deletions, SFV4-2SG-Gluc-∆CSE, SFV4-2SG-Gluc-∆URE+∆CSE and SFV4-2SG-
Gluc-∆URE+∆11CSE, produced a heterogeneous population of plaque sizes. This suggests the presence 




















Figure 4.4 Plaque morphology from rSFV4. Serial dilutions from rSFV4 stocks were used to infect BHK-
21 cells in standard plaque assay. SFV4-2SG-Gluc-∆URE exhibited turbid plaques, SFV4-2SG-Gluc-
5xURE plaques are comparable to SFV4-2SG-Gluc-WT. Plaques produced from infection with virus 
stocks that contained deletions from the CSE exhibit a heterogeneous population of small and large 
plaques suggesting genetic variations between virions within the same virus stocks.  
 
4.4.4 SFV4 infection causes HuR subcellular relocalisation 
As part of this study, the potential roles mediated by URE and CSE of the 3’UTR of SFV4 to bind host 
protein HuR were investigated. To assess the subcellular location of HuR following infection with the 
rSFV4 viruses, murine NIH/3T3 cells were immunostained against HuR protein. Previous groups have 
shown that HuR relocates to the cytoplasm where it binds to the alphavirus 3’UTR during infection 
(Sokoloski et al., 2010). However key parameters such as the proportion of HuR that relocates to the 
cytoplasm compared to the proportion remaining in the nucleus during SFV4 infection, the rate at 
which this occurs and whether this is maintained throughout infection had not been addressed fully. 
A second cellular RNA-binding cellular protein, PABPC, was also investigated because PABPC also binds 








In murine NIH/3T3 cells HuR is located predominantly (~80%) in the nucleus (Figure 4.5 and 4.10). 
Infection of NIH/3T3 cells with SFV4 viruses retaining the WT 3’UTR results in HuR relocalising 
predominantly (79.8%) to the cytoplasm by 6 h.p.i., reaching 91.2% by 9 h.p.i. and being retained in 
the cytoplasm during the remaining course of infection (Figure 4.5 and 4.10). HuR was dispersed 
throughout the cytoplasm and appeared to colocalise with PABPC, and sometimes in discrete 
cytoplasmic foci. The cytoplasmic HuR and PABPC had left large areas in the cytoplasm by 15 h.p.i. and 
concentrated around the cytoplasmic face of the nuclear and cytoplasmic membranes (Figure 4.5 and 
4.10).  The SFV4(3F)-eGFP virus encodes eGFP fused to nsP3.; therefore, the location of nsP3 can be 
used as a marker for SFV4 induced CPV-I spherules where SFV genome replication is actively taking 
place. The re-localised HuR to the cytoplasm following infection with SFV4(3F)-eGFP did not co-localise 
with nsP3-eGFP suggesting that the HuR was removed from the SFV4 CPV-I (Figure 4.5). Taken 
together, imaging data illustrates a cumulative migration of HuR into the cytoplasm from 3 h.p.i. 
onwards in NIH/3T3 cells following infection with SFV4(3F)-eGFP. The relocalised HuR is retained in 


















Previous studies have shown that HuR binds the URE of alphaviral 3’UTRs including SFV4. This 
interaction may be responsible for the re-localisation of HuR to the cytoplasm following infection with 
SFV4(3F)-eGFP. The deletion of URE from the SFV4 3’UTR resulted in a lower proportion of HuR 
relocating to the cytoplasm following infection with SFV4(3F)-eGFP-∆URE compared to SFV4(3F)-eGFP 
during the entire course of infection (Figure 4.6). The proportion of HuR in the cytoplasm following 
infection with SFV4(3F)-eGFP-∆URE increased from 20.2% at 0 h.p.i. to 27.5% by 3 h.p.i. (Figure 4.6 
and 4.10). This proportion peaked at a mean of 57% at 9 h.p.i. and droped to 43% by 12 h.p.i and 34% 
by 15 h.p.i. (Figure 4.6 and 4.10). Although a significant amount of HuR was relocated to the cytoplasm 
by 9 h.p.i. (57%) compared to NIC (20%), there was a following drop in the proportion of cytoplasmic 
HuR by 12 h.p.i. This 14% drop in quantity of cytoplasmic HuR in three hours was in contrast to the 
11.4% increase from 9 to 12 h.p.i. observed following infection with SFV4(3F)-eGFP. Taken together 
these data show that HuR re-localisation to the cytoplasm following SFV4 infection still occurs when 
the URE of the SFV4 3’UTR is deleted but is significantly reduced. Furthermore, less HuR is retained in 




















Addition of 4 extra URE elements to SFV4 3’UTR resulted in HuR relocating at a faster rate to the 
cytoplasm, 46.3% by 3 h.p.i and 98% by 6 h.p.i. Furthermore, this ratio of cytoplasmic HuR to nuclear 
HuR was maintained during the course of infection, still 98% at 12 h.p.i. and 94.5% by 15 h.p.i. (Figure 
4.7 and Figure 4.10). The differences in the ratio of re-localised HuR between infection with SFV4(3F)-
eGFP-5xURE compared to SFV4(3F)-eGFP was statistically significant at all time points post-infection.  
As with the other rSFV4 viruses the re-localised cytoplasmic HuR following SFV4(3F)-eGFP-5xURE 
infection co-localised with PABPC but not with nsP3-eGFP. 
Taken together these data suggest that the relocalisation of HuR during SFV4 infection is significantly 
decreased by the deletion of the URE from the SFV4 3’UTR and significantly increased by the addition 






















Infection of NIH/3T3 cells with SFV4(3F)-eGFP-∆CSE resulted in cellular HuR re-localising to the 
cytoplasm to 31.9% by 3 h.p.i., 65.8% by 6 h.p.i. and peaking at 79.1% by 9 h.p.i. (Figure 4.8 and Figure 
4.10). The proportion of HuR which was cytoplasmic then dropped between 9 and 12 h.p.i. similar to 
infection with SFV4(3F)-eGFP-∆URE but only by 3% to 75.9%. The re-localised HuR co-localised with 
PABPC, including in distinct foci in some cells as with the other rSFV4 viruses. The difference in the 
ratio of cytoplasmic HuR between infection with SFV4(3F)-eGFP-∆CSE and SFV4(3F)-eGFP was not 
statistically significant (p=0.07) at 3 h.p.i, but was significant at all later time points measured 
(p=<0.05).  
Taken together these results indicate that the initial re-localisation and subsequent retention of HuR 
in the cytoplasm following SFV4 infection is partially increased by the retention of the CSE in the SFV4 













Infection with SFV4(3F)-eGFP-∆URE+∆CSE caused an initial rate of HuR relocalisation comparable to 
the control, i.e. 71% at 6 h.p.i., but dropped sharply to 64% at 9 h.p.i. and 51% at 12 h.p.i, respectively 
(Figure 4.9 and Figure 4.10). The difference in percentage of cytoplasmic HuR during infection 
between SFV4(3F)eGFP-∆URE+∆CSE and SFV4(3F)eGFP was not significant at 3 or 6 h.p.i. (p=0.47 and 
p=0.18 respectively), but was significant at all later time points measured. 
There are large standard deviations when analysing the ratios of cytoplasmic HuR to nuclear HuR 
between individual cells following infection with SFV4(3F)eGFP-∆URE, SFV4(3F)eGFP-∆CSE and 
SFV4(3F)eGFP-∆URE+∆CSE. In contrast, there is a relatively small standard deviation seen during 
infection with SFV4-2SG-Gluc-5xURE.  This may suggest that the overall phenotype is dominated by a 
















4.4.5 Viral replication of rSFV4 URE+CSE mutants 
The replication of the rSFV4 mutants in single and multi-step growth curves were assessed by plaque 
assay. The deletion of the URE from the SFV4 3’UTR not only resulted in the least propotion of HuR 
being retained in the cytoplasm during infection but also caused a significant reduction in infectious 
virion production (Figure 4.11).  
At a high MOI (MOI=10), infection of murine NIH/3T3 cells with SFV4-2SG-Gluc-∆URE caused a 
significant reduction in virus production in the initial hours of infection (6 h.p.i., p=<0.001) compared 
to infection with SFV4-2SG-Gluc-WT (Figure 4.11). SFV4-2SG-Gluc-∆URE produced similar levels of 
virus compared to wild type infection by 12 h.p.i. During a multi-step growth curve (infection at MOI 
=0.01) SFV4-2SG-Gluc-∆URE produced infectious virus at consistently lower titres compared to SFV4-
2SG-Gluc-WT throughout the course of infection (Figure 4.11).  
The deletion of the URE resulted in the reduction of infectious virus released following infection of 
NIH/3T3 cell. In contrast, the addition of 4 extra URE elements in the SFV4-2SG-Gluc-5xURE virus 
resulted in an increase in production of infectious virus compared to SFV4-2SG-Gluc-WT (Figure 4.11). 
During a one-step growth curve (MOI=10) in NIH/3T3 cells following infection with SFV4-2SG-Gluc-
5xURE, there was a significantly higher production of infectious virus produced compared to SFV4-
2SG-Gluc-WT infection at 6 and 9 h.p.i. (p = <0.01 at both time points) (Figure 4.11). The higher 
quantities of infectious virus produced during SFV4-2SG-Gluc-5xURE infection compared to SFV4-2SG-
Gluc-WT showed a reduced trend by 12 h.p.i. and thereafter; reaching levels which were no longer 
statistically significant (p=0.98 at 12 h.p.i.) (Figure 4.11). Following infection at a lower MOI (0.01) 
SFV4-2SG-Gluc-5xURE infection of NIH/3T3 cells produced higher quantities of infectious virus from 6 
to 18 h.p.i. (p=<0.01 at all time points), and  was comparable to infection with SFV4-2SG-Gluc-WT at 
24 h.p.i.  
Taken together these results indicate the frequency of the URE in the SFV4 3’UTR affects the initial 
concentration of infectious virus propagated in murine NIH/3T3 cells. A deletion of the URE results in 
an initial significant decrease in production of infection virus and the addition of 4 extra URE results 












Despite the delayed propagation of virus from the counterpart icDNAs, the three rSFV4 viruses that 
contained CSE deletions in their 3’UTR, SFV-2SG-Gluc-∆CSE, SFV4-2SG-Gluc-∆URE+∆11CSE and SFV4-
2SG-Gluc-∆URE+∆CSE replicated in NIH/3T3 cells at a rate comparable to the SFV4-2SG-Gluc-WT virus 
(Figure 4.12).  
The SFV-2SG-Gluc-∆CSE replicated at levels comparable to SFV4-2SG-Gluc-WT for both one-step and 
multi-step growth curves. In the one step-growth curve the SFV-2SG-Gluc-∆CSE virus produced 
infectious virus at levels (PFU) that were not significantly different to infection with SFV4-2SG-Gluc-
WT at all points throughout the course of infection (Figure 4.12). During the multi-step growth, the 
SFV4-2SG-Gluc-∆CSE virus produced less infectious virus at 6 h.p.i. but then later surpassed the levels 
of infectious virus from cells infected with SFV4-2SG-Gluc-WT at later time points post infection. 




















At a MOI of 0.01, the two rSFV4 viruses which contained both deletion of the URE and either partial 
or almost full deletion of the CSE, initially grew significantly slower up to 6 h.p.i. when compared to 
the wild type virus SFV4-2SG-Gluc-WT (Figure 4.12, p=<0.01 for both viruses). Thereafter, both mutant 
viruses (SFV4-2SG-Gluc-∆URE+∆11CSE and SFV4-2SG-Gluc-∆URE+∆CSE) propagated at comparable 
levels to SFV4-2SG-Gluc-WT (Figure 4.12). Infection of NIH/3T3 cells with SFV4-2SG-Gluc-
∆URE+∆11CSE produced significantly more infectious virus comparable to WT virus at 24 h.p.i (Figure 
4.12, p=<0.01), and infection with SFV4-2SG-Gluc-∆URE+∆CSE produced significantly more infectious 
virus comparable to WT virus at both 18 and 24 h.p.i. (Figure 4.12, p=<0.01 for both time points).  
During a one-step growth curve SFV4-2SG-Gluc-∆URE+∆11CSE and SFV4-2SG-Gluc-∆URE+∆CSE viruses 
initially replicated at comparable levels to the wild type virus SFV4-2SG-Gluc-WT.  SFV4-2SG-Gluc-
∆URE+∆11CSE then produced significantly higher amount of infectious virus compared to the SFV4-
2SG-Gluc-WT at 12 h.p.i (Figure 4.12, p=<0.01). Moreover, SFV4-2SG-Gluc-∆URE+∆CSE propagated at 
a significantly higher levels compared to the wild type virus SFV4-2SG-Gluc-WT at both 9 and 12 h.p.i. 
(Figure 4.12, p=<0.01 for both time points).  
The SFV4 genome replication was also monitored by measurement of luciferase activity which is 
proportional to the concentration of luciferase produced during infection with the rSFV4 viruses 
expressing Guassia luciferase under a duplicated subgenomic promoter. The luciferase mRNA is 
replicated with the same 3’ UTR as the viral genome and thus the changes to the URE/CSE should 
affect the luciferase mRNA and expression in an analogous manner to the viral genome. The luciferase 
expression therefore reflects the viral RNA abundance, stability and translation rather than the 
production of viable virus.  
The analysis of viral replication through luciferase production complements the plaque assay data for 
SFV4-2SG-Gluc-∆URE and SFV4-2SG-Gluc-5xURE infection at both MOI of 10 and MOI of 0.01.  
Luciferase production was significantly lower at all time points post infection (apart from 48 h.p.i.) 
following infection of NIH/3T3 cells with SFV4-2SG-Gluc-∆URE at a MOI of 0.01 compared to the wild 
type virus SFV4-2SG-Gluc-WT (Figure 4.13, p=<0.01). Furthermore, luciferase production was 
significantly lower at 3 h.p.i. following infection with SFV4-2SG-Gluc-∆URE at MOI 10 compared to 
SFV4-2SG-Gluc-WT (Figure 4.13, p=<0.01) but then reached a comparable level to the wild type virus 
at later time points post infection.  
In direct contrast to SFV4-2SG-Gluc-∆URE, infection with SFV4-2SG-Gluc-5xURE produced significantly 
higher levels of luciferase at all time points post infection (apart from 48 h.p.i.) in NIH/3T3 cells at a 
MOI of 0.01 compared to SFV4-2SG-Gluc-WT (Figure 4.13, p=<0.01). In addition, luciferase activity was 
significantly higher at 3 h.p.i. following infection with SFV4-2SG-Gluc-5xURE at MOI 10 compared to 
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the wild type virus SFV4-2SG-Gluc-WT but comparable levels were reached thereafter (Figure 4.13, 
p=<0.01). 
Taken together the results from luciferase assays suggest that the URE sequence promotes viral 
protein production either through stability and/or translation of viral RNA. This compliments the data 
from plaque assay which indicated the URE increases the propagation of infectious virus during initial 





















Deletion of the CSE appears to have minimal effect on luciferase signal. There were no significant 
changes in luciferase activity produced following infection of NIH/3T3 cells with SFV4-2SG-Gluc-∆CSE 
compared to the wild type virus SFV4-2SG-Gluc-WT at any time point post infection either at low or 
high MOI (Figure 4.14). A plausible suggestion is that deletion of the CSE has minimal effect on viral 
RNA replication rate through either RNA stability or translation. An alternative possibility is that virions 
that are eventually propagated from a transfected SFV4 icDNA with a deleted CSE, replicate at a 
comparable rate to the wild-type SFV4 despite a delay in initial propagation from icDNA.  
An engineered virus with a deletion of the entire URE element and 18 bases of the CSE element  (SFV4-
2SG-Gluc-∆URE+∆CSE), produced less luciferase at all time points post infection when compared to 
the wild type virus SFV-2SG-Gluc-WT (Figure 4.14). The differences in luciferase production following 
NIH/3T3 infection with SFV4-2SG-Gluc-∆URE+∆CSE compared to SFV-2SG-Gluc-WT was substantial 
and statistically significant at all time points measured and at both high (10) and low (0.01) MOI (Figure 














4.4.6 Analysis of caspase-mediated apoptosis following infection of rSFV4 URE+CSE 
mutants 
The HuR protein has been implicated in both cell survival as well as caspase-mediated apoptosis. 
Therefore, caspase activity and cell viability assays were utilised to assess if deletions or additions of 
the viral URE and CSE could result in enhanced or reduced caspase-mediated apoptosis.  
At low MOI, deletion of the viral URE element resulted in a reduction in rate and quantities of caspase 
3/7 activities and a slower rate of cell viability decline (Figure 4.14). Moreover, following infection of 
NIH/3T3 cells with SFV4-2SG-Gluc-∆URE at an MOI of 10, the caspase 3/7 activity was significantly 
lower at 30 h.p.i compared to infection with the wild type virus SFV-2SG-Gluc-WT (Figure 4.14, 
p=<0.01), and then increased and was significantly higher at 42 h.p.i. (Figure 4.14, p=<0.01). At MOI 
of 0.01, cell viability also declined more rapidly from 30 to 42 h.p.i. following infection of NIH/3T3 cells 
when compared with SFV-2SG-Gluc-WT compared to SFV4-2SG-Gluc-∆URE (Figure 4.14, p=<0.01). At 
a higher MOI of 10 there was no significant change in caspase 3/7 activity between infection of SFV-
2SG-Gluc-WT and SFV4-2SG-Gluc-∆URE and only a significantly higher decline in cell viability was 
observed at 24 h.p.i. These data suggest that deletion of the URE from the SFV4 3’UTR results in 
delayed caspase 3/7 activity and a corresponding reduction in loss of cell viability at low MOI but not 
at high MOI. Given the reduction in virus replication and production of infectious virus as indicated by 
viral replication luciferase assay and the plaque assay, respectively, the reduction in caspase 3/7 
activity and loss of cell viability may correspond to concentration of virus and not be directly related 
to the deletion of the URE.  
Infection of NIH/3T3 cells with SFV4-2SG-Gluc-5xURE resulted in an earlier peak of caspase 3/7 activity 
at 30 h.p.i. at a high MOI (while caspase 3/7 activity peaks at 42 h.p.i. during infection with SFV-2SG-
Gluc-WT) but the differences were not statistically significant (Figure 4.15). Furthermore, there were 
no significant differences in loss of cell viability at high MOI nor significant differences in either caspase 
3/7 activity or cell viability between at MOI of 0.01 (Figure 4.15). Taken together these results suggest 
that the deletion or addition of URE to the SFV4 3’UTR has minimal effect on caspase 3/7 activity or 
loss of cell viability following infection of NIH/3T3 cells.  
Following infection of NIH/3T3 cells with SFV4-2SG-Gluc-∆CSE or SFV4-2SG-Gluc-∆URE+∆11CSE there 
was a significant increase in caspase 3/7 activity from 12 to 18 h.p.i. at 10 MOI compared to infection 
with the wild type virus SFV-2SG-Gluc-WT (Figure 4.16, p=<0.01). Infection of NIH/3T3 cells with SFV4-
2SG-Gluc-∆URE∆CSE resulted in increased caspase 3/7 activity compared to infection with the wild 
type virus but this increased trend was only statiscaly significant at 30 h.p.i and thereafter (Figure 4.16, 
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p=<0.01). The increase in caspase 3/7 activity was matched by a corresponding decrease in cell 
viability compared to WT that was not significant following SFV4-2SG-Gluc-∆CSE infection but 
significant at 30 h.p.i. following SFV4-2SG-Gluc-∆URE+∆11CSE infection and 30 and 36 h.p.i. infection 
following SFV4-2SG-Gluc-∆URE∆CSE infection (Figure 4.16, p=<0.01).  Following infection at a low MOI 
(0.01) there was a significant increase in caspase 3/7 activity at 60 h.p.i., 48 and 60 h.p.i. and 42, 48 
and 60 h.p.i. from infection of NIH/3T3 cells with SFV4-2SG-Gluc-∆CSE, SFV4-2SG-Gluc-∆URE+∆11CSE 
and SFV4-2SG-Gluc-∆URE∆CSE respectively compared to SFV-2SG-Gluc-WT (Figure 4.16, p=<0.01). 
This is correlated with a significant higher reduction in cell viability at 48 and 60 h.p.i. following 
infection with SFV4-2SG-Gluc-∆CSE, SFV4-2SG-Gluc-∆URE+∆11CSE and SFV4-2SG-Gluc-∆URE∆CSE 
compared WT at all time points but these were not statistically significant (Figure 4.16). Infections in 
NIH/3T3 cells at low MOIs with SFV4-2SG-Gluc-∆CSE resulted in caspase 3/7 activity levels comparable 
to the wild type SFV-2SG-Gluc-WT infection (from 0 to 42 h.p.i.); caspase activity was significantly 
higher levels at 60 h.p.i. (Figure 4.16, p = <0.01). There was a corresponding increased drop in cell 
viability of NIH/3T3 cells infected at low MOIs with SFV4-2SG-Gluc-∆CSE, SFV4-2SG-Gluc-
∆URE+∆11CSE, and SFV4-2SG-Gluc-∆URE∆CSE compared to with the wild type SFV-2SG-Gluc-WT; 
these reductions in cell viabilities were statistically significant at both 48 and 68 h.p.i. (Figure 4.16, p 
= <0.01).  
Taken together these results indicate that the deletion of the CSE with either no deletion of the URE 
(SFV4-2SG-Gluc-∆CSE), partial deletion of the URE (SFV4-2SG-Gluc-∆URE+∆11CSE) or full deletion of 
the URE (SFV4-2SG-Gluc-∆URE+∆CSE) results in higher levels of caspase 3/7 activity and a larger 
reduction in cell viability following infection of NIH/3T3 cells when compared to SFV-2SG-Gluc-WT.  
These three viruses also produced higher levels of infectious virus at the corresponding time points at 














4.4.7 Effect on host-cell mRNA transcripts following sequestration of HuR 
The sequestration of HuR on the viral genome can deplete the nuclear pool of HuR. To decipher if this 
HuR re-localisation and sequestration on the viral genome resulted in changes in gene expression of 
host mRNA transcripts containing HuR binding sites, the abundance of several host transcripts 
containing HuR binding sites was assessed during virus infection. In SINV infection where cellular 
mRNAs containing HuR binding sites encoding TUT1, RSPRY1, LEPROTL1 and DDX58 were assessed, it 
was shown that these cellular transcripts degraded at a faster rate following actinomycin D treatment 
and when compared to mock infected cells (Barnhart et al., 2013). Interestingly, host mRNAs encoding 
RNAse-L and KAT5 (both contain putative HuR binding sites), were not shown to degrade faster than 
mock infected controls.  
The β-actin mRNA contains multiple HuR binding sites. Following infection of NIH/3T3 cells with SFV-
2SG-Gluc-WT there was a significant decrease in β-actin mRNA abundance in both the nucleus and the 
cytoplasm compartments at both 6 and 12 h.p.i when compared to NIC (Figure 4.17, p = <0.01). 
Furthermore, a smaller reduction in β-actin mRNA abundance occurs following infection with SFV-
2SG-Gluc-∆URE compared to infection with SFV-2SG-Gluc-WT at both 6 and 12 h.p.i. in both the 
nuclear and the cytoplasmic fractions. In comparison, a significantly higher loss of β-actin mRNA 
abundance occurs following infection with SFV-2SG-Gluc-5xURE compared to infection with SFV-2SG-
Gluc-WT at both 6 and 12 h.p.i. in both the nuclear and the cytoplasmic fractions. This suggests that 








Figure 4.17 β-actin mRNA reduction during SFV infection is relative to abundance 
of uracil rich elements (to which HuR binds) in the viral 3’NTR. i) Putative HuR 
binding sites in the murine β-actin mRNA 3’UTR. ii) β-actin mRNA levels in the 
cytoplasm and nucleus following infection with SFV4 containing URE deletions or 
additions. NIH/3T3 cells were infected with rSFV4 virus at an MOI of 10 and subject to 
nuclear and cytoplasmic fractionation, RNA extraction and qPCR at 6 or 12 hpi. Values 
represent an average of 3 biological replicates and error bars represent standard 
deviation. Differences in β-actin mRNA abundance between the rSFV4 viruses are 
significnt  in both the cytoplasmic and nuclear fractions (p = <0.0001). The results are 










































































Mus musculus 3’UTR of β-actin mRNA
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Another cellular transcript that contains putative HuR binding sites is IFN-β. IFN-β as discussed in 
Chapter 1 is pivotal in the initiation of the antiviral responses and the subsequent production of a large 
number of anti-viral IFN-stimulated genes (ISGs).  Infection of NIH/3T3 cells with SFV-2SG-Gluc-WT, 
SFV-2SG-Gluc-∆URE or SFV-2SG-Gluc-5xURE resulted in significantly higher IFN-β mRNA abundance in 
the nuclear and cytoplasmic fractions of NIH/3T3 cells compared to NIC. Interestingly, infection with 
SFV-2SG-Gluc-5xURE results in significantly higher level of IFN-β mRNA in the nucleus and the 
cytoplasm at 6 hp.i. compared to infection with SFV-2SG-Gluc-WT. Furthermore, infection with SFV-
2SG-Gluc-∆URE results in a significantly lower level of IFN-β mRNA in the nucleus and cytoplasm at 6 
hp.i. when compared to infection with the SFV-2SG-Gluc-WT. Differences in IFN-β mRNA abundance 









Figure 4.18 IFN-β mRNA abundance during SFV infection following infection 
with rSFV4 with URE deletions or additions.  i) Putative HuR binding sites in the 
murine IFN-β mRNA 3’UTR. ii) IFN-β mRNA levels in the cytoplasm and nucleus 
following infection with SFV4 containing URE deletions or additions. NIH/3T3 cells 
were infected with rSFV4 virus at an MOI of 10 and subject to nuclear and cytoplasmic 
fractionation, RNA extraction and qPCR at 6 or 12 hpi. Values represent an average 
of 3 biological replicates and error bars represent standard deviation. Differences 
in IFN-β mRNA abundance between the rSFV4 viruses are significnt  in both the 
cytoplasmic and nuclear fractions (p = <0.0001) at 6 hpi but not at 12 hpi. The results 
































































Mus musculus 3’UTR of IFN-β mRNA
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The control of cellular apoptosis is mediated through a number of host proteins and cellular signaling 
pathways involving caspase enzymes as discussed in Chapter 1. Caspase 9 mRNA contains putative 
HuR binding sites. Caspase 9 mRNA abundance was lower in the cytoplasm at 12 h.p.i. following SFV-
2SG-Gluc-5xURE infection compared to the SFV-2SG-Gluc-WT, yet higher following SFV-2SG-Gluc-
∆URE compared to SFV-2SG-Gluc-WT. These differences between caspase 9 mRNA levels in the 
cytoplasm between the three viruses were significant at 6 and 12 h.p.i. (Figure 4.19, p=<0.01). 
Caspase-9 mRNA abundance was significantly decreased in the cytoplasm and the nucleus of cells at 
12 h.p.i. following infection with SFV-2SG-Gluc-WT, SFV-2SG-Gluc-5xURE or SFV-2SG-Gluc-∆URE 
compared to NICs (Figure 14.19, p=<0.01). Differences in caspase 9 mRNA abundance were not 
significant between SFV-2SG-Gluc-WT, SFV-2SG-Gluc-∆URE or SFV-2SG-Gluc-5xURE in the nuclear 






Figure 14.19 Caspase-9 mRNA abundance during SFV4 infection following 
infection with rSFV4 with URE deletions or additions i) Putative HuR binding sites 
in the murine caspase-9 mRNA 3’UTR. ii) Caspase-9 mRNA levels in the cytoplasm 
and nucleus following infection with SFV4 containing URE deletions or additions. 
NIH/3T3 cells were infected with rSFV4 virus at an MOI of 10 and subject to nuclear 
and cytoplasmic fractionation, RNA extraction and qPCR at 6 or 12 hpi. Values 
represent an average of 3 biological replicates and error bars represent standard 
deviation. Differences in caspase-9 mRNA abundance between the rSFV4 viruses 
are signific
a
nt  in cytoplasmic fractions at 6 and 12 hpi but not in the nuclear fractions. 























































































RNAse-L is a key anti-viral effector and it is activated in the host cell as a response to viral infections 
and subsequently degrades global RNA in the cytoplasm. RNase-L mRNA abundance was comparable 
in the cytoplasm of NIH/3T3 cells following infection with SFV-2SG-Gluc-WT, SFV-2SG-Gluc-∆URE or 
SFV-2SG-Gluc-5xURE when compared to NIC. When the NIC sample is included in the statistical 
analysis the differences in RNase-L mRNA in the nucleus following infection with SFV-2SG-Gluc-WT, 
SFV-2SG-Gluc-∆URE or SFV-2SG-Gluc-5xURE were statistically significant (Figure 4.20, p = <0.01) but 
not when NIC is excluded from the analysis (Figure 4.20, p = 0.2565). Taken together these data 
suggest that SFV4 infection results in a higher level of RNase-L mRNA in the nucleus but not in the 
cytoplasm and the differences in the frequency of URE in the SFV4 3’UTR produces no corresponding 






Figure 4.20 RNase-L mRNA abundance during SFV infection following infection 
with rSFV4 with URE deletions or additions  i) Putative HuR binding sites in the 
murine RNase-L mRNA 3’UTR. ii) RNase-L mRNA levels in the cytoplasm and nucleus 
following infection with SFV4 containing URE deletions or additions. NIH/3T3 cells 
were infected with rSFV4 virus at an MOI of 10 and subject to nuclear and cytoplasmic 
fractionation, RNA extraction and qPCR at 6 or 12 hpi. Values represent an average 
of 3 biological replicates and error bars represent standard deviation. Differences in 
RNase-L mRNA are signific
a
nt  between rSFV4 viruses in cytoplasmic fractions at 6 
and 12 hpi. Differences in RNase-L mRNA are significa nt  between rSFV4 viruses in 
nuclear fractions at individual time points but not when considering both time points 


























































































Figure 4.21 TTP mRNA abundance during SFV infection following infection 
with rSFV4 with URE deletions or additions  i) Putative HuR binding sites in 
the murine TTP mRNA 3’UTR. ii) TTP mRNA levels in the cytoplasm and nucleus 
following infection with SFV4 containing URE deletions or additions. NIH/3T3 cells 
were infected with rSFV4 virus at an MOI of 10 and subject to nuclear and cytoplasmic 
fractionation, RNA extraction and qPCR at 6 or 12 hpi. Values represent an average of 
3 biological replicates and error bars represent standard deviation. Differences in TTP 
mRNA are signific
a
nt  between rSFV4 viruses in cytoplasmic fractions and nuclear 
fractions at 6 hpi but not at 12 hpi unless including NIC in the analysis. The results are 














































































In contrast to RNase-L, RNA degradation can be orchestrated indirectly through the binding of TTR-
BPs such as tristetraprolin. TTP binds uracil rich sequences that are similar or identical to those which 
HuR binds. Following infection of NIH/3T3 cells with SFV-2SG-Gluc-WT, SFV-2SG-Gluc-∆URE or SFV-
2SG-Gluc-5xURE the abundance of TTP was significantly higher than in the NIC sample in both the 
nucleus and the cytoplasmic fractions at both 6 and 12 h.p.i. (Figure 4.21, p=<0.001). The differences 
in TTP mRNA abundance between cells infected with SFV-2SG-Gluc-WT, SFV-2SG-Gluc-∆URE or SFV-
2SG-Gluc-5xURE not including NIC sample were only significant when the time points are analysed 
separately whereby differences are significant at 6 h.p.i. (Figure 4.21, p=<0.001 for nucleus and 
cytoplasmic fractions) but not 12 h.p.i. (Figure 4.21, p=0.7531 and p=0.4714 for cytoplasmic and 
nuclear fractions, respectively). At the earlier time points post infection the higher frequency of URE 
in the SFV4-3’UTR the higher the abundance of TTP mRNA in both the nucleus and the cytoplasm 
(Figure 4.21). Taken together these results suggest that TTP is upregulated during SFV4 infection 
compared to NIC regardless of the frequency of URE in the SFV4 3’UTR and is upregulated significantly 
earlier in infection with a higher frequency of URE in the SFV4-3’UTR. 
The host cellular HuR binds the SFV4-3’UTR and relocates HuR to the cytoplasm where the viral RNA 
is replicated and HuR binding generally promotes RNA stability. This suggests that the greater the 
extent of HuR binding to the SFV4-3’UTR the greater the stability to the SFV4 RNA. Infection of 
NIH/3T3 with SFV-2SG-Gluc-5xURE resulted in higher abundance of SFV4 nsP3 RNA (and by extension 
the full RNA genome) at 6, 9 and 12 h.p.i. compared to infection with SFV-2SG-Gluc-WT or SFV-2SG-
Gluc-∆URE. Infection of NIH/3T3 with SFV-2SG-Gluc-∆URE resulted in lower abundance of SFV4 nsp3 
RNA at 6 and 9 h.p.i. when compared to infection with SFV-2SG-Gluc-WT or SFV-2SG-Gluc-5xURE. The 
difference in SFV4 nsp3 RNA following infection with the three viruses were larger at the earlier time 
points post infection and were statistically significant (Figure 4.22, p = <0.001). These data suggest 
additional URE in the SFV4 3’UTR result in a greater abundance of viral RNA in murine cells during 

















Figure 4.22 Viral nsP3 RNA abundance during SFV infection following infection 
with rSFV4 with URE deletions or additions. mRNA bundance is shown as fold 
change from SFV4-WT. NIH/3T3 cells were infected with rSFV4 virus at an MOI of 
10 and subject to RNA extraction and qPCR at 3, 6 and 12 hpi. Values represent 
an average of 3 biological replicates and error bars represent standard deviation. 
Differences in viral nsP3 RNA levels are highly significa nt  between rSFV4 viruses 


































The SFV4-3’UTR binds HuR and TTP is upregulated during SFV4 infection (Figure 4.21). TTP binds uracil 
rich sequences similar to those which HuR binds. On a number of host mRNA transcripts, HuR and TTP 
competitively bind the same uracil rich sequences and promote transcript stability or turnover, 
respectively. Therefore, HuR and TTP may both bind the SFV4-3’UTR and co-localise in the cytoplasm. 
TTP localizes in both the nucleus and the cytoplasm in NIH/3T3 cells (Figure 4.23). Following infection 
with SFV4, TTP remains localised in the nucleus and the cytoplasm. Furthermore, the vast majority of 
cytoplasmic TTP does not co-localise with cytoplasmic HuR. It is known that both HuR and TTP co-
localise in stress-granules and there are a small number of foci in which TTP and HuR co-localise. Most 
of the cytoplasmic TTP did not co-localise with HuR following infection with any of the rSFV4 tested 
irrespective to sequence changes to the SFV4-3’UTR. Taken together, these results suggest that HuR 









HuR binding sites have been stringently conserved in alphaviral genomes indicating the significance of 
the role they play during infection. Alphaviruses which do not encode the conserved URE, such as 
CHIKV and RRV, have evolved other HuR binding sites in their 3’UTR (Dickson et al., 2012). 
Furthermore, the CSE, which also binds HuR, is conserved among all known alphaviruses (George and 
Raju, 2000). This study has demonstrated the significance of the URE during SFV4 infection. The SFV4 
URE is likely responsible for the sequestration of HuR in the cytoplasm during infection of mammalian 
cells (shown by immunostaining against HuR), since HuR has previously been shown to bind directly 
to the SFV4 URE (Dickson et al., 2012). The study also found that retention of the URE and additional 
URE present in the SFV4 3’UTR, result in increased viral RNA replication, viral RNA stability, viral RNA 
translation and increased infectious virion production. This was shown by luciferase assay following 
infection of mammalian cells with rSFV4 encoding gaussia luciferase, SFV4 nsP3 viral RNA levels during 
infection as determined by RT-qPCR, and infectious virus concentrations shown by plaque assay. A 
possible destabilising effect on a number of host mRNA transcripts (containing putative HuR binding 
sites) may also be evident during rSFV4 infection. The sequesteration of HuR on the viral SFV4 genome 
may be responsible for this reduction in host mRNA transcript abundance. This work also indicates 
that TTP mRNA abundance is increased during SFV4 infection and the majority of the re-localised 
cytoplasmic HuR following SFV4 infection does not co-localise with TTP. 
The utilisation of a host RNA-binding proteins to enhance viral infection is not specific to Alphaviruses. 
Until recently, however, the utilisation of specifically HuR having a significant role during a viral 
infection was only demonstrated in alphaviral infections (Sokoloski et al., 2010; Dickson et al., 2012; 
Barnhart et al., 2013; Hyde et al., 2015). There are now emerging roles for HuR during infections of 
other virus families that bare striking resemblance to those of alphavirus; HuR has been shown to bind 
the 3’UTR of Hepatitis C virus (HCV) RNA, resulting in HuR relocalisation to the cytoplasm and 
stabilisation of HCV RNA (Shwetha et al., 2015). Furthermore, HuR is used to facilitate the formation 
of the cellular and viral ribonculeoprotein complexes used to circularise the HCV RNA and facilitate 
HCV replication. In contrast, during SFV4 replication, HuR appears to not localise to replication 
complexes as indicated through the absence of its co-localisation with nsP3, meaning that unlike HCV 
infection, the binding of HuR to the SFV4 3’NTR is not likely to play a direct role in viral RNA replication 
despite increasing SFV4 RNA stability and translation. It is worth noting, however, that the URE is 
situated adjacent to the CSE at the very end of the SFV4 3’UTR (Hardy and Rice, 2005). The CSE is the 
start site of the negative strand SFV genome replication; CSE also binds HuR itself.  Therefore, a direct 
role for HuR in the assembly of proteins for negative strand replication cannot be ruled out.  
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The CSE sequence element found in the 3’NTR of all known alphaviruses has been proposed to act as 
an RNA promoter for negative strand synthesis (Hill et al., 1997; Lemm et al., 1998) but also contains 
AU-rich regions which can bind host cell RNA binding proteins including HuR. The 19 nt CSE of SINV 
has been proposed to be indispensable for viral replication and negative strand synthesis (Hardy and 
Rice, 2005). Other groups have shown that SINV lacking part (Kuhn, Hong and Strauss, 1990) or all 
(Raju et al., 1999) of the 19nt CSE in its 3’NTR is still able to produce viable virus and propagate an 
infection of BHK-21 cells.  Following a number of virus passages many of the SINV CSE deletion mutants 
gained AU-rich additions to their 3’NTR (Raju et al., 1999, George and Raju, 2000).  These data suggest 
that although not absolutely required for viral replication in BHK-21 cells the CSE is important for viral 
replication and the AU-richness of the CSE plays an important role in its function.   
The rSFV4 viruses which contained deletions of the CSE, SFV4-2SG-Gluc-∆CSE, SFV4-2SG-Gluc-
∆URE∆11CSE and SFV4-2SG-Gluc-∆URE∆CSE, showed delayed growth kinetics to propagate virus 
following transfection into BHK-21 cells compared to SFV4-2SG-Gluc-WT, SFV4-2SG-Gluc-∆URE or 
SFV4-2SG-Gluc-5xURE. Some virions propagated from pSFV4-2SG-Gluc-∆CSE contained two additional 
nucleotide deletions in its 3’UTR near the site of the CSE deletion compared to the transfected 
replicon. The two additional nucleotide deletions were not identical between virions. It is possible that 
the two deleted nucleotides allowed for an RNA secondary structure to re-form that is lost following 
deletion of the CSE, or reformed part of the CSE sequence to facilitate replication. Virus propagated 
from pSFV4-2SG-Gluc-∆URE∆11CSE and pSFV4-2SG-Gluc-∆URE∆CSE did not, however, contain 
nucleotide changes adjacent to the intended deletions.  Since CSE is involved in the initiation of 
negative strand replication of alphaviruses (Hardy and Rice, 2005; Raju et al., 1999), the delayed 
propagation from transfected icDNAs encoding viruses which contain a CSE deletion was not 
unexpected.  
The amount of infectious virus produced over time (as shown by plaque assay) at high MOIs by SFV4-
2SG-Gluc-∆CSE, SFV4-2SG-Gluc-∆URE∆11CSE and SFV4-2SG-Gluc-∆URE∆CSE was comparable or 
higher than the levels produced following infection with the wild type virus SFV4-2SG-Gluc-WT. The 
contrast between the delayed time taken for production of virus from transfected icDNAs containing 
a CSE deletion and the number of virions produced over time following infection of NIH/3T3’s is 
intriguing. It is possible that virions in the generated viral stocks from icDNA containing CSE deletions 
have acquired compensatory mutations to allow efficient replication in murine cells despite not 
containing a CSE in their 3’UTR. For instance, a compensatory mutation may have occurred in the RNA-
dependent polymerase so that it can still bind the 3’UTR of the SFV4 genome without the CSE. This 
theory is supported by the heterogeneous population of plaque sizes in BHK-21 cells following 
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infection with SFV4-2SG-Gluc-∆CSE, SFV4-2SG-Gluc-∆URE∆11CSE and SFV4-2SG-Gluc-∆URE∆CSE 
which suggest variations between virions (Liu and Wu, 2004) in contrast to the homogenous plaque 
sizes formed following infection with SFV4-2SG-Gluc-WT, SFV4-2SG-Gluc-∆URE and SFV4-2SG-Gluc-
5xURE. Further study to sequence the full genomes of these viruses is required before drawing any 
strong conclusions as to whether compensatory mutations may have occurred in their genomes. 
The luciferase assay indicated that SFV4-2SG-Gluc-∆URE∆CSE replicates/translates its RNA at 
significantly slower rate than SFV4-2SG-Gluc-WT in contrast to the plaque assay data. One reason for 
this could be that the double deletion (URE+CSE) removed all the proposed HuR binding sites from 
this part of the viral genome. The complete loss of HuR binding sites from the 3’ end of the 3’UTR may 
cause the significant loss of luciferase activity seen during replication with SFV4-2SG-Gluc-∆URE+∆CSE 
compared to control. An alternative explanation is a range of mutations that have acquired in the viral 
genome from the URE/CSE mutants which took significantly longer to produce viable virus from the 
icDNAs.  A number of mutations that were acquired during virus stock production from the SFV4-2SG-
Gluc-∆URE+∆CSE may have occurred in the non-essential luciferase gene which may impede the 
luciferase activity of the luciferase encoded by this virus. Full sequencing of the SFV4-2SG-Gluc-
∆URE+∆CSE including the luciferase gene woule be needed to determine if mutations have occurred 
in this gene that may have affected the luciferase assay. 
HuR relocalisation to the cytoplasm occurs in the early hours of infection following infection with 
SFV4-2SG-Gluc-∆URE and SFV4-2SG-Gluc-∆URE∆CSE but is not retained in the cytoplasm to the same 
proportions when compared to infection with SFV4-2SG-Gluc-WT or SFV4-2SG-Gluc-5xURE. This 
suggests that initial HuR relocalisation may be less dependent on the presence of the URE but caused 
by a separate event. This may be caused by stress to cells by the virus infection (Peng et al., 1998) 
and/or the phosphorylation state of HuR (Pullmann et al., 2007). It has been previously demonstrated 
that HuR is dephosphorylated at a residue on the protein’s hinge region during SINV infection (Dickson 
et al., 2012) and that this may result in re-localisation to the cytoplasm.  The amount of HuR that is 
retained in the cytoplasm following an initial relocalisation to the cytoplasm is shown to be correlated 
to the number of URE in the SFV4 genome. It has been previously shown the URE of a number of 
alphaviruses including SINV and SFV directly binds cellular HuR (Dickson et al., 2012). This suggests 
that the high levels of retention of HuR in the cytoplasm following infection with SFV4-2SG-Gluc-
5xURE is because the virus contains more HuR binding sites on the viral RNA which sequester HuR on 
the viral RNA in the cytoplasm. In support of this, the nuclear localization of HuR during the later hours 
of infection with SFV4-2SG-Gluc-∆URE after an initial partial movement of HuR to the cytoplasm is 
likely due to a limited number of HuR binding sites on the SFV4-2SG-Gluc-∆URE viral RNA (SFV4 CSE 
141 
 
loosely binds HuR so retains a smaller percentage of HuR in the cytoplasm (Dickson et al., 2012)). 
Unbound HuR in the cytoplasm is likely to shuttle back to the nucleus or bind host mRNAs. 
There are large standard deviations when analyzing the ratio of cytoplasmic HuR to nuclear HuR 
between individual cells following infection with SFV4(3F)eGFP-∆CSE and SFV4(3F)eGFP-∆URE+∆CSE. 
This may be a result of varying virion populations in the virus preparations or the number of virions 
that initially infect each individual cell. The contrasting relatively small standard deviation seen during 
infection with SFV4-2SG-Gluc-5xURE is likely due to the increased HuR binding sites in the 3’UTR which 
bind all relocated HuR irrespective of small differences in viral RNA concentration between cells.  
Infection with an rSFV4, in particular with SFV4(3F)-eGFP-∆URE+∆CSE, caused foci of HuR and PABPC 
co-localisation in the cytoplasm. These foci may be stress-granules which are known to form during 
environmental stress including viral infections and contain both HuR and PABPC. SFV4 disrupts the 
formation of stress-granules on viral RNA through the action of nsP3. SFV4 nsP3 binds Ras-GAP SH3-
domain–binding protein (G3BP) and sequesters it into CPV-I replication complexes inhibiting G3BP 
from forming stress-granules (Panas et al., 2012). The increased number of putative stress-granules 
seen during SFV4(3F)-eGFP-∆URE+∆CSE may be relating to an increase in stress induced on the cell by 
this virus or a loss of the nsP3-mediated G3BP inhibition. 
The relocalised HuR colocalises with PABPC in the cytoplasm even when not in discrete foci. This is not 
surprising since both host proteins bind viral RNA and are both likely omitted from similar subcellular 
compartments. Interestingly, it has been reported that HuR can increase stability of an mRNA when 
bound to the 3’UTR through interaction with PABPC. The 3’ end of -casein structurally interacts with 
the poly(A) tail through the formation of a protein complex of HuR (binding to the 3’UTR) and PABPC 
(binding to the poly(A) tail) (Nagaoka et al., 2006). Given the proximity of the URE and CSE (known to 
bind HuR) to the poly(A) tail (known to bind PABPC) in the SFV4 genome it is reasonable to suggest 
that the SFV4 RNA may form such an interaction possibly via a stem-loop structure to inhibit 
deadenylation in host cells.   
The mechanisms by which HuR protects viral transcripts in host mammalian cells have not been fully 
elucidated. The rate limiting step of basal decay of host mRNA transcripts typically starts with 
deadenylation. Deadenylation is mediated in two pathways involving a super complex of PAN2-PAN3 
and CCR4-NOT which binds poly(A) tails and shortens them however most commonly poly(A) specific 
ribonuclease (PARN) mediates host cell mRNA deadenylation (Wu et al., 2005; Moraes, Wilusz and 
Wilusz, 2007; Bartlam and Yamamoto, 2010). Once the tail is removed deadenylation-dependent 
decapping can occur utilising the decapping complex (Wu et al., 2005) of decapping enzymes 1 and 2 
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which remove the m7G cap (Coller and Parker, 2004). The remaining transcript is then degraded at the 
5’ or 3’ by XRN1 or the exosome respectively (Parker and Song, 2004).  The interaction of HuR and 
PABPC while bound to mRNA (Nagaoka et al., 2006) suggests this interaction may inhibit the 
recruitment of deadenylation enzymes and its subsequent degradation.  
The deletion of the URE from the SFV4 3’UTR not only decreased retention of HuR in the cytoplasm 
but it also reduced the levels of infectious virus (as shown by plaque assay) produced in the early hours 
of infection and initial rate of viral RNA replication and/or translation (as shown by luciferase assay). 
This observation concurs with studies which show HuR increases the translation rate of mRNA to 
which HuR binds (Mazan-Mamczarz et al., 2003; Galban et al., 2008). This effect was augmented 
during a multi-step growth curve. Adding validity to the URE’s role in initial viral replication/translation 
and effect on production of infectious virions, an SFV4 virus containing four additional UREs had the 
opposite effect to deleting the URE. Infection with SFV4-2SG-Gluc-5xURE increased the initial amount 
of infectious virus and initial rate of viral RNA replication/translation and again the effect was 
augmented when infecting murine cells at a low MOI.  Interestingly, the increased initial rate at which 
the SFV4-2SG-Gluc-5xURE virus replicated during the 1-step growth curve sharply reduced at 12 hpi 
and this slower rate was maintained during the course of infection.  This could be a result of the cell’s 
anti-viral IFN responses, which is supported by the higher IFN-beta mRNA levels produced during 
infection with SFV-2SG-Gluc-5xURE compared to SFV-2SG-Gluc infection. 
The advantage that multiple URE in the SFV4 3’UTR has on initial viral replication following infection 
with SFV4(3F)-eGFP-5xURE may appear contradictory to predicted course of virus evolution since SFV4 
has not duplicated these URE sequences over time. There are multiple logical deductions as to why 
this has not occurred. Firstly, the replication of alphaviruses is complex; alphaviruses not only replicate 
in vertebrate hosts but also in arthropod vectors such as mosquitoes, which spread these viruses. This 
means that any change on the viral genome which optimises replication in the vertebrate hosts may 
in turn eliminate their ability to establish a consistent (and not fatal) infection in their arthropod hosts. 
Secondly, the additional URE in the SFV4 increased initial viral replication but did not result in a higher 
number of virions at later time points post infection at a high MOI. This is not surprising when 
identifying the higher IFN- mRNA levels produced during infection with SFV4(3F)-eGFP-5xURE. IFN- 
as discussed is a primary and broad initiator of the anti-viral response during alphaviral infections  
(Ryman and Klimstra, 2008; Akhrymuk, Frolov and Frolova, 2016; Chawla-Sarkar et al., 2003).  The 
initial higher levels of SFV4 RNA produced during infection with SFV4(3F)-eGFP-5xURE as compared to 
the wild type virus may infer a stronger anti-viral response since double stranded RNA acts as a 
pathogen associated molecular pattern (PAMP). This stimulates an antiviral IFN response through 
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recognition by PRR (pathogen recognition receptors) as discussed in Chapter 1 (Akhrymuk, Frolov and 
Frolova, 2016). Thirdly, since the recruitment of HuR to viral genomes infers a disadvantage to host 
cells, mammalian cells may have evolved a secondary pathway to promote the transcription of IFN-
 when available HuR levels are depleted.  
The deletion or addition of URE to the SFV4 3’UTR did not appear to have a significant effect on 
caspase 3/7 activity and cell death although small and when statistically significant differences did 
occur, these correlated with differences in production of infectious virus and virus RNA abundance 
which are known to affect apoptosis pathway. 
The presence and frequency of URE in the viral genome affects the rate of HuR relocalisation to, and 
predominantly its retention in the cytoplasm. HuR binds to a number of host transcripts in basal 
and/or stress conditions and increases their stability and half-lives. This suggests that during SFV4 
infection, the SFV4 3’UTR acts as a molecular sponge to quench the infected cell with HuR binding 
sites so less HuR is available to bind to host-cell transcripts. A destabilising effect on host mRNA 
(containing HuR binding sites) occurs during SINV infection following HuR sequestration on SINV RNA 
(Barnhart et al., 2013).  It, therefore, seems likely that the sequestration of HuR on the SFV4 URE 
during SFV4 infection would have a similar effect. The significant decrease seen in -actin mRNA 
during SFV4 infection supports this assumption. Furthermore, this decrease is inhibited or enhanced 
with the removal or addition of URE to the SFV4 3’UTR, respectively. This is further supported by 
studies which have shown the down regulation of -actin expression observed following silencing of 
HuR at the mRNA and protein levels. Silencing of HuR using siRNA in HeLa cells results in a 70% 
decrease in beta-actin mRNA (Dormoy-Raclet et al., 2007) and similar effects are seen in corneal 
fibroblasts (Joseph, Srivastava and Pfister, 2014).  This supports the theory that the more HuR binding 
sites in the viral genome (URE’s), the higher the subsequent destabilising effect during infection on 
host cell transcripts which bind HuR.  
Herdy et al. (2015) used affinity purification, mass spectrometry and immunoprecipitation against HuR 
followed by RNA isolation and qPCR to show specific binding of HuR to IFN- mRNA. Overexpression 
of HuR in HeLaS3 cells showed no effect on IFN-beta mRNA levels, however, lowering HuR expression 
or chemically inhibiting its dimerisation significantly inhibited the IFN- response in HeLaS3 cells and 
in rheumatoid arthritis fibroblast like synoviocytes (FLSs) (Herdy et al., 2015). Unexpectedly more HuR 
binding sites in the SFV4 3’UTR resulted in higher levels of IFN- mRNA in host cells at 6hpi. Although 
unexpected, there is a number of logical explanations for this. Firstly, infection with SFV4-2SG-Gluc-
5xURE in NIH/3T3 cells results in higher levels of viral RNA during the early hours of infection. Double-
stranded RNA present during viral genome replication of an RNA virus infection is known to be 
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detected by pattern recognition receptors (PRRs) such as RIG-I and MDA5 as well as the toll-like 
receptors which then stimulate IFN transcription. The differences in cytoplasmic IFN- mRNA 
abundance between the rSFV4 viruses is less pronounced at 12 hpi than at 6hpi which would coincide 
with differences in SFV4 RNA abundance, lending support to the theory that the increased viral RNA 
abundance seen during infection with SFV4-2SG-Gluc-5xURE is responsible for the increased IFN- 
levels. Alternatively, mammalian cells may have evolved a redundant pathway to stimulate IFN- 
mRNA transcription during a viral infection which sequesters HuR. Finally, the increased IFN- 
abundance may be a result of decreased IFN protein levels if IFN-beta mRNA is being inefficiently 
translated following the sequestration of HuR on the viral genome. HuR has been shown in many 
instances to increase the translation of mRNA to which it binds (Mazan-Mamczarz et al., 2003; Galban 
et al., 2008) thus the absence of HuR to bind to IFN- mRNA may result in a decrease translation of 
that mRNA. Reduced IFN- protein levels may stimulate the cell to increase IFN- mRNA transcription. 
Further analysis to measure IFN- protein levels by western blot or other protein analysis would help 
elucidate if a lack of IFN- protein was evident during infection with SFV4-2SG-Gluc-5xURE despite 
higher levels of IFN- mRNA, this would suggest an inhibition of IFN- mRNA translation. 
Apoptosis is orchestrated through a number of caspase enzymes. Caspase 9 contains HuR binding sites 
which are thought to stabilize the caspase-9 mRNA. Furthermore, during initial apoptosis signaling, a 
proportion of HuR is cleaved in a caspase-dependent manner and the HuR cleavage products have 
been demonstrated to amplify the apoptotic response (Mazroui et al., 2008). HuR that translocates to 
the cytoplasm during SINV infection has been demonstrated not to be the cleaved form of HuR 
(Sokoloski et al., 2010).  The sequestration of HuR on the viral genome in SFV4 infection may therefore 
reduce the available HuR that is able to bind and stabilize caspase-9 mRNA and also reduce the amount 
of HuR available to be cleaved and promote apoptosis which would lead to decreased caspase-9 mRNA 
levels. This is reflected in caspase-9 cytoplasmic mRNA abundance during infection with SFV4 whereby 
the caspase-9 mRNA levels were significantly decreased to when compared to NIC. When more URE 
elements are present in the 3’UTR of the SFV4 genome, caspase-9 mRNA levels are decreased most 
significantly and when the URE is removed from the viral genome caspase-9 mRNA levels are 
decreased least significantly. This supports the notion that the more URE present in the viral genome, 
the larger proportion of cellular HuR is sequestered on the viral genome and thus the less HuR is able 





RNase-L mRNA 3’UTR contains cis-acting elements which bind TTR-RBPs that either promote or inhibit 
its degradation. HuR binds the RNase-L mRNA in the 3’UTR region and has been shown to increase its 
stability and protein expression. Furthermore, this interaction has been demonstrated to enhance 
antiviral activity presumably by creating higher levels of RNase-L (Li et al., 2007). Interestingly, RNAse-
L has been shown to downregulate HuR expression which is dependent on the 3’UTR of the HuR 
mRNA. In one study the half-life of HuR mRNA increased from 1.5 to 6 hours from wild-type to RNase-
L KO cell lines, respectively (Al-Ahmadi et al., 2009b).  The significance of the RNase-L inhibitory effect 
on HuR expression in wild-type cells was shown to have variations depending on the cell-cycle state, 
the confluency of the cells, and the subcellular location of HuR (Al-Ahmadi et al., 2009b).  The 
abundance of RNase-L mRNA during infection with the rSFV4 tested shows no direct correlation to 
frequency of URE elements in the SFV4 3’UTR. There could be a more complicated explanation for this 
such as the wild type virus produces a better infection than SFV4-2SG-Gluc-∆URE so stimulates the 
production of more RNase-L but sequesters more HuR in the cell to it’s genome so RNase-L is 
destabilised or unable to be exported out of the nucleus. However, when comparing to NIC, it appears 
there is a higher ratio of RNase-L mRNA in the nucleus compared to the cytoplasm at both 6 and 12 
hpi for all rSFV4 viruses.  This suggests SFV4 infection may be inhibiting RNase-L mRNA’s nuclear 
export. An alternative explanation could be the abundance of RNase-L mRNA in the nucleus is 
increased during SFV4 infection compared to NIC because of an increase in transcription but this 
difference is quenched when looking at the cytoplasmic fraction due to the increased mRNA density 
in this fraction.  
TTP mRNA was significantly increased at both 6 and 12 hpi for all 3 rSFV4 viruses compared to NIC. 
Since the frequency of URE in the SFV4 3’UTR appears to affect TTP mRNA abundance significantly at 
the beginning of infection (6hpi) but not later, this may be an indirect effect on viral replication and 
viral RNA abundance rather than sequestration of HuR on the viral genome. TTP is known to bind 
sequences analogous to HuR, i.e. AU-rich elements in particular AUUUA, AUUUUA, AUUUUUA and 
there is evidence that HuR and TTP competitively bind the same mRNA to regulate its stability or 
degradation, respectively (Young et al., 2009; Dean et al., 2004). The increased TTP mRNA abundance 
may be stimulated by SFV4 to facilitate TTP binding to host cell transcripts, which have lost HuR after 
HuR has been sequestered by the virus RNA. TTP almost exclusively promotes mRNA degradation so 





It is unclear which effect of the URE and HuR is more significant for enhancing infection. The URE 
appears to promote translation of virus RNA and increase stability of the RNA but it also destabilises 
host cell transcripts through the sequestration of HuR away from host transcripts. During SINV 
infection the sequestration of HuR on the viral genome was shown to inhibit a range of mRNA 
including RIG-1 (DDX58) which is involved in initiating the anti-viral response (Barnhart et al., 2013).  
It is possible the increased translation and stability of viral RNA is most significant in initiating infection 
of the host cell and the destabilisation of host transcripts inhibits the anti-viral response, possibly 
apoptosis and therefore promotes the late stages of infection.  
The increase in TTP mRNA during SFV4 infection is also interesting since it is a TTR-RBP which promotes 
degradation of RNA. This suggests that the host cell may have upregulated TTP to increase the 
degradation of viral RNA. However, the majority of TTP does not colocalise with HuR during SFV4 
infection which suggests that TTP is not binding the viral RNA (since HuR has been previously shown 
to bind SFV4 3’UTR) so it may be binding host mRNAs instead. Despite TTP and HuR binding different 
transcripts in some instances and competitively binding other, the binding of HuR to viral RNA may 
sterically inhibit TTP binding thus protect it from degradation. Other RNA binding proteins which bind 
the 3’UTR of transcripts and promote their degradation are the TTP paralog Bfr1 and the different 
isoforms of Auf1. In contrast to HuR, these RNA-binding proteins act in synergy to recruit mRNA decay 
machinery and promote mRNA decay (Gratacos and Brewer, 2010; Raineri et al., 2004). For instance 
Auf1 can act as a co-activator of TTP by facilitating it’s recruitment to the 3’UTR (Kedar et al., 2012). 
HuR has been shown to bind to TTP mRNA and increase its stability (Pullmann et al., 2007), so given 
that HuR is sequestered during SFV4 infection and thus not able to stabilize TTP mRNA an increase in 
TTP abundance is surprising. The SFV4 virus infection may have stimulated the transcription of TTP. 
This may be beneficial to SFV infection since it may assist in the degradation of host mRNA which bind 
TTP in the absence of HuR.  
The ability of the URE to increase protein levels either through increasing the stability of RNA and/or 
its translation lends itself to be utilised as a stability element perhaps to be located immediately 5’ of 
a polyadenylation signal sequence for transfected RNA or RNA transcribed from plasmids or vector 
inserted transgenes (Powell, Rivera-Soto and Gray, 2015). This will likely increase the protein 
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In Chapter 3, translocation dynamics of key RNA-binding protein where investigated during lytic 
infections with SFV (an RNA virus) and MHV-68 (a DNA virus).  The ability to compare two viruses 
which cause comparable lytic infections in murine cells provided the opportunity to investigate 
whether changes in translocation dynamics of key RNA-binding proteins were primarily driven by 
viruses or were the results of stress response from cells and therefore virus-independent. The 
observations that MHV-68 infection resulted in the translocation of PABPC, suggested obstructions in 
bulk mRNA export which warranted further investigation.  
The alkaline DNase gene, found in all herpesviruses studied so far, has evolved a distinct function in 
gamma-herpesviruses to enable viral mediated host shut-off. The homologs discussed in Chapter 1, 
kSOX, muSOX and BGLF5 induce a significant increase in the rate of host mRNA turnover during KSHV, 
MHV-68 and EBV lytic infection, respectively (Covarrubias et al., 2009; Rowe et al., 2007; Glaunsinger, 
Chavez and Ganem, 2005). The expression of these homologs in host cells also results in the build-up 
of PABPC in the nucleus (Kumar and Glaunsinger, 2010).  
The current established mechanism by which PABPC builds up in the nucleus during MHV-68 infection 
is due to the loss of poly(A) mRNA in the cytoplasm following viral muSOX expression (Kumar, Shum 
and Glaunsinger, 2011). In basal conditions, PABPC is retained in the cytoplasm while bound to the 
poly(A) tail on mRNA. When poly(A)+ mRNA in the cytoplasm is degraded post-muSOX expression the 
cytoplasmic PABPC binds to Importin-alpha and is translocated back to the nucleus (Kumar, Shum and 
Glaunsinger, 2011).  
An alternative mechanism by which PABPC accumulates in the nucleus occurs when bulk poly(A) 
mRNA nuclear export is blocked (Burgess et al., 2011). Results from PABPC immunostaining following 
MHV-68 infection in NIH/3T3 cells indicated that the translocation of PABPC to the nucleus occurs 
gradually from 8 to 24 h.p.i. This supports a model whereby the PABPC relocation is gradual over the 
course of infection. PABPC is a known nucleo-cytoplasmic shuttling protein and it has been 
demonstrated to be exported from the nucleus into the cytoplasm while bound to poly(A) mRNA. 
Furthermore, when bulk poly(A) mRNA nuclear export is blocked via knock-down of NXF1 a build-up 
of PABPC in the nucleus occurs (Burgess et al., 2011). It is therefore possible that a build-up of PABPC 
in the nucleus occurs as a consequence of a block in bulk poly(A) mRNA nuclear export rather than as 




The mRNA nuclear export of host mRNA transcripts is a dynamic process involving ribonucleoprotein 
complexes which facilitate the transport of mRNA through the nuclear pore; mRNA is then released 
in the cytoplasm. As discussed in Chapter 1, the bulk of mRNA is exported out the nucleus as part of a 
ribonucleoprotein complex containing NXF1-NXT1 (Carmody and Wente, 2009). The NXF1 
ribonucleocomplex is bound by RAE1 which directs it to the nuclear pore, binds Nup98 of the nuclear 
pore and translocates through it (Blevins et al., 2003). RAE1 does not dissociate from the 




In Chapter 3 it was concluded that in stark contrast to infection with SFV, PABPC enters the nucleus 
gradually over 24 hours following muSOX expression during MHV-68 infection. It was hypothesised 
that the gradual nuclear build-up of PABPC in MHV-68 lytic infection occurs because of a gradual block 
in mRNA nuclear export. 
1. The study aimed to determine if muSOX results in a block in mRNA nuclear export during MHV-68 
infection by specifically assessing: 
• The subcellular localisation of RAE1 in NIH/3T3 cells after infection with MHV-68 or MHV-68 
ORF37stop viruses. 
• A possible build-up of host mRNA transcripts in the nucleus following infection with MHV-68 
or MHV-68 ORF37stop viruses. 
2. The study also assessed if host mRNA degradation is inhibited during MHV-68 ORF37stop infection 
as compared to MHV-68 infection and if this occurs predominantly in the cytoplasm or nucleus.  
 
5.3 Results  
 
As discussed in Chapter 1 many RNA-binding proteins are utilised in mRNA nuclear export that shuttle 
between the nucleus and cytoplasm as part of a ribonucleoprotein complex with mRNA. To decipher 
if muSOX created a block in the mRNA nuclear export protein machinery the sub-cellular location of 




RAE1 is distributed between the nucleus and cytoplasm in basal conditions in NIH/3T3 cells with a 
higher proportion in the nucleus and no distinct build-up at the nuclear envelope (Figure 5.1). This is 
akin to the subcellular location of RAE1 in the same cell type following infection with MHV-68 
ORF37stop virus at both 12 and 24 h.p.i (Figure 5.1). Interestingly, during infection of NIH/3T3 cells 
with MHV-68 with a functional muSOX gene, RAE1 builds up at the nuclear envelope by 12 h.p.i and 













































Figure 5.1. RAE1 builds-up around nuclear envelope following MHV-68 infection but 
not MHV-68  ORF37stop infection or NIC. NIH/3T3 cells were infected at an MOI of 5 with 
MHV-68 or MHV-68 ORF37stop viruses and fixe d at 12 or 24 hours post infection. Cells were 
stained against MHV-68 capsid (green), RAE1 (red) and DAPI staining (blue). Experiment was 















The build-up of RAE1 at the nuclear envelope following infection with MHV-68 suggests there may be 
a break-down of bulk mRNA nuclear export since RAE1 is exported out of the nucleus as part of a 
ribonucleoprotein complex that exports mRNA out of the nucleus (Blevins et al., 2003; Cheng et al., 
2006). To assess this at the mRNA level NIH/3T3 cells were infected with MHV-68 and MHV-68 
ORF37stop viruses and the nuclear and cytoplasmic fractions were separated. Following separation of 
subcellular fractions, RNA was extracted for analysis by qPCR for viral and cellular transcripts. 
Following infection of mammalian cells with MHV-68, muSOX is expressed from 6-8 h.p.i. onwards and 
muSOX mediated host shut-off is evident from 8-12 h.p.i. and continues throughout the course of 
infection (Covarrubias et al., 2009). The build-up of PABPC in the nucleus was measured as 53% 
nuclear at 16 h.p.i. infection in murine NIH/3T3 cells (Chapter 3). Therefore, if a block in mRNA nuclear 
export was responsible for the nuclear build-up of PABPC following muSOX expression then 16 h.p.i. 
was deemed an adequate time point to quantify the level of specific mRNA transcripts in the nucleus 
and cytoplasm.  
The relative abundance of MHV-68 gB mRNA was assessed as an indication of the level of viral mRNA 
expression and by extension, viral lytic infection. Infection of NIH/3T3 cells with MHV-68 resulted in 
an abundance of MHV-68 gB mRNA in the cytoplasm that was moderately yet significantly higher than 
the level of MHV-68 gB mRNA in the cytoplasm in cells infected with MHV-68 ORF37stop virus (Figure 
5.2, p = 0.011). The levels of MHV-68 gB in the nucleus following infection from the two viruses were 
not-significantly different (Figure 5.2, p = 0.273). This suggests that both viruses were able to produce 













Figure 5.2 MHV-68 and MHV-68 ORF37stop viruses produce comparable levels of MHV-68 gpB 
mRNA in the cytoplasmic and nuclear fraction following infection of NIH/3T3 cells. NIH/3T3 cells 
were infected an MOI of 10 with MHV-68 or MHV-68 ORF37stop. Samples were collected at 16 h.p.i. 
The results are representative of n=2 experiments. 
 
As discussed in Chapter 1, it has been indicated that host mRNA nuclear export machinery begins to 
assemble on pre-mRNA simultaneously to on-going transcription and splicing, illustrating that mRNA 
maturation and its nuclear export are physically linked processes (Masuda et al., 2005). Subtle 
differences in mRNA nuclear export machinery and dynamics can also occur depending on the 
existence or absence of introns within the gene (Masuda et al., 2005; Chi et al., 2013). Therefore, a 
block in mRNA nuclear export may occur at any one of multiple steps during mRNA transcription, 
maturation and nuclear export. Although the NXF-1-dependent pathway for mRNA nuclear export is 
responsible for host bulk mRNA nuclear export it has been demonstrated that viruses can adapt the 
pathway or utilise NXF1-independent pathways (such as via CRM1 and an adapter protein) (Carmody 
and Wente, 2009)) for viral mRNA nuclear export. Alterations to the host ribonucleoprotein complexes 
involved in mRNA nuclear export pathways have been identified during herpes simplex virus (Soliman 
and Silverstein, 2000) and KSHV (Jackson et al., 2011).  
For this reason, a range of representative transcripts, which either were intronless or contained a 
varied number of introns, were chosen. These transcripts may follow subtly different sets of processes 
before nuclear export and may be exported by messenger ribonucleoprotein (mRNP) complexes of 
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For detection of host cyclophillin A mRNA, primers that amplify an amplicon containing a splice 
junction were designed. With the designed primers, the cyclophilin A spliced mRNA should amplify an 
amplicon of 100 bases. Any larger amplicon (from a build-up of unspliced cyclophilin A mRNA) would 
be detected during the melt-curve assay in the qPCR as a double peak.  
 
 
Figure 5.3 Cyclophilin A mRNA abundance is decreased in the cytoplasmic and nuclear fraction 
during MHV-68 infection compared to NIC or MHV-68 ORF37stop infection. (i) Cyclophilin A mRNA 
sequence with indicated splice junctions (pink) and primers used (red and blue) in qPCR (ii) 
Cyclophilin A mRNA abundance in cytoplasm and nucleus following infection with MHV-68 or 
MHV68 lacking functional muSOX gene. NIH/3T3 cells were infected an MOI of 10 with MHV-68 or 
MHV-68 ORF37stop. Samples were collected at 16 h.p.i. The results are representative of n=2 
experiments. 
 
The abundance of cyclophillin A mRNA in the cytoplasm of NIH/3T3 cells infected with MHV-68 is 
significantly less compared to its levels in the NIC (Figure 5.4, p = <0.01) and cells infected with MHV-
68 ORF37stop virus (p = 0.01). This decrease in cyclophillin A mRNA is also seen in the nucleus and is 


















































































is also a decline in cyclophillin A mRNA in the nucleus of cells infected with MHV-68 ORF37stop virus 
compared to NIC (p = <0.01).  
Taken together these results suggest that a significant decrease in cyclophilin A mRNA in the 
cytoplasm occurs following infection with MHV-68 but not MHV-68 lacking a functional muSOX gene. 
A similar significant decrease of cyclophilin A mRNA is seen in the nucleus following MHV-68 infection 
and to a lesser extent following MHV-68 ORF37stop infection. This may relate to a decrease in 
cyclophilin A transcription or an increase in cyclophilin A mRNA turnover. No apparent build-up of 
cyclophilin A mRNA occurred in the nucleus following infection of MHV-68 as compared to NIC or 
MHV-68 ORF37stop infection. The meltcurve from the qPCR showed one clean peak suggesting that 
minimal or no unspliced pre-mRNA was duplicated in the qPCR reaction. This suggests that a build-up 
of non-spliced cyclophilin A mRNA also did not occur in the nucleus. Taken together, these data 









Figure 5.4 Cytoplasmic PARN mRNA abundance is decreased in the cytoplasm and nucleus during 
MHV-68 infection compared to NIC or MHV-68 ORF37stop infection. (i) PARN mRNA sequence with 
indicated splice junctions (pink) and primers (red and blue) used in qPCR (ii) PARN mRNA abundance 
in cytoplasm and nucleus following infection with MHV-68 or MHV68 lacking functional muSOX 
gene. NIH/3T3 cells were infected at an MOI of 10 with MHV-68 or MHV-68 ORF37stop. Samples 
were collected at 16 h.p.i. The results are representative of n=2 experiments. 
 
PARN mRNA decreases in abundance in NIH/3T3 cells following infection with MHV-68 in both the 
cytoplasm (Figure 5.5, p=<0.01) and nucleus compared to NIC (p=<0.01).  There is a decrease in PARN 
mRNA levels following MHV-68 ORF37stop virus infection in both the cytoplasm (p=0.06) and nucleus 
(p=0.02) compared to NIC but this decrease is only significant in the nucleus. The difference between 
PARN abundance between MHV-68 infection and MHV-68 ORF37stop infection is also significant both 
in the cytoplasm (p=0.01) and nucleus (p=0.04). This suggests that muSOX results in a significant 
decrease in PARN mRNA at 16 h.p.i. in both the cytoplasm and nucleus following infection with MHV-



















































































compared to NIC or MHV-68 ORF37stop infection suggesting muSOX does not cause a nuclear build-
up of PARN mRNA.  
Primers against host XRN1 mRNA amplified an amplicon containing no introns despite containing 
many in the full pre-mRNA transcript. This enabled inclusion of the relative quantification of XRN1 
unspliced pre-mRNA as well as spliced XRN1 mRNA in to the total relative XRN1 mRNA abundance 
compared to NIC.  This would allow detection of a block in XRN1 mRNA nuclear export if it was 




















Figure 5.5 Cytoplasmic XRN1 mRNA abundance is decreased in the cytoplasm and nucleus during 
MHV-68 infection compared to NIC or MHV-68 ORF37stop infection. (i) XRN1 mRNA sequence with 
indicated splice junctions (pink) and primers (red and blue) used in qPCR (ii) XRN1 mRNA abundance 
in cytoplasm and nucleus following infection with MHV-68 or MHV68 lacking functional muSOX 
gene. NIH/3T3 cells were infected at an MOI of 10 with MHV-68 or MHV-68 ORF37stop. Samples 
were collected at 16 h.p.i. The results are representative of n=2 experiments. 
 
Cytoplasmic XRN1 decreases in mRNA abundance following MHV-68 infection compared to NIC 
(Figure 5.6, p=<0.01) or MHV-68 ORF37stop infection (p=<0.01). XRN1 mRNA abundance also 
decreases in the nucleus following MHV-68 infection compared to NIC (p=<0.01) or MHV-68 
ORF37stop infection (p=<0.01). Infection of NIH/3T3 cells with MHV-68 ORF37stop infection causes 

















































































significant reduction in the nucleus (p=0.047). There is no significant increase in XRN1 mRNA 
abundance in the nucleus following infection with MHV-68 suggesting that MHV-68 infection with or 
without a functional muSOX gene has not caused a build-up of XRN1 mRNA in the nucleus. 
Finally, host HSP70 mRNA abundance was measured because HSP70 transcript is intronless so its 
mRNA maturation and nuclear export pathway may involve mRNP complexes and processes that differ 
slightly from transcripts with introns that undergo splicing. This allowed for assessment of a wider 
range of mRNA export pathways. 
 
 
Figure 5.6 Cytoplasmic HSP70 mRNA abundance is decreased in the cytoplasm and nucleus during 
MHV-68 infection compared to NIC or MHV-68 ORF37stop infection. (i) HSP70 mRNA sequence 
containing no splice junctions, primers (red and blue) used in qPCR (ii) HSP70 mRNA abundance in 
cytoplasm and nucleus following infection with MHV-68 or MHV68 lacking functional muSOX gene. 
NIH/3T3 cells were infected at an MOI of 10 with MHV-68 or MHV-68 ORF37stop. Samples were 



















































































The abundance of HSP70 mRNA in the cytoplasm of NIH/3T3 cells significantly decreased by 16 h.p.i. 
with MHV-68 compared to NIC (Figure 5.7, p=<0.01) and MHV-68 ORF37stop infection (p=<0.01). 
Following MHV-68 infection in the nucleus this reduction is also seen compared to NIC (p=<0.01) and 
MHV-68 ORF37stop infection (p=<0.01).  There are no significant differences between HSP70 mRNA 
abundance in the cytoplasm at 16 h.p.i with MHV-68 ORF37stop compared to NIC (p=0.32) and a small 
but significant decrease in the nucleus (p=0.04). Taken together this data suggests that despite not 




The inhibition of host mRNA nuclear export is targeted by a wide range of virus families. Since 
inhibition of mRNA nuclear export inhibits host-cell protein production this targeted action results in 
suppression of the host-cell anti-viral response. It also increases the availability of host translation 
machinery for translation of viral proteins. 
The bulk of host mRNA nuclear export occurs through a NXF1/NXT1 pathway (as discussed in Chapter 
1) whereby the host mRNA-NXF1/NXT1 mRNP translocates to the nuclear pore through binding to 
RAE1 (Blevins et al., 2003). RAE1 is targeted during vesicular stomatitis virus (VSV) infection of 
mammalian cells. Vesicular stomatitis virus (VSV) inhibits host cell protein production through 
inhibition of transcription and host mRNA nuclear export (von Kobbe et al., 2000; Petersen et al., 
2000). The inhibition affects poly(A) mRNA nuclear export without affecting nucleocytoplasmic traffic 
of host proteins. VSV M protein interacts with Nup98 via Nup98 amino acids 173-213 (Faria et al., 
2005) containing the GLEBS motif (Pritchard et al., 1999) which binds RAE1. VSV M protein interaction 
with RAE1 is independent of Nup98 whereas VSV M protein interaction with Nup98 is RAE1 
dependent. This promotes a model whereby RAE1 is the primary interaction target of VSV M protein 
which forms incompetent export complexes with RAE1 and Nup98 (Faria et al., 2005). The block in 
host mRNA export is alleviated/prevented by transfection with RAE1 or Nup98 on an expression 
plasmid (Faria et al., 2005). The increased Nup98 expression may outcompete VSV M protein for 
binding to RAE1 and thus alleviate an inhibition of mRNA nuclear export. The reversion of host mRNA 
export block by RAE1 over expression was shown to be RAE1 dose dependent in cells transfected with 
M protein or VSV infected cells (Faria et al., 2005). This suggests quenching the cell with RAE1 provides 
enough to alleviate a block in mRNA export despite the presence of VSV M protein. 
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The build-up of RAE1 around the nuclear envelope during MHV-68 infection may indicate a break-
down or adjustment to the host bulk mRNA nuclear export pathway. This change in RAE1 subcellular 
location may be occurring directly due to changes to the RAE1 protein itself, or other indirect changes 
including changes to the mRNA nuclear export machinery. Despite the build-up of RAE1 around the 
nuclear envelope however, no nuclear build-up of the host mRNA transcripts analysed in this chapter 
was observed. Recently a similar study has found that MHV-68 and KSHV ORF10 protein bind RAE1 
and form a complex with Nup98. This results in a block in nuclear export of a subset of host mRNA 
transcripts (Gong et al., 2016).   
It was demonstrated using a sequential Immunoprecipitation assay (IP) that KSHV and MHV-68 ORF10 
form a complex with Nup98 through an interaction with RAE1 (Gong et al., 2016). Furthermore, using 
oligod(T) in-situ hybridisation it was shown that expression of ORF10 from either KSHV and MHV-68 
results in poly(A) nuclear accumulation. The increased signal from oligod(T) staining was attributed to 
a block in mRNA nuclear export to a subset of host mRNA transcripts and it was also demonstrated 
that the mRNA transcripts blocked from nuclear export become hyper-adenylated (Gong et al., 2016).  
RAE1 is thought to be a key RNA nuclear export protein in the bulk mammalian mRNA nuclear export 
pathway. However, knock-down of RAE1 did not duplicate the same phenotype as ORF10 protein 
expression (Gong et al., 2016). Therefore it was concluded that it is the complex of ORF10, RAE1 and 
Nup98 which selectively inhibits a sub-set of host mRNA transcripts and not just the removal of 
available RAE1 through sequestration by ORF10 (Gong et al., 2016). Through RNA sequencing analysis 
of host nuclear and cytoplasmic fractions, the block in mRNA nuclear export following ORF10 
expression was evident in only a subset of genes analysed (Gong et al., 2016). Of the 12,181 host genes 
analysed, 686 genes had more than a 50% increase in their nuclear to cytoplasmic mRNA transcript 
location ratios. Importantly, despite some of the genes analysed in this study being included in the 
original 12,181 genes analysed in the ORF10 study, CYPA, PARN, XRN1 or HSP70 did not show an 
increase in their nuclear to cytoplasmic mRNA transcript location ratios following ORF10 expression 
(Gong et al., 2016). This agrees with the data in this study which found no nuclear build-up of mRNA 
from these four genes following MHV-68 infection (during which ORF10 is expressed). Since all four 
genes tested, including HSP70, did not build-up in the nucleus following MHV-68 infection then any 
muSOX or ORF10 mediated block in mRNA export is likely not defined to all transcripts with introns or 
all transcripts without introns. This is important because the bulk NXF1-NXT1 mRNA nuclear export 
pathway (which includes RAE1) has been previously demonstrated to be functionally linked to mRNA 
splicing (Masuda et al., 2005; Cheng et al., 2006) so any nuclear mRNA export block involving RAE1 
may have been specific to spliced transcripts. 
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Interestingly, poly(A) transcript nuclear accumulation including host transcript hyper-adenylation 
following MHV-68 or KSHV infection has already been previously attributed to expression of viral 
muSOX (MHV-68) or SOX (KSHV) and the subsequent nuclear build-up of poly(A) binding protein 
(Kumar and Glaunsinger, 2010; Covarrubias et al., 2009). This suggests that there are two gamma-
herpesviral proteins, muSOX/SOX and ORF10, resulting in a nuclear accumulation of host mRNA 
transcripts and host mRNA hyperadenylation. This study suggests however that CYPA, PARN, XRN1 
and HSP70 are genes that are not susceptible to this nuclear accumulation resulting either through 
expression of muSOX or ORF10. Interestingly in this study, a build-up of RAE1 around the nuclear 
envelope during infection of MHV-68 only occurred during infection with MHV-68 encoding a 
functional muSOX gene. This suggests that either muSOX also directly effects RAE1 function or 
alternatively that the functions of muSOX, including host mRNA degradation, have an indirect effect 
on RAE1 subcellular location. It has been demonstrated that muSOX and SOX target similar subsets of 
host mRNAs but both proteins elicit a more potent host shut-off when expressed during viral infection 
rather than on an expression plasmid (Clyde and Glaunsinger, 2011). This supports the idea that 
multiple gamma-herpesviral proteins contribute to the host shut-off phenotype evident during 
gammaherpesviral infection. Finally, the expression of RAE1 and NUP98/96 is up-regulated by IFN-γ 
(Faria et al., 2005) suggested that cells have evolved to attempt to compensate for viral infections 
targeting RAE1 and/or NUP98. 
Degradation of the host mRNA transcripts analysed occurred significantly in both the cytoplasm and 
nucleus of NIH/3T3 cells infected with MHV-68 compared to NIC or cells infected with MHV-68 
ORF37stop virus. This coincides with current data that identifies muSOX (and it’s homologs in other 
gamma-herpesviruses) as the principal viral protein responsible for the bulk of host mRNA 
degradation that is evident during gammaherpesvirus infection (Glaunsinger and Ganem, 2004; 
Ebrahimi et al., 2003). However, in contrast to previous works muSOX expression during MHV-68 
infection in this study elicited a decrease in mRNA abundance in both the cytoplasm and the nuclear 
fractions.  
KSHV SOX contains a nuclear localization signal 315PRKKRK320, and is predominantly located in the 
nucleus during infection (Glaunsinger, Chavez and Ganem, 2005). Its nuclear localization is important 
for its alkaline exonuclease and resolvase activity, conserved among homologs seen in other 
herpesviruses, used to process and package the herpesviral DNA genome. The exonuclease and 
resolvase functions of KSHV SOX and the ability to induce global mRNA turnover have been shown to 
be genetically separable by mutagenesis of SOX genes (Glaunsinger et al., 2005). This supports the 
contention that KSHV SOX has evolved the ability to promote mRNA turnover separately from the 
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protein’s DNase functions. Interestingly, following transfection of SOX and GFP expression plasmids in 
to 293T cells and subsequent sub-cellular fractionation, the SOX mediated mRNA turnover was found 
to occur predominantly in the cytoplasm. This finding was strengthened by the ability of a mutant SOX 
protein with a deleted nuclear localization signal (SOX-∆NLS) and thus predominant (but not total) 
localization in the cytoplasm that retained the ability to cause host shutoff (Glaunsinger et al., 2005). 
These findings were not conclusive since SOX-∆NLS still partially resided in the nucleus. Furthermore, 
the GFP plasmid may have been transcribed at such a rate as to overcome a loss of GFP mRNA levels 
seen in the nuclear fraction. Additionally, a block in a subset of mRNA nuclear export may have 
compensated for the RNA loss induced by SOX in the nuclear fraction. For instance GFP mRNA was 
found to be blocked from nuclear export following ORF10 interaction with RAE1 during KSHV and 
MHV-68 infection (Gong et al., 2016) and this study suggests that both muSOX and ORF10 affect RAE1 
function.  
During MHV-68 infection, muSOX also locates predominantly to the nucleus but akin to KSHV SOX and 
EBV BGLF5 it also partially resides in the cytoplasm (Covarrubias et al., 2009). A mutant muSOX fused 
to a nuclear retention peptide, muSOX-NRS, can restrict muSOX subcellular location to the nucleus. 
muSOX-NRS is unable retain host shutoff activity following transfection suggesting the requirement 
for at least partial cytoplasmic location of muSOX to induce host shutoff (Covarrubias et al., 2009). 
However, despite muSOX-NRS retaining in vitro DNAse activity, the same NRS fused to KSHV SOX 
caused a complete inhibition of DNase activity. This suggests the NRS tag could interfere with host 
shut-off activity in muSOX-NRS since even though the NRS doesn’t interfere with DNAse activity in 
muSOX-NRS the DNase and host shut-off functions are genetically separable. Furthermore, the notion 
that muSOX location in the cytoplasm is required for host shut-off activity does not confirm that mRNA 
loss is also not seen in the nucleus since muSOX may be degrading mRNA through indirect and/or 
multiple mechanisms. Finally, the retention of muSOX-NRS in the nucleus may appear to prevent host 
shut-off in the cell as a whole rather than just the cytoplasm because the cytoplasm contains a much 
higher abundance of mRNA. 
Due to the vastly higher concentration of mRNA in the cytoplasm of mammalian cells compared to 
the nucleus it should be noted that minor amounts of cytoplasmic mRNA contaminating the nuclear 
mRNA fractions prepared in this study may also confound results. Therefore, further study should be 
able to confirm or refute the findings of this study that muSOX can elicit mRNA loss in both the nucleus 
and cytoplasm and whether this also occurs with KSHV SOX. Most transcripts studied also showed loss 
of mRNA in the nucleus following infection of MHV-68 ORF37stop compared to NIC. This relatively 
smaller loss of mRNA compared to that seen during infection with MHV-68 infection was significant 
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when comparing to NIC. This loss is likely attributed to the viral genome hijacking the host 
transcription machinery for transcription of its genes thereby causing some level of inhibition to host 














































6.1 Successful manufacture of recombinant viruses used in this study  
For this study recombinant SFV4-based viruses were successfully engineered to encode SFV4 with 
sequence additions or deletions in the SFV4 URE and/or CSE region(s). Recombinant viruses containing 
deletions of the CSE took ≥3 days longer (than WT viruses or viruses containing only URE deletions or 
additions) to produce cytopathic effect (CPE) following transfection  of BHK-21 cells. The rSFV4 viruses 
with CSE deletions generated some virions with mutations in virion DNA sequence that differed from 
their parental sequence at the 3’UTR however there was poor recovery of the WT CSE sequence. These 
rSFV4s (∆CSE) replicated at comparable rates to WT SFV4 and produced heterogenous plaque 
populations of varying sizes (compared to uniform plaque size produced by the other rSFV4 viruses 
used in these studies). This suggested asymmetry between virions derived from ∆CSE viruses possibly 
arising from compensatory mutations occurring elsewhere in the viral genome, however full 
sequencing of these viral genomes would be required to confirm this. This makes drawing conclusions 
and comparisons from results using viruses derived from ∆CSE viruses subject to possible confounding 
variables. Future work could investigate which, if any, mutations occurred elsewhere in the genome 
of rSFV4s with deletions in their CSE (∆CSE). This may highlight/identify which viral proteins or RNA 
sequences interact with the CSE and/or sequences which promote viral efficacy in murine cells. More 
reliable conclusions can be drawn from the comparison between SFV4-dURE, SFV4-5xURE and WT 
SFV4 which, when electroporated/transfected in susceptible cells produced CPE at similar time points 
post-transfection, produced plaques with a uniform plaque size, and sequence analysis of their 
genomes showed that their 3’UTR sequences were identical to the transfected icDNA’s. 
The MHV-68 ORF37stop mutant has been engineered and tested for reversion during previous work 
(Sheridan et al., 2014) and in this study (data not shown). This study contradicted previous findings by 
Sheridan et al. which showed that MHV-68 ORF37stop could not replicate in IFN-α/β receptor-positive 
cells (NIH/3T3). 
6.2 Sub-cellular localisation of TTR-RBPs during SFV4 infection  
Viral infection induces changes in the sub-cellular localisation of a broad set of host proteins, many of 
which are TTR-RBPs and their exact topology in the cell is often linked to their activity (Pullmann et 
al., 2007; Kishore, Luber and Zavolan, 2010). The findings of this study suggest that the nuclear 
localisation of nsP2 is unlikely to be involved in the nuclear efflux of HuR seen during SFV4 infection. 
However, it is not possible to extract concrete conclusions since SFV4-RDR, which has a mutation in 
the nuclear localisation signal (NLS) of nsP2, allows some nsP2 to enter the nucleus. Further studies 
could utilise a virus strain capable to better exclude nsP2 from the nuclear compartment such as SFV4-
RDD (Tamm, Merits and Sarand, 2008). 
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SFV4-WT infection was shown to result in HuR subcellular re-localisation to the cytoplasm, starting at 
approximately 3 hpi. An initial influx of HuR in to the cytoplasm following infection with SFV4-∆URE is 
comparable to WT however less HuR is subsequently retained in the cytoplasm during the late stages 
of infection. This suggests that a biochemical event may initiate the HuR nuclear efflux following SFV4 
infection and how much HuR is retained in the cytoplasm is dependent on the frequency of HuR 
binding sites in the 3’UTR of the SFV4 RNA. Previous work has suggested that this initial event relates 
to the phosphorylation state of HuR (Dickson et al., 2012) but the exact mechanism is yet to be 
determined. The addition of 4 additional URE copies to the 3’UTR of SFV4 increased the retention of 
HuR in the cytoplasm suggesting that the addition of UREs to other viruses or transfected nucleic acids 
may produce a similar phenotype. Further work could investigate the use of the URE sequence in 
producing this phenotype and/or acting as an element with the ability to stabilise viral RNA and/or 
enhance its translation efficiency.  
Immunostaining against HuR during infection with the rSFV4 viruses in this study also suggested that 
HuR does not predominantly co-localise with nsP3. This proposes that HuR is omitted from CPV1 
replication complexes where SFV4 negative strand synthesis takes place (Kallio et al., 2016; Kujala et 
al., 2001). This is intriguing since it suggests that HuR may not be directly required for SFV4 genome 
negative strand synthesis despite binding t o the N’terminus of the SFV4 3’UTR. Further study could 
attempt to isolate such replication complexes and determine if HuR is associated with CPV1. 
TTP and HuR have been previously shown to bind overlapping/identical uracil rich RNA sequences on 
host mRNA transcripts (Khalaj et al., 2017; Wang et al., 2016). TTP and re-
localised cytoplasmic HuR do not co-localise during infection of NIH/3T3 cells with any of the rSFV4 
used in this study, suggesting that TTP may not be binding to the 3’UTR of SFV4. Interestingly, TTP 
mRNA abundance increased during infection with all rSFV4 in this study, indicating that increased host 
TTP mRNA transcription and/or stability may be a general feature of SFV4 infection. TTP can facilitate 
host cell shut-off during infection by recruiting deadenylases (Fabian et al., 2013), RNase-L (Brennan-
Laun et al., 2014) or viral enzymes to host cell transcripts. This is observed during HSV infection when 
TTP recruits the viral host shut off RNAse (VHS) to cellular mRNAs leading to their degradation (Shu, 
Taddeo and Roizman, 2015). The possibility of TTP facilitating host cell mRNA degradation during 
alphavirus infection has not yet been investigated. In addition, the recruitment of muSOX to host cell 




6.3 Sub-cellular localisation of TTR-RBPs during MHV-68 infection 
PABPC co-localised with HuR in the cytoplasm during infection with the rSFV4 viruses. During MHV-68 
infection host HuR also localised in the same subcellular compartment as PABPC but in the nucleus 
rather than the cytoplasm. The colocalisation of HuR and PABPC during SFV4 infection is likely 
attributed to both host proteins binding to the 3’ end of viral RNA (Dickson et al., 2012). During MHV-
68 infection both HuR and PABPC in the nucleus may be bound to newly transcribed viral mRNA and 
likely bound to host mRNA. There is suspected interaction of PABPC with HuR when bound to mRNA 
that provides the bound transcript with protection from deadenylation (Nagaoka et al., 2006). AU-rich 
sequences similar to those which HuR bind to, are present in both IL-6 and AEN mRNA, both of which 
show resistance to muSOX mediated turnover (Clyde and Glaunsinger, 2011).  
 
A role for HuR in protecting host transcripts during MHV-68 infection is unlikely however since the 
addition of these specific AU-rich 3’UTR’s to reporter RNA’s fail to confer protection from muSOX 
mediated degradation (Clyde and Glaunsinger, 2011). Further study could examine the protection of 
host transcripts during MHV-68 infection in TTR-RBP KO cell lines. This would not only elucidate if the 
transcripts that are resistant to muSOX utilise host TTR-RBPs but also if host RNA-destabilising RBPs 
are involved in the muSOX mediated host RNA turnover. 
 
PABPC begins to build-up in the nucleus of MHV-68 infected cells by 8 h.p.i. In contrast to the HuR 
build-up in the cytoplasm seen during SFV4 infection, the PABPC is not retained in the nucleus by 
binding viral RNA since the PABPC nuclear build-up is observed in mammalian cells transfected with a 
muSOX expression plasmid (Covarrubias et al., 2009). The PABPC nuclear influx, which is not seen in 
this study during infection with MHV-68 ORF37stop virus, is thought to be initiated by muSOX 
expression. There are a number of mechanisms by which this could occur directly or indirectly as a 
consequence of mRNA degradation (Kumar, Shum and Glaunsinger, 2011) or a block in host mRNA 
nuclear export (Burgess et al., 2011).  
 
6.4 Interplay of HuR, TTP and RNAse-L in SFV4 infection 
Regardless of HuR being sequestered on viral RNA, an increased TTP abundance 
alone may facilitate SFV4 infection though increased instability of host mRNAs involved in the innate 
and acquired immune responses. For instance, TTP has been shown to bind to and decrease the half-
life of IFN-gamma mRNA thereby reducing the anti-viral response (Ogilvie et al., 2009). Since HuR and 
TTP co-regulate a number of host mRNA transcripts, the increased TTP mRNA abundance and the 
sequestration of HuR on viral RNAs may simultaneously promote host mRNA transcript 
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degradation. TTP has also been shown to recruit deadenylases specifically the CCR4-NOT complex (Lai 
et al., 1999; Fabian et al., 2013) and/or RNase-L (Brennan-Laun et al., 2014) to mRNA to assist in the 
degradation of the transcript. This study found that RNase-L mRNA transcript abundance in the 
cytoplasm during infection with any rSFV4 in this study was comparable to a NIC yet the abundance 
in the nuclear fraction was raised compared to NIC suggesting active transcription or a block in nuclear 
export of RNAse-L mRNA. RNAse-L activity degrades both host HuR (Al-Ahmadi et al., 2009b) and TTP 
mRNA in mammalian cells (Al-Haj, Blackshear and Khabar, 2012) whereas HuR stabilises host RNAse-
L mRNA .  
 
The interplay of these TTR-RBPs is likely to facilitate SFV4 infection. HuR binds to the viral transcripts 
while TTP may bind specific host transcripts during infection. HuR likely provides SFV4 RNA with 
protection from degradation (deadenylation) and possibly RNAse-L activity, which along with host 
deadenylases, can be recruited to host transcripts via TTP (Brennan-Laun et al., 2014).   
 
 
6.5 Interplay of muSOX generated RNA loss and PABPC during MHV-68 infection 
This study found that NIH/3T3 cells infected with MHV-68 ORF37stop virus showed comparable 
abundance of the host mRNA transcripts tested in this study to the abundance in NIC. There was a 
significantly larger reduction in host mRNA transcript abundance seen during MHV-68 infection 
compared to NIC and MHV-68 37stop infection. Only MHV-68 infection resulted in the nuclear build-
up of host PABPC. This suggests a link between muSOX, RNA loss and PABPC nuclear retention. 
Previous work has shown that muSOX causes host RNA loss and this leaves PABPC unbound to mRNA 
in the cytoplasm so its RNA recognition motif (RRM) is available to bind importin-alpha which imports 
PABPC in to the nucleus (Kumar, Shum and Glaunsinger, 2011). This study showed that over 85% of 
host PABPC resided in the nucleus of NIH/3T3 cells during late infection with MHV-68 suggesting that 
a partial loss in RNA is not solely responsible to the nuclear build-up of PABPC since host and viral RNA 
(both of which bind PABPC) are still present in the cytoplasm. PABPC is a nuclear shuttling protein and 
is exported out of the nucleus bound to mRNA (Burgess et al., 2011). Not surprisingly an additional 
cause for PABPC nuclear build-up is a block in host mRNA nuclear export (Burgess et al., 2011) which 
is thought to occur partially during MHV-68 infection (Kumar and Glaunsinger, 2010). This study did 
not find nuclear build-up of the specific host mRNA transcripts tested following MHV-68 infection 
suggesting that these transcripts are not blocked from mRNA nuclear export. Alternatively, there may 
be no net gain of mRNA abundance in the nucleus of the specific host transcripts because a build-up 
of mRNA in the nucleus is prevented by an increase in host transcript turnover and/or reduction in 
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host transcription as the transcription machinery is utilised for viral transcription. There may also be 
technical limitations in the absolute fractionation of the nucleus and cytoplasm as explained later. 
 
 
6.6 The effect of the manipulation of SFV4 URE on host and viral transcripts  
This study showed that following infection of NIH/3T3 cells with SFV4, the presence of URE in the 
3’UTR of the viral genome appears to increase the abundance of viral RNA, the translation of viral 
RNA, the amount of infectious virus particles produced and a decrease in the abundance of host 
transcripts that usually bind HuR (albeit an increase in IFN-ß mRNA). These differences are not only 
illustrated following the deletion of the URE from the 3’UTR of SFV4 but are also shown to significantly 
increase when additional UREs are added to the 3’UTR of SFV4. The effects are likely resulting from 
the ability of the URE to bind host HuR (Sokoloski et al., 2010). This is due to the known functions of 
HuR resulting in increased RNA stability and translation (Mazan-Mamczarz et al., 2003; Brennan and 
Steitz, 2001). Similar results have been shown during SINV infection (Sokoloski et al., 2010; Dickson et 
al., 2012; Barnhart et al., 2013). 
 
This study found that the higher the frequency of URE in the SFV4 3’UTR the more HuR protein is 
retained in the cytoplasm, most likely bound to viral RNA. In addition, the higher the frequency of URE 
in the 3’UTR of SFV4 the more HuR was likely sequestered on viral RNA, suggesting less HuR was 
available to bind host transcripts. This would predict that those host transcripts which usually bind 
HuR would have decreased stability and abundance. Both β-actin and caspase-9 mRNA (containing 
HuR binding sites) had decreased abundance the higher the frequency of URE in the 3’UTR of SFV4  
however the opposite was true for IFN-β. β-actin represents host transcripts that usually bind HuR in 
their 3’UTR for increased stability but are not universally and significantly affected by viral infections. 
IFN-β mRNA levels may have been increased more following infections with SFV4 containing higher 
numbers of UREs as these rSFV4s result in higher levels of viral RNA and virions which induce antiviral 
responses and production of IFN-β (Akhrymuk, Frolov and Frolova, 2016; Ryman and Klimstra, 2008; 
Randall and Goodbourn, 2008).   
 
The higher the frequency of URE in the 3’UTR of SFV4 the greater the abundance of viral RNA (nsP3) 
in murine cells that there was present early in infection (at 3 and 6 h.p.i.), also the higher the luciferase 
activity observed during infection with rSFV4s expressing Gaussia luciferase (SFV4-2SG-Gluc). This was 
also reflected in the initial number of infectious virus particles produced. These findings suggest that 
omitting the URE from the SFV4 genome inhibits viral replication by reducing the stability and 
translation of viral RNA. Furthermore, by including 4 additional copies of the URE in the SFV4 3’UTR 
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viral infection is enhanced by increasing viral RNA stability and translation.  As discussed earlier, 
following infection of murine cells, RNAse-L and tristeroprolin mRNA abundance were not affected at 
both 6 and 9 h.p.i. or just 9 h.p.i. respectively, by the frequency of UREs in the 3’UTR of the rSFV4. 
 
6.7 The effect of the manipulation of MHV-68 muSOX on host and viral transcripts  
Multiple studies have demonstrated that muSOX of MHV68 causes both RNA loss and nuclear 
retention of PABPC in mammalian cells (Covarrubias et al., 2009). This is also evident through the 
activity of SOX during KSHV infection (Glaunsinger, Chavez and Ganem, 2005) and BGLF5 (Rowe et al., 
2007) and ZEBRA (Park et al., 2014) during EBV infection. Evidence for at least two theories as to how 
the PABPC nuclear retention and host RNA loss are correlated, exist. Firstly, a loss in RNA via the action 
of muSOX causes PABPC to expose its RRM that is able to bind importin-α and thus is imported in to 
the nucleus (Kumar, Shum and Glaunsinger, 2011). Secondly, PABPC nuclear build-up leads to 
hyperadenylation of host transcripts and subsequent degradation (Kumar and Glaunsinger, 2010).  
 
This study highlighted that the nuclear build-up of PABPC observed in NIH/3T3 cells is a gradual 
process spread over the course of lytic infection and is relying on a functional muSOX protein. This 
provides evidence that unlike BGLF5 and ZEBRA (Park et al., 2014) during EBV infection there are not 
multiple viral proteins in muSOX infection that elicit PABPC nuclear retention. Since PABPC is a nucleo-
shuttling protein and is exported bound to mRNA (Burgess et al., 2011) this suggests that PABPC 
nuclear retention could also be caused by a block in mRNA nuclear export. The mRNA nuclear export 
pathway that is used for a given transcript can be different depending on the specific transcript (Cheng 
et al., 2006; Chi et al., 2013; Carmody and Wente, 2009). The mRNA maturation and splicing 
requirements can also affect which export pathway is utilised (Chi et al., 2013).  Four different host 
transcripts containing either no or multiple splice junctions were tested for nuclear build-up during 
infection and no build-up was observed. This may be a result of the nuclear and cytoplasm 
fractionation process since the cytoplasmic fraction is likely to have RNA in excess compared to the 
nuclear fraction. It also may mean that retained host transcripts are reserved for a sub-set of host 
mRNAs or the retained mRNAs are quickly degraded. This study confirmed that host transcripts 
containing either no or many splice junctions are destabilised in the cytoplasm during lytic infection 
with MHV-68 only when muSOX protein is functional. The lack of RNA loss seen during MHV-68 
ORF37stop infection was not the result of a poor infection since both MHV-68 and MHV-68 ORF37stop 
produced comparable levels of MHV-68 gpB mRNA in the nucleus and cytoplasm following infection 




The build-up of RAE1 around the nuclear envelope is evident during MHV-68 infection with a 
functional muSOX gene but not without. Interestingly MHV-68 ORF10 is known to interact with RAE1 
and Nup98 leading to a block in the nuclear export of a subset of mRNAs and their hyperadenylation 
(Gong et al., 2016). MHV-68 muSOX has been previously shown to lead to a block in mRNA nuclear 
export and hyperadenylation (Kumar and Glaunsinger, 2010) so the possibility of muSOX interacting 
directly or indirectly with RAE1 is plausible. Further work could note the 686 different mRNA 
transcripts (genes) blocked from nuclear export by ORF10 expression (Gong et al., 2016) (none of 
which were analysed for the purposes of the present study) and investigate their nuclear and 
cytoplasmic abundance following transfection of a muSOX expression plasmid. This will decipher if a 
similar subset of mRNA transcripts are inhibited from nuclear export following muSOX expression as 
those which are inhibited from nuclear export following ORF10 expression.  
6.8 Evaluation of qRT-PCR data and subcellular fractionation method  
The fractionation process despite being performed by a commercial kit (QIAGEN, PARIS kit) and 
confirmed by western blot, is not believed to be absolute in terms of mRNA contamination between 
the cytoplasmic and nuclear fractions. Since there is usually a much higher concentration of mRNA in 
the cytoplasm of NIH/3T3 cells compared to the nucleus then any small contamination of the nuclear 
fraction with the cytoplasm fraction could confound results derived from the nuclear mRNA. Since 
spliced mRNA occurs in both the nucleus and cytoplasm it is difficult to test for contamination of the 
nuclear fraction with cytoplasmic mRNA. Results from the cytoplasmic mRNA are likely to be 
unaffected by the fractionation process. Results from the nuclear mRNA could be more reliable if new 
and more stringent fractionation processes are developed in the future.  
6.9 Medical intervention for alphaviruses and gammaherpesviruses 
Alphaviruses have been utilised as vectors in the development of vaccines against a wide range of 
viruses including alphaviruses themselves (Lundstrom, 2014).  The targeting of TTR-RBPs through 
antivirals could be an avenue for future research considering that many of the TTR-RBPs activities are 
controlled through phosphorylation or other post-translational events (Pullmann et al., 2007; 
Abdelmohsen et al., 2007). TTR-RBPs are however required for normal physiological functions of 
mammalian cells and are involved in developmental processes in mammals (Colombrita, Silani and 
Ratti, 2013), immune responses (Ogilvie et al., 2009) and normal organ function (Pullmann and Rabb, 
2014). TTR-RBPs KO cell lines (Al-Haj, Blackshear and Khabar, 2012) and conditional KO mice (Gubin 
et al., 2014; Qiu, Stumpo and Blackshear, 2012) have been successfully manufactured suggesting that 
temporary inhibition of TTR-RBP function may be a feasible target for the development of novel 
antiviral drugs. The mechanisms through which viruses manipulate TTR-RBPs can also significantly 
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improve our knowledge on the functions of TTR-RBPs and how these are regulated. Given the role of 
TTR-RBPs in human cancers (Wang et al., 2016; Young et al., 2009), manipulation of their activities 
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